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Adult central nervous system tissue does not retain the ability to regenerate and restore 
functional tissue lost to disease or trauma.  The peripheral nervous system only has the capacity 
to regenerate when tissue damage is minor.  Most in vitro research investigating the 
neurobiological mechanisms relevant for enhancing nerve regeneration has focused on culture of 
neuronal cells on a 2D surface under static conditions.  We have performed studies enabling 
development of an advanced in vitro culture model based on hollow fiber-based bioreactors to 
allow high density neuronal cell networking with directed axonal outgrowth. 
The model neuronal-like PC12 cell line was initially used to compare neurite outgrowth 
after nerve growth factor stimulation between cultures under either static or dynamic conditions 
with 2D or 3D configurations.  High density PC12 cell cultures with extensive neurite outgrowth 
in three dimensional collagen gels were only possible under the dynamically perfused conditions 
of a hollow fiber-based bioreactor.  Analysis of neurite networking within cultures demonstrated 
enhanced active synapsin I+ synaptic vesicle clustering among PC12 cells cultured within the 3D 
dynamic bioreactor compared to cells cultured statically on a 2D surface.  We further used two 
different hollow fiber-based bioreactor designs to investigate primary mouse neural stem cell 
differentiation within different injectable extracellular matrix hydrogel scaffolds cultured under 
dynamic conditions.  HyStem, a cross-linked hyaluronan hydrogel, allowed structure formation 
with improved neuronal differentiation compared to collagen and Matrigel hydrogels. 
DEVELOPMENT OF HOLLOW FIBER-BASED BIOREACTOR SYSTEMS FOR 3D 
DYNAMIC NEURONAL CELL CULTURES 
Candace A. Brayfield, PhD 
University of Pittsburgh, 2008
 v 
We have made further developments in order to create a new hollow fiber-based 
bioreactor device for controlling directed axonal growth.  Excimer laser modification was 
utilized to fabricate hollow fiber scaffolds allowing control over axonal outgrowth from neurons 
within a 3D space.  Incorporation of these scaffolds into a novel hollow fiber-based bioreactor 
design will produce a device for high density neuronal tissue formation with axonal outgrowth in 
a 3D configuration.  Such a device will provide an advanced research tool for more accurate 
evaluation of neurobiological events and development of therapeutic strategies useful for 
enhancing nerve regeneration.  
 vi 
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1.0  INTRODUCTION  
Recent trends for studying neurobiological mechanisms in vitro have been to develop substrates 
that can control specific arrangements of neuronal axon growth and synaptic connectivity in 
neuronal networks.  Advantages of these neuronal cell cultures lie in the ability to separate 
multiple interactions in order to study single events.  Information gathered from studying these 
cultures could permit synthetic manipulation of events such as directed axonal regeneration.  For 
example, Aguayo et al. demonstrated that central nervous system neurons retain the ability to 
regenerate after damage given the proper environment [1, 2].  An in vitro system for neuronal 
cell cultures allowing controlled growth and signaling in a three-dimensional space could be 
used as a diagnostic tool for unveiling the permissive environments for nerve regeneration.  The 
system could specifically be used to test diffusible molecules such as drugs and therapeutic 
proteins on their effects on directed neurite outgrowth for nerve regeneration.  The responses of 
these 3D neuronal cell cultures could translate better from the in vitro models to animal models 
and clinical applications for deriving therapeutic strategies enhancing nerve regeneration. 
Much research has been performed to investigate the mechanisms involved in nerve 
regeneration in order to derive clinical solutions to these problems.  However, most of this 
research has focused on culturing neuronal cells on 2D surfaces without any compartmentalizing 
features specifically directing axonal growth.  It is likely that primary neuronal cell types 
cultured on conventional 2D plates will not maintain growth, differentiation, and synaptic 
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formation characteristics similar to that in vivo.  These unnatural culture environments might 
generate neuronal cell cultures that give atypical responses to therapeutic drugs or proteins and 
could increase the chance of failure with these therapies in patients.  The same problems apply to 
tests of these reagents in animal models where different species might respond entirely different 
than humans.  An optimal system for accurately testing therapies consisting of therapeutic drugs 
or proteins on the enhancement of nerve axonal regeneration would be one permitting use of 
human neuronal cell cultures in an environment mimicking the in vivo one. 
1.1 DISEASES/DISORDERS OF THE NERVOUS SYSTEM 
There are many diseases, disorders, and injuries affecting the nervous system that could benefit 
from a culture system allowing more accurate investigations of neurobiological mechanisms of 
these events and testing of potential novel treatments.  The nervous system provides control over 
vital functions of the body and damage to this system can result in a large range of devastating 
effects.  The potential diseases and injuries experienced within the nervous system with less than 
optimal current treatment strategies are discussed below. These clinical problems could benefit 
from advanced research methods such as using 3D dynamic in vitro neuronal culture systems.  
The advanced models could allow neuronal cell cultures that mimic brain or nerve tissue in order 
to further manipulate the cultures to study natural neurobiological events or induction of disease 
pathologies allowing testing of new therapies on their resolution of these states. 
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1.1.1 Diseases of the brain 
Many disorders within the brain could be reversed if regeneration of the brain tissue could be 
enhanced to correct the affected regions.  Many disorders due not have a cure and have only few 
treatment options available for relieving symptoms.  Traumatic brain injuries (TBI) result in 
destruction of the brain tissue leaving loss of function according to the location of the injury 
within the brain [3].  Many diseases such as Parkinson’s and Alzheimer’s diseases cause 
neurodegeneration within the adult brain and also require regeneration of neurons to restore 
function.  There are more than one million people in North America diagnosed with Parkinson’s 
disease and two to four million people with Alzheimer’s disease [3-5].  There are also diseases of 
the brain caused by disruption beginning within the vascular supply to the brain such as stroke, 
where thromboembolism or hemorrhage causes ischemic conditions leading to death of neuronal 
cells [3].  Strokes are the third most common cause of death in the United States and the most 
common cause of disability [6, 7].  Some diseases are genetically inherited, such as Batten’s 
disease or neuronal ceroid lipofuscinosis (NCL), a rare and fatal lysosomal storage disease due to 
mutations in genes encoding necessary enzymes produced by neurons [3].  Multiple sclerosis 
(MS) is an autoimmune disease caused by demyelination and degeneration of neurons within the 
brain caused by cells of the immune system attacking oligodendrocytes, the cells within the brain 
that myelinate and insulate neurons [3].  Brain tumors are relatively rare in occurrence (1.4% of 
all cancers), but can be extremely invasive with poor prognoses.  The American Cancer Society 
estimates 20,000 people within the United States will be diagnosed with a brain tumor each year  
[8].   
All of these disorders of the brain could benefit from advanced research methods able to 
investigate new therapies for either enhancing endogenous brain tissue regeneration or therapies 
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able to replace dysfunctional cell products or lost tissue.  Current treatments for Parkinson’s 
disease (PD) include a drug called Levodopa which allows neurons to make and replenish the 
decreased dopamine neurotransmitter lost in this disease [3].  However, late stage PD continues 
to have a poor outcome in patients and newer treatment strategies should not focus only on 
dopamine deficiency [9].  There are currently no treatments to slow the progression of 
Alzheimer’s disease (AD), but there are four FDA-approved medications able to treat symptoms 
[3].  Many novel therapies in clinical trials have moved forward due to their positive outcomes 
treating transgenic mouse models of AD [10].  Strokes occur with relation to poor cardiovascular 
conditions in which there are many preventative measures possible to prevent strokes and 
therapies after strokes revolve around the prevention of further strokes.  The most promising 
therapies for stroke aim to protect further damage to neurons from the ischemic conditions 
created by stroke or to replace the lost tissue due to these conditions.  Currently, there are many 
clinical trials for neuroprotective reagents such as nitric oxide [11].  However, some of the most 
promising trials involve use of autologous adult stem cells, mostly bone marrow derived, in order 
for the transplanted cells to facilitate neuroprotection [7].  There are no effective therapies for 
Batten’s disease and are fatal after a long period of disability [12].  Although in March 2006 the 
company Stem Cells Inc. initiated a clinical trial treating Batten’s disease with human fetal 
brain-derived neural stem cells [13].  The most popular treatment currently for MS is doses of 
the immunomodulatory therapeutic protein interferon-beta, but the response to this therapy is 
only partial and dosing has not fully been optimized [14].  Newer treatments in clinical 
development include monoclonal antibodies that deplete or inhibit immune cells [15].  However, 
there are concerns that these long-term therapies will have serious complicating side-effects 
where protective and regenerative therapies are still desired [16]. 
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1.1.2 Spinal cord injuries 
According to the National Spinal Cord Injury Database, disabling spinal cord injuries occur in 
around 11,000 Americans yearly.  Approximately 250,000 Americans are already living with 
spinal cord injuries (SCI) [17].  Contusions are the most common type of injury due to 
mechanical damage to nerve tissue with following cell necrosis [18].  Inflammation following 
the injury can further lead to secondary injuries such as oligodendrocyte apoptosis.  The gap 
created within the spinal cord at the site of injury fills with a fluid-filled cyst associated with 
secondary complications. Eventually glial cells migrate through and contribute to scar formation 
within this gap creating a barrier preventing nerve regeneration [18].  These events contribute to 
a hostile environment created at the site of injury that inhibits regeneration of the spinal cord.  
The current theory holds that the central nervous system has the ability to regenerate with axonal 
outgrowth from the proximal spinal cord reconnecting with the distal ends, but is only inhibited 
by the glial scar, inflammatory conditions, and inhibitory molecules.  Research has been focused 
on better understanding this environment and factors contributing to inhibition of spinal cord 
regeneration. 
The only way for functional restoration to occur is for treatments to result in proximal cut 
nerve ends reconnecting with their distal targets between the gap created from the injury.  
Immune and glial cells secreting molecules inhibitory to axonal regeneration has led traditional 
research to investigate drugs or therapeutic proteins that block or overcome these molecules in 
order to treat SCI.  Regenerative medicine with tissue engineering has taken the approach to 
research engineered biomaterial scaffolds for enhancing axonal growth, controlled local release 
of neurotrophic factors, or transplantation of cellular therapies within animal models of SCI.  The 
environment created after the spinal cord injury in vivo most likely requires optimal therapies to 
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be a combination of strategies that neutralize the inflammatory environment and allow neurons 
to reconnect in order to restore function of the spinal cord. 
Despite the overwhelming difficulties of a new therapy to achieve functional recovery in 
spinal cord injuries, it has been noted that injuries leaving only 10-15% of spinal cord white 
matter results in significant functional sparing [18].  This small amount of tissue preservation 
gives hope that even a small degree of nerve regeneration from a new therapy could be a 
valuable treatment.  Over half of the SCI cases since 2000 have been reported as functionally 
incomplete due to some sparing of the spinal cord tissue after injury [17, 18].  The secondary 
injuries resulting from inflammation and cascading events following injury can damage the 
conserved functioning tissue.  According to Becker et. al., these secondary injuries are the 
current primary goals of any SCI treatments including a cellular therapy [19].  There are many 
basic benefits to using a cell therapy to treat SCI than the more complicated goal of creating 
functional integrated neurons.  These benefits could be the neuro-protection or facilitation of re-
growth of existing neurons by trophic support from transplanted cells with the secretion of anti-
apoptotic factors, growth factors, angiogenic factors, inflammatory inhibitors, or deficient 
neurotransmitters [18, 20, 21].  Some associated symptoms/complications with SCI are spasticity 
of muscles, post-traumatic syringomyelia (PTS), autonomic dysreflexia, chronic pain, loss of 
bowel and bladder control, and sexual dysfunction [18].  Since 2000 the leading cause of death 
of patients with SCI surviving the first 24 hours after injury are due to respiratory diseases, 
mainly pneumonia [17].  The cause being due to the functional loss of a simple cough reflex 
[18].  If any improvements with new treatments could prevent any of these secondary 
complications it would be a tremendous clinical gain.  The current treatments for SCI are high 
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dose corticosteroids, spine stabilization, and rehabilitation which usually help prevent further 
problems [22]. 
1.1.3 Peripheral nerve injuries 
Unlike the central nervous system (CNS), the peripheral nervous system (PNS) has the ability to 
regenerate and repair small segments of damaged nerve tissue.  The mediators involved in nerve 
regeneration after an injury is very different within peripheral nerves.  First, there are different 
cell types within the CNS and PNS.  Astrocytes are the reactive cells within the CNS that 
contribute to the inhibitory glial scar formation within the CNS.  Also, oligodendrocytes are the 
myelinating cells of the CNS, but have been shown to deposit myelin-associated glycoproteins 
that are some of the inhibitory molecules deposited after CNS injuries.  Within the PNS, there 
are no astrocytes because the normal immune system cells are able to assume the role of 
scavengers aiding in repair.  Furthermore, Schwann cells are the myelinating cell types of the 
PNS instead of the CNS, which significantly contribute to the ability of the PNS to regenerate 
[23].  Peripheral nerves have the ability to regenerate at a rate of 1-5 mm per day.  However, 
damage of peripheral nerves leaving gaps greater than 4 mm long surgical intervention is 
required for repair.  Approximately 100,000 patients undergo surgical procedures for correction 
of the peripheral nervous system each year [24].  The standard technique in plastic surgery for 
reconstruction of very short nerve gaps is to surgically reconnect the severed nerve ends 
together, but if the gap is too long this will create tension and instead an autologous nerve graft is 
used to bridge the gap [25].  The autologous nerves used for these grafts are typically sensory 
nerves that leave donor site sensory loss and morbidity.  Therefore, engineered strategies have 
been developed to create implantable nerve guidance channels made from either natural matrices 
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or biodegradable synthetic polymers.  There are currently four different FDA approved nerve 
guidance channels available for use in reconstruction of peripheral nerve gaps up to 4 cm in 
length [25].  
 Initial studies of peripheral nerve regeneration events have been performed with 
transection of rat sciatic nerves with following connection to synthetic nerve guidance channels 
in order to observe the regenerating tissue within the channels at different time points.  The 
sciatic nerve within the rat is the largest peripheral motor neuron and has been utilized by many 
researchers to study events related to peripheral nerve regeneration.  In the first few days after 
injury the process of Wallerian degeneration occurs where distal axons degenerate, Schwannn 
cells break down their myelin sheath, and macrophages remove debris [26].  Studies using 
impermeable channels (mostly made from silicone), preventing external factors from affecting 
the sciatic nerve regeneration, have observed no nerve regeneration if the distal nerve stump is 
placed at a distance greater than 10 mm from the proximal nerve ending or if the distal end of the 
channel is capped demonstrating the importance of the distal nerve ending in enhancing 
regeneration [27, 28].  However, Aebischer et al. discovered some tissue regeneration in semi-
permeable channels in blind-ended tubes [29].  Also, the molecular weight cutoff of the channel 
significantly affected the ability of the regenerated tissue to have healthy myelinated axons 
where this was inhibited using channels with a higher molecular weight cutoff.  Some have 
demonstrated that contribution of factors and cells influencing the axonal regeneration from the 
proximal nerve stump is equal from both nerve ends [30].  Many groups have observed the 
sequence of events that occur within impermeable silicone tubes forming a connection between 
the proximal and distal nerve stumps.  Temporal changes of the events differ according to the 
length of gap created between the two nerve stumps, but the following describes events in a 
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shorter <6 mm gap.  Within the first few days after transection and tube connection, a fibrin 
matrix is secreted within the tube to be used as a scaffold for infiltrating cells [31].  After one 
week perineurial cells migrate along the fibrin matrix through the tube and form a perineurial 
tube.  Next, multiple cells types infiltrate the tube such as endothelial cells, pericytes, fibroblasts, 
and most importantly Schwann cells [31, 32].  Schwann cells and fibroblasts can secrete multiple 
factors of neurotrophins, neurokines, and growth factors to enhance the axonal growth through 
the tube [33-35].  After a few weeks within short gap distances, regenerated nerve fascicles can 
be seen with blood vessels and myelinated axons. 
1.2 NEURAL ENGINEERING 
Section 1.1 described major disorders and injuries experienced within the central and peripheral 
nervous system.  Also included were the current treatments available for these disorders where 
almost none of the diseases mentioned have therapies providing complete long-term cures or 
allowing restoration of complete functional recovery of the brain or nerve tissue.  This section 
further discusses current research areas focusing on development of novel therapies for nerve 
regeneration.  
1.2.1 Cell therapies for enhancing nerve regeneration 
Many of the neurological disorders result in functional impairments of either sensory or motor 
nerve tissue.  One possible strategy for restoring nerve tissue function is to completely replace 
the lost tissue with transplantation of exogenous cells or tissue.  Stem cell research has allowed 
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development of many potential therapeutic sources for cell therapies for nerve regeneration and 
tissue restoration.   
In 1997 clinical trials began testing the the safety and feasibility of intraspinal 
transplantation of human fetal spinal cord (huFSC) tissue in a small number of patients in 
Gainesville, FL, Sweden, Denver, CO, and Russia [18].  Animal experiments leading to these 
trials showed extensive filling of cavitation in contusion injuries with injections of dissociated 
fetal CNS cell suspensions [18].  The patients used in the trial had previously suffered post-
traumatic syringomyelia (PTS) so the goal was to observe improvements in decreasing cyst 
formation [18].  Several showed prevention of cyst formation with one patient having gait 
performance improvement.  These clinical trials, however, came to a close after the FDA 
released a new memorandum in November 30, 2000 stating that Investigational New Drug 
applications were required for the use of fetal cells and tissues in human subjects [18].  Fetal 
tissue still could lead to a successful treatment for certain complications of SCI and should not be 
left behind.  However, the disadvantages of this cell source are the non-uniformity in different 
tissue samples and the low availability of obtaining such grafts. 
Embryonic stem cells (ESCs) can be derived from the inner cell mass of cultured 
embryos at the blastocyst stage [20].  These cells have the ability to divide into a self-renewed 
pluripotent parent cell and lineage-specific progenitor that may further divide into a specific 
differentiated cell type.  The most advantageous feature of ESCs for creating a cell therapy for 
nervous system disorders is that the neuronal lineage is the default differentiation pathway of 
these cells.  This might allow the easiest method for obtaining functional neurons that may 
integrate into the damage area after transplantation.  The major disadvantage to ESCs are that the 
major requirement of the cells being designated as stem cells lies in their ability to form multi-
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lineage cell teratocarcinomas after injection into mice, which means a significant chance for this 
same outcome in patients if the cells are transplanted in their undifferentiated state.  The 
disadvantage again of having to transplant the ESCs as already differentiated neuronal cell types 
is that they will be post-mitotic and the amount of cells added to the injured site will be the 
maximum number of cells that will need to fill the lesion and recreate all of the functional 
circuitry.  Also, mature neurons are fragile which limits their capacity for surviving after 
transplantation into the hostile diseased or trauma environment. 
Despite these disadvantages, many researchers have shown promising results with in 
vitro differentiation and in vivo animal model experiments.  In vitro differentiation of ESCs has 
shown that specific protocols can easily differentiate the cells into a specific neuronal cell type.  
Tang et. al. were able to develop a protocol for differentiating ESCs specifically into astrocytes 
[36].  Astrocytes could be beneficial in treatments because these cells can secrete many different 
desirable trophic factors, however they also have the ability to secrete undesirable factors that 
might further hinder nerve regeneration like Interleukin-6 (IL-6) [37].  A more relevant neuronal 
cell type in treating demyelinating diseases is the oligodendrocyte. These cells provide the 
myelin sheath necessary to insulate and protect the neurons spared after injury.  Billon et. al. 
were able to develop a protocol for differentiating ESCs into oligodendrocytes [38].  Liu et al. 
were able to treat ESCs in vitro to make ‘oligospheres’ that contributed to myelination of 
neurons in the spinal cords of shiverer mice that lack the ability to form mature myelin [39].  The 
most important work to date with ESCs in treating SCI is the ability of these cells to differentiate 
into functional motor neurons that integrate with the host spinal cord.  As early as 1999, 
McDonald et al. showed mouse ESCs survived and differentiated into astrocytes, 
oligodendrocytes, and neurons after transplantation into injured rat spinal cords [40].  These rats 
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showed hindlimb weight support and partial hindlimb coordination.  In vitro differentiation of 
ESCs into motor neurons can be achieved using retinoic acid and Shh [20].  Most recently, 
Deshpande et. al. published experiments showing recovery of paralysis in rats from 
transplantation of motor neuron-committed ESCs with the evidence of hundreds of axons 
extending from the spinal cord to peripheral nervous system [20, 41].  Recently, Geron 
Corporation announced they are initiating a Phase I clinical trial treating patients with spinal cord 
injuries using their product of human embryonic stem cel-derived oligodendrocytes 
(www.geron.com). 
Another source of cells useful in treating nervous system disorders via cell therapy are 
olfactory ensheathing cells (OECs) isolated from the adult olfactory bulb and possibly a patient 
biopsy of the olfactory mucosa [42].  An advantage of OECs is that serum-free media containing 
FGF2, forskolin, and heregulin-beta1 conditioned by astrocytes will allow significant growth of 
the OECs into a large amount of cells [42].  Amazingly, over 400 people with SCI throughout 
China, Portugal, and Australia have undergone fetal OEC transplantations [18].  However, there 
are no significant published results from these trials and the follow-up examinations only went 
out to 8 weeks post-transplantation [18].  Hopefully future clinical trials will allow collection of 
more useful data.  ProCord, developed by the company Proneuron Biotechnologies, is a product 
created by culture of a patient’s autologous macrophages that are specifically activated by 
culturing with the patient’s skin biopsy.  This product is currently FDA approved and in Phase II 




  Another major cell source for treatment of nervous system disorders is bone marrow-
derived mesenchymal stem cells.  Clinical trials by Sykova et. al. in Prague were initiated in 
2003 using MSC intravenous delivery into 9 patients with SCI [18].  6 patients seem to have 
some improvement, but still within the range of spontaneous recovery.  One patient had 
significant recovery with the reappearance of motor-evoked potentials.  There are currently 
multiple clinical trials using bone marrow-derived adult autologous stem cells for treating stroke.  
There are also a few using these cells to treat multiple sclerosis. 
The most promising cell source for treating nervous system diseases and injuries are 
human neural stem/progenitor cells isolated from human fetal or adult central nervous system 
tissue.  These cells retain the ability to specifically differentiate into neurons, astrocytes, or 
oligodendrocytes directly applicable to restoring function to nervous system tissue.  The work 
performed in Chapter 3 has focused on research using mouse neural stem cells demonstrating the 
need to elaborate on the properties and capabilities of these cells in order to optimize therapeutic 
strategies for transplantation of human neural stem cells.  Further details on the potentials and 
previous research using these cells are described in the introduction of Chapter 3.  We have used 
the hollow fiber-based bioreactor systems for testing mouse neural stem cell differentiation under 
3D dynamic conditions, mimicking the environment observed by the cells after transplantation in 
vivo.  We believe the bioreactor systems provide an advanced research tool replacing traditional 
2D cell culture or animal experiments allowing eventual culture of human neural stem cells for 
further elaboration on optimizing protocols for transplantation of these cells. 
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1.2.2 Chemotropic factors  
During embryonic nervous system development many chemical factors are secreted in the 
surrounding areas to properly pattern the nervous system by either attracting or repelling 
neuronal cell migration or axonal growth to form the proper functional synapse connections 
between neurons throughout the body [43].  More specifically, gradients of factors can attract or 
repel the cells or axons in order to lead them to the proper final special destination throughout 
the developing tissue.  The ends of growing axons, or axonal growth cones, express multiple 
receptors that enable sensitivity to these factors for directing the growth of the axon to the proper 
target.  The protein family of neurotrophins includes chemotropic factors such as nerve growth 
factor (NGF), glial derived neurotrophic factor (GDNF), brain-derived neurotrophic factor 
(BDNF), ciliary neurotrophic factor (CNTF), and others such as NT3 that are present in the 
developing nervous system to act as attractive molecules directing axonal growth [44-47].  Other 
protein families involved in axonal attraction are netrins and slits [48].  Gradients of these 
molecules exist during development and can direct the axonal growth cones and migratory neural 
progenitor cells towards the higher concentrations.  Semaphorins are a group of proteins that act 
as inhibitory molecules to axonal growth cones [49].  Other major inhibitory molecules include 
ephrin-A5, wnts, and repulsive guidance molecule (RGM) proteins [49].  These molecules also 
act by binding to receptors on axonal growth cones, but initiate signal cascades that encourage 
growth cone collapse and retraction [49].  They also can act to inhibit axonal growth by lining 
the surroundings of the desired path [48]. Chondroitin sulfate proteoglycans (CSPGs), Nogo-A, 
myelin-associated glycoprotein (MAG), and oligodendrocyte myelin glycoprotein (OMGp) are 
repulsive molecules present in adulthood with upregulation after injury to the CNS [49].  These 
molecules aid in the prevention of nerve regeneration within the damaged CNS tissue. 
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 These natural mechanisms have initiated development of drug or protein therapies for 
enhancing nerve regeneration by applying gradients of these factors to attract the axons towards 
their distal targets for enhancing nerve regeneration.  A small clinical trial consisting of three 
patients with Alzheimer’s disease in Sweden in the 1990s were given intracerebral doses of 
NGF.  Some results in cognitive tests were improved, but was associated with side-effects of 
weight loss and pain [47].  Also, animal studies testing rhNGF doses revealed non-malignant 
Schwann cell hyperplasia [47].  There have been some early trials of BDNF administration to 
patients with amyotrophic lateral sclerosis (ALS) showing possible improvements [47].  A 
preclinical trial has been recently implemented involving NT-3 administration to patients with 
Charcot-Marie-Tooth type 1A (CMT1A), a demyelinating syndrome [50].  However, direct 
administrations of these neurotrophic growth factors have the ability to stimulate neuronal 
plasticity in undesirable ways.  Further research is necessary for fully understanding effects of 
the amounts and combinations of these factors on neuronal plasticity in order to benefit clinical 
therapies. 
1.2.3 Substrates for directing axonal outgrowth 
The topography of biomaterial surfaces used for directing neurite outgrowth is currently a useful 
topic in nerve tissue engineering in order to devise methods for improving nerve regeneration in 
vivo.  Hirono et al in 1988 was one of the first groups to realize patterned substrates could 
control axonal outgrowth in neuronal cell cultures in vitro [51].  Many groups since then have 
studied different methods for creating structured biomaterial surfaces for controlling axonal 
guidance.  One extensively studied method in generating these structured surfaces has been the 
microfabrication technology of photolithography.  This method can be used to create different 
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topographical structures on a surface to construct grooved pathways for specific axonal growth 
[52-56].  Another attractive method for surface patterning has been the technique of microcontact 
printing.  Wheeler et al. used microcontact printing to direct hippocampal neuronal growth on 
lysine and laminin patterned surfaces [57].  Others have created microcontact printed surfaces 
with even more complex patterns using adhesive proteins and molecules [58-62].  Thiebaud et al. 
have combined photolithography and microcontact printing in order to create a microfluidic 
device for continued in vitro growth of specific neuronal cell arrangements [63].  Using these 
two methods to pattern substrates in more than two dimensions can be very complex.  It is 
possible to stack layers of the modified surfaces to create three-dimensional scaffolds, but this 
has not yet been achieved for neuronal cell culture scaffolds with the exception of creating a tube 
out of the layer for use as in vivo peripheral nerve guide conduits [52, 64, 65].  A technique that 
could also be scaled up to achieve three-dimensional neuronal in vitro scaffolds is that of 
polymer/extracellular matrix protein ink-jet printing [66].  These studies will all help lead to the 
establishment of scaffolds used for improving neural engineering strategies for either in vitro 
studies controlling axonal growth or in vivo nerve regeneration therapies. 
 
1.2.4 Nerve guide conduits 
Nerve guides are typically hollow tubes used to enhance regeneration of damaged peripheral 
nerve segments.  The proximal and distal cut nerve stumps are sutured into the ends of the tube.  
The lumens of the nerve guides provide the mechanical contact guidance cues for directing the 
proximal nerve end to regenerate towards its distal target.  There are currently five FDA 
approved commercially available nerve guides used clinically for peripheral and cranial nerve 
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repair [24, 25].  NeuraGen and NeuroMatrix NeuroFlex are two of these nerve guides comprised 
of collagen type I.  Neurotube and Neurolac are the other two of these nerve guides which are 
composed of synthetic degradable polyester polymers.  SaluBridge is a nerve guide consisting of 
a polyvinyl alcohol hydrogel [24].  Clinical use of these nerve guides is limited by the gap 
distance between damaged nerve endings, ranging from less than 2.5-4 cm in length for the 
different guides.  Neurotube is currently the preferred guide used clinically because it is offered 
with the longest length of 4 cm, is the least expensive, and has more clinical data available.   
Even with the availability of these products for short peripheral nerve gaps, surgeons 
often still prefer correction with a second surgery removing a sensory autologous nerve for use 
as a graft bridging the defect gap.  The nerve guides have not been able to demonstrate results 
superior to the autologous nerve use and are also a much more expensive solution.  Further 
research and development of novel advanced nerve guides has therefore been necessary to create 
a product allowing enhanced functional restoration after nerve regeneration when compared to 
autologous nerve grafts.  Aspects investigating in creating a more superior nerve guide have 
ranged from varying the nerve guide conduit material properties, dimensions, and configurations 
[29, 67-74].  Methods to further improve functional nerve regeneration within these conduits 
have ranged from surface modifications or natural matrix incorporation (collagen or fibrin gels) 
to enhance cell adhesion, growth factor immobilization to conduit walls or microcarrier 
incorporation, and use of novel biomaterial surfaces i.e. electrically conducting polymers [75-
90]. 
In order for us to develop an in vitro culture model used for analyzing directed neurite 
outgrowth, we have capitalized on the nerve guide concepts.  In Chapter 4 we have developed a 
scaffold able to be incorporated into a hollow fiber-based bioreactor device in order to control 
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and manipulate directed neurite outgrowth within the device.  The scaffold is based on a nerve 
guide consisting of a porous, cylindrical polymer conduit where contact guidance directs axon 
growth through the lumen. 
1.3 PREVIOUS NOVEL NEURONAL CULTURE SYSTEMS 
1.3.1 3D dynamic bioreactors 
The ultimate goal of tissue engineering is to synthetically re-create tissues in vitro that are useful 
in clinical transplantation for reconstructing or replacing damaged tissue in the body lost to 
trauma or disease.  However, creating a tissue implies a thick composite of cells and matrix in a 
3D configuration instead of the monolayers achieved with traditional cell culture methods with 
cells grown on a 2D surface.  These traditional methods rely on nutrition of cells with medium 
nutrients and oxygenation via passive diffusion of molecules such as glucose, amino acids, and 
O2 with a thin layer of medium stagnantly covering the monolayer of cells on the bottom of the 
culture dish with allowing the diffusion of gas.  However, as the layers of cells increase in order 
to build the cells into a tissue, under static culture conditions diffusion of nutrients to the inner 
layers of cells becomes limited by the cells on the outer layers consuming these products before 
they are able to diffuse to the inner cell layers.  This could partially be solved by the addition of 
more medium to the culture, but a thicker layer of medium will begin to prevent diffusion of gas 
transport of O2 and CO2 to and from the cells.  Therefore, advanced culture methods have been 
implemented in order to improve nutrition and oxygenation conditions for creating tissues in 
vitro. 
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 An efficient method for improving nutrition conditions is to surpass static conditions 
relying on diffusive transport by adding features allowing dynamic pressure-driven convective 
transport with flow of medium in the cultures.  Advanced culture systems controlling dynamic 
flow of medium have been termed bioreactors.  One of the first groups to develop a mammalian 
cell culture system with dynamic medium flow through the system was Kruse et al. in 1963 [91, 
92].  These authors also coined the term “perfusion” to indicate continuous medium flow through 
the cell culture system with mechanical pumps.  The perfusion system within this work consisted 
of tubing connected to a traditional cell culture flask in which medium perfusion was performed 
through the flask via pumping.  The perfusion enabled culture of tumor cells up to 17 
monolayers thick [92]. 
 The term bioreactor has been used because initial bioreactors were based on traditional 
designs of reactors used for chemical engineering.  One of the most commonly used bioreactors 
still used today are spinner flask devices.  Spinner flasks are based on the traditional reactor 
design for continuous stirred tank reactors (CSTRs) used for batch processing of chemical 
reactions.  These systems require culture of cells suspended within a large volume of medium 
contained in a closed glass beaker (flask).  The convective transport of medium nutrients is 
provided by an impeller extending into the flask able to mechanically be rotated to stir the 
suspended cells cultured within the medium.  Typically adherent cell types are cultured on 
microcarrier beads that are also cultured in suspension within the spinner flasks.  In 1983 Butler 
et al. described culture of fibroblasts attached to microcarriers in a spinner flask device with 
incorporation of connected tubing used to additionally perfuse medium through the flask [93]. 
 Researchers investigating development of scaffolds useful in tissue engineering allowing 
tissue formation within these scaffolds have utilized direct perfusion bioreactors.  These systems 
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are typically based on a single compartment supporting and immobilizing a cylindrical shaped 
cell seeded scaffolds with connections on the top and bottom for tubing used to pump medium 
flow through the compartment for direct perfusion of the scaffold.  The cells seeded on scaffolds 
cultured in direct perfusion bioreactors observe shear forces from the flow directly around the 
cells.  Bone tissue engineering has benefitted from the use of these bioreactor designs because 
cultured osteoblasts have been demonstrated to increase their bone matrix secretion with the 
shear flow of direct perfusion bioreactor cultures compared to static cultures [94-97].  The 
concept of direct perfusion bioreactors has been further adapted for culture of tissue engineered 
vascular grafts, where medium is perfused with pulsatile flow through the lumen of a hollow 
tube scaffold resembling a blood vessel with blood flow.  Niklason et al. have been able to 
develop this type of bioreactor in creating superior tissue engineered vascular grafts [98]. 
 A table listing some examples of different bioreactor designs and constructions is shown 
in Table 1.  Another well-established bioreactor design is a rotating wall vessel bioreactor.  
These bioreactor designs were first developed by NASA to culture cells on microcarriers in 
suspension experiencing microgravity environments [99].  Saini and Wick have developed a 
similar bioreactor consisting of rotation of concentric cylinders containing medium with 
immobilized constructs on the inner walls observing shear flow from the rotation of the cylinders 
useful for creating cartilage tissue engineered constructs [100, 101].  A more complex bioreactor 
design useful for small scale hepatocyte cultures have been developed by Griffith et al. to be 
used as a diagnostic tool for toxicology and drug screening [102, 103].  Fabrication of these 
bioreactors have utilized the concepts of photolithography and micropatterning to achieve 
channels through a substrate creating control over directional flow through the device [104]. 
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Advanced bioreactor designs achieve control over both medium perfusion and gas 
exchange through the cell compartment of the system.  Most of the bioreactor designs focusing 
on perfusion of medium rely on the use of silicone tubing which is permeable to gas and require 
maintenance of these bioreactors in a humidified incubator with oxygenation of the medium by 
diffusion of gas into the medium reservoir and tubing to dissolve in the medium. Also, some 
designs incorporate an additional source of gas able to bubble into the medium reservoir to 
dissolve oxygen into the medium.  Bioreactor designs based on woven sets of semi-permeable 
hollow fibers compared to direct perfusion and rotating wall vessel suspension designs have the 
advantage of providing both uniform nutrient and uniform gas exchange to the entire cell 
compartment volume.  Medium and gas can be perfused through the hollow fibers running 
through a cell compartmenter where flow exchange through the porous walls of the fibers 
delivers nutrients and O2 to the cells within the surrounding compartment and removes waste 
products and CO2.  These bioreactors offer a homogeneous environment with uniform nutrition 
and oxygenation for sustained long term cultures of cell types not requiring mechanical stimuli.   
There have been many reports on the use of hollow fiber bioreactor designs used for 
hepatocyte cultures [105-110].  These hollow fiber bioreactors were first developed to be used as 
bioartificial livers or bioartificial kidneys with either hepatocyte cultures or kidney epithelial 
cultures with clinical use for extracorporeal organ support bridging patients with liver or kidney 
failure until supplied with a transplanted organ [111-114].  Hollow fiber-based bioreactors are 
preferable to other designs for the culture of soft tissues due to transport of medium via hollow 
fibers creating lower shear stresses compared to direct perfusion systems.  The cell cultures 
within these devices have often shown improved tissue formation and structure by the inoculated 
 22 
cell types compared with 2D cultures [115-118].  A table of bioreactor systems that have reached 
clinical trials for use in bioartificial kidney or liver support of patients is listed in Table 2. 
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Table 1. Listing of some examples of publications describing different bioreactor designs used for in vitro 
cell cultures with dynamic conditions. Literature citations for these publications are as follows [104, 119-151]. 
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Table 2. List of hollow fiber-based bioreactor systems used for kidney or liver support systems that have 
entered clinical trials. Literature references cited are the following [107, 114, 152-158]. 
 
 
1.3.2 Directed neurite/axonal outgrowth models 
Suspension bioreactors have already been used to culture neuronal precursor cells, neural 
progenitor cells, or neuronal like cell lines to achieve tissue-like structures that more closely 
resemble natural neuronal tissues compared to 2D cultures [159-161].  Lelkes et al. have 
demonstrated enhanced neuronal like differentiation of the PC12 cell line within the NASA 
designed rotating wall vessl bioreactor [162].  Lin et. al. recently demonstrated synapsin I+ 
staining in differentiated neural progenitor cells growing within collagen constructs suspended in 
the NASA designed rotating wall vessel bioreactor [163].  These stirred tank and rotating wall 
vessel systems can easily allow manipulation of the culture environment to change important 
features such as cell aggregate size and viability, but are unable to address the functional 
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neuronal property of directed neurite outgrowth [161, 164, 165].  3D in vitro neuronal culture 
work in the past was mainly dedicated for preliminary testing of implantable tissue engineered 
constructs, but not for the goal of long term in vitro neuronal cultures [166-169].   
 Recently some groups have begun developing in vitro culture models as a first step 
toward producing long-term 3D neuronal cell interactions in vitro.  Microfluidic devices with 
channels for directed neuronal culture growth have been investigated as initial devices for 
establishing long term 3D neuronal interactions in vitro [63, 170, 171].  Some other 3D neuronal 
cell cultures have been based on the incorporation of collagen hydrogels or synthetic 3D matrices 
[54, 172-174].  All of this work will significantly contribute to creating long term 3D in vitro 
neuronal cell culture devices used as tools for studying neurobiological mechanisms. 
The hollow fiber-based bioreactors used in the work presented within this thesis are 
current versions of those described in Table 1 and Table 2 by Gerlach et al.  We have used 
laboratory scale versions of these four compartment hollow fiber-based bioreactors in order to 
culture both the PC12 cell line and mouse neural stem cells.  The bioreactors have allowed high 
density cultures of the PC12 cells with continuous tissue formation throughout the cell 
compartment.  The bioreactors have also provided a tool for testing behavior of mouse neural 
stem cell differentiation with 3D dynamic conditions similar to the in vivo environment in order 
to facilitate development of strategies using these cells clinically. 
Further developments have been made to modify the hollow fibers used for perfusion in 
the bioreactors to be used also as scaffolds for directing neurite/axonal outgrowth.  These fiber 
scaffolds can be incorporated into novel hollow fiber-based bioreactor systems that can achieve 
cultures of high density of neuronal cells into tissue like structures with the additional feature of 
directing axonal growth in a 3D space through the high density cultures.  We believe this will 
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allow an advanced culture model as a diagnostic tool for enhancing assessment of 
neurobiological mechanisms such as screening for therapeutic factors for nerve regeneration and 
for observing behavior of neural stem cells in a 3D dynamic environment. 
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2.0  HIGH DENSITY NEURONAL CELL GROWTH AND NEURITE NETWORK 
FORMATION IN A 3D DYNAMIC HOLLOW FIBER-BASED BIOREACTOR 
COMPARED TO 2D AND 3D STATIC CULTURES 
2.1 INTRODUCTION 
2.1.1 Non-neuronal tissue formation within 3D dynamic cultures 
The field of tissue engineering has endeavored to create either improved tissue culture models 
for in vitro studies or functional tissue constructs that may be used clinically in humans to 
replace lost or damaged tissue.  This field has necessitated advanced methods beyond traditional 
2D static cell culture methods in order to overcome diffusion limitations when scaling up in the 
z-direction in addressing tissue functionality.  Many reports have documented the inability to 
generate tissue constructs in vitro with thicknesses greater than 100 µm having continuous viable 
cellular content by static culture methods that allow transport of nutrients and gas by diffusion 
alone [175-182].  There are two possible solutions to this problem for generating tissues in vitro.  
The most desirable goal in order to produce transplantable tissues for clinical therapies is to 
achieve a vascularized tissue for blood perfusion that permits incorporation into the surrounding 
host tissue and continued survival.  However, this solution is tremendously complicated due to 
the ability to first tissue engineer viable and stable blood vessels that are composed of multiple 
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cell types and matrix components and second to achieve integration into the host blood 
circulation after transplantation.  The earliest resolutions to overcoming the diffusion limitations 
in static cultures were to create systems with dynamic environments that sustain convective 
transport, termed bioreactors.  Many different bioreactor designs with different flow patterns 
exist today and were elaborated previously in section 1.3.1.  Bioreactors allow the most effective 
solutions for generating thick 3D tissue constructs.  Bioreactor systems can especially be 
designed for creating and sustaining better in vitro models to more accurately study the desired 
tissues. 
There are numerous previous demonstrations of enhancing tissue formation among non-
neuronal cell types within bioreactor systems having a 3D culture space under dynamic flow 
conditions.  Carrier et al. in 1999 were one of the first groups to systematically compare 
bioreactors (with different methods of creating dynamic flow by stirring) to static control 
cultures for cardiac tissue engineered constructs [176].  They were able to show dynamically 
created tissues had higher cellular content where convective transport allowed more aerobic 
metabolism than the static cultures limited to transport by diffusion resulting in anaerobic 
metabolism.  Kim et al. have demonstrated increased elastin and collagen production from 
smooth muscle cells seeded on polyglycolic acid (PGA) scaffolds when cultured in spinner 
flasks having dynamic flow versus control cultures under static conditions [183].  Chondrocyte 
growth rates on PGA scaffolds have been shown to stop at 3 weeks of culture whereas well-
mixed bioreactor cultured constructs maintained high growth rates over 7 weeks with normal 
tissue cell densities [180, 181].  Many groups have seen enhanced tissue-like growth of cell 
bodies among tumor cells when cultured in 3D matrices [184, 185].  Bone tissue engineering has 
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benefitted from direct perfusion bioreactors stimulating better osteoblast growth and matrix 
production on 3D scaffolds compared to statically cultured scaffolds [94-97]. 
2.1.2 Potential limitations of traditional 2D cell culture 
Traditional neuronal cell culture systems only allow axonal projection and synapse formation 
between cells on the two dimensional culture plate surfaces.  However, in an in vivo environment 
neuronal cells have the ability to organize and form connections in three dimensions.  This 
difference might be crucial when observing how axonal growth cones migrate and connect with 
their distal target cells.  Some groups have begun investigation into the differences in 
organization of neuronal cells cultured in 3D fibrin and collagen matrices compared to 2D 
surfaces [85, 186-190].  O’Shaughnessy et. al. have demonstrated 3D synapse formation between 
rat cortical neurons in 3D collagen gel matrices [172].  The significance of the 3D environment 
for the neuronal cell bodies is the ability for the cells to form high density cultures with tight 
tissue-like configurations.  This close proximity of cell bodies in three dimensions is more 
similar to that in vivo and could result in more precise cell functioning.  A 3D environment for 
this axonal growth might enable differential spatial reorganization of multiple axons due to 
responses in changes applied to the culture environment, especially concerning testing of drugs 
and therapeutic proteins and their potential for enhancing axon regeneration for clinical 
therapies.  We have therefore performed studies comparing neurite outgrowth and synapse 
formation of the model neuron-like cell line PC12 cells within cultures maintaining 3D 
configurations at high densities. 
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2.1.3 Model neuronal PC12 cell line with NGF stimulation 
The PC12 cell line was first derived from a pheochromocytoma in the medullary part of a rat 
adrenal gland in 1976 by Greene and Tischler [191, 192].  These cells have the ability to undergo 
changes when stimulated with nerve growth factor (NGF) that extend processes resembling that 
of sympathetic neurons.  These neurite-like processes have been demonstrated by voltage patch 
clamp studies to produce Na+-dependent action potentials, while the unstimulated PC12 cells 
cannot sustain action potentials [193, 194].  PC12 cells can be used as model neurons because 
their normal non-neoplastic counterparts are chromaffin cells of the adrenal gland that are 
derived from the same primitive stem cell of neural crest origin during embryogenesis that gives 
rise to many types of neurons, especially sympathetic neurons [195].  It is thought that the 
neoplastic PC12 cells act more like this primitive stem cell and the stimulation of NGF 
differentiates them towards the sympathetic neuronal phenotype.  Many researchers have 
consequently used the PC12 cell line to investigate many aspects modeling real neurons, 
specifically such as the mechanisms involved in neurite outgrowth to better understand axonal 
growth of real neurons [196-198].  The PC12 cell line has also been significantly used to study 
neurotoxicology of reagents [199, 200].  Recently, these cells have also been used as model 
neurons with neurite outgrowth to assess treatments useful for nerve regeneration using tissue 
engineering [75, 201].  PC12 cells have also been useful in developing tissue engineering 
strategies for enhancing nerve repair and regeneration because the neurite outgrowth from these 
cells is dependent on increasing NGF concentrations where neurites are longer with increased 
concentrations as well as being gradient dependent with neurites growing towards the source of 
NGF [75, 89, 202-204].   
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 Our initial work utilized the PC12 cell line, but the growth of these cells is not contact 
dependent allowing these cells to remain within aggregates during proliferation.  This 
complicates analysis of neurite outgrowth from individual cells.  Therefore, we have performed 
most of the work presented here using the cell line Neuroscreen-1 (Cellomics Inc., Pittsburgh, 
PA).  This line was created by subcloning a population of the PC12 cell line that had superior 
properties.  This line of cells exhibits the property of contact inhibition, preventing the cells from 
aggregating with each other allowing observation of neurite outgrowth from single cells. 
2.1.4 Hollow fiber-based bioreactor for PC12 cultures 
In order to create high density neuronal-like cell cultures in more physiologically relevant 
arrangements we have cultured the PC12 cell line with nerve growth factor (NGF) stimulation in 
a hollow fiber-based bioreactor consisting of a three-dimensional culture space under 
homogeneous nutrient and gas perfusion. Our group has previously developed this hollow fiber-
based bioreactor system for high density 3D hepatocyte cell culture [118].  We have used this 
sytem here to demonstrate 3D neuronal-like cell growth and neurite networking using the PC12 
cell line.  We have been able to demonstrate improved growth and 3D neurite networking when 
compared to 3D static collagen gel cultures at high densities in order to form tissue-like 
structures.  In order to more accurately assess the neuronal networking between the cells in these 
cultures, we have examined synapsin I expression  within the PC12 cells. 
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2.1.5 Synapsin I as a marker for synaptogenesis in neurons 
Synapsins are abundant brain proteins involved in regulation of neurotransmitter release from 
synaptic vesicles in nerve terminals [205, 206].  There are three synapsin genes that are highly 
conserved with several protein isoforms due to alternative splicing [207]. The dominant isoforms 
in the mature nerve terminal are synapsins Ia, Ib, IIa, and IIb.  It is currently unknown the exact 
distinct functions each of the synapsin gene products have in relation to each other [207].  
Synapsins in neurons are exclusively localized to peripheral membrane proteins coating synaptic 
vesicles [205, 206, 208, 209].  The function of synapsin proteins is to tether the synaptic vesicles 
to each other and the actin-based cytoskeleton creating synaptic vesicle clusters (SVCs) in 
reserve pools within nerve terminals [205].  Upon changes in intraterminal Ca2+ concentrations 
due to excitation of a nerve terminal, the synapsin proteins are phosphorylated to their active 
form that decreases the affinity for synaptic vesicles to release them from the reserve pools, 
allowing them to leave the presynaptic nerve ending for neurotransmitter release from the 
synapse [205, 206, 210-212]. 
Many researchers in the fields of neurobiology and neuroscience have used Synapsin I as 
markers for synapses between neurons.  De Camilli, Cameron, and Greengard first demonstrated 
that Synapsin I protein is present in all neuronal synapses in vivo using immunohistochemical 
light microscopy [213].  The immunohistochemical staining in nervous tissue sections from this 
work revealed Synapsin I staining as bright fluorescent dots or puncta.  It is likely these bright 
puncta display where the Synapsin I is clustered, tethering the synaptic vesicles together in 
SVCs.  Gitler et al. have demonstrated this same punctate staining localized to only mark 
presynaptic terminals in cultured hippocampal neurons [212].  Using transmission electron 
microscopy Bloom et al. studied synapsin I staining in presynaptic terminals explicitly showing 
 33 
the staining within the SVCs at the presynaptic terminals of the giant synapse of the lamprey 
[207].   
Furthermore, Lohmann et al. demonstrated that synapsin I appearance correlated with 
synapse formation during development [214].  DeGrennaro et al. as well as Lu et al. have 
showed synapsin I is greatest at the time of maximal synaptogenesis in the developing rat brain 
[214, 215].  Also, researchers have shown a reduction in synapsins leads to delayed neuronal 
differentiation, axonal outgrowth, and synaptogenesis [216-218].  Kao et al. demonstrated a role 
for synapsin with increased neurite outgrowth in Xenopus laevis embryonic neuronal cultures 
expressing a mutation mimicking constitutive phosphorylation of site I (Ser9) on synapsin.  In 
human brain samples it has been shown that there is a reduction of synapsin proteins by Western 
blot in patients having bipolar disorder and schizophrenia relating the importance of maximal 
synapsin expression and synaptogenesis [219].  Romano, Nichols, Greengard, and Greene (co-
developer of PC12 cell line) first characterized the effects of NGF on synapsin I in PC12 cells 
[214].  They specifically showed by Western Blot a significant increase of synapsin I in PC12 
cells stimulated with NGF for 14 days, with a low detection in the nontreated cells.  Das et al. 
described neurite outgrowth with increasing levels of synapsin I and growth associated protein 
43 (GAP-43) in PC12 cells reaching maximal levels and plateau at 6 days of NGF stimulation 
[220].  We therefore proceeded to investigate synapsin I expression by immunostaining, Western 
blot, and quantitative RT-PCR among the NGF stimulated PC12 cells in this work between 2D 
static, 3D static, and the 3D dynamic perfusion bioreactor culture system. 
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2.2 METHODS 
2.2.1 PC12 cell cultures with NGF stimulation 
Two initial experiments used the original rat pheochromocytoma-derived PC12 cell line (ATCC; 
Manassas, VA). However, due to cell aggregation, neurite observation of individual cells was not 
possible and these experiments are described in Appendix A. All further experiments utilized the 
Neuroscreen-1 cell line (Cellomics Inc.; Pittsburgh, PA), which is an expansion of a sub-cloned 
population of the PC12 cell line having the beneficial property of contact inhibition.  The 
Neuroscreen-1 cells (all Neuroscreen-1 cells now referred to as PC12 cells) enable direct 
visualization of individual neurites from all cells in order to demonstrate the 3D neurite 
outgrowth.   
 All cultures were carried out for a total of 6 days with the first day consisting of cell 
seeding and serum starvation without NGF following with continued low serum plus NGF for 5 
days.  Medium formulation included RPMI-1640 (containing L-glutamine and HEPES, Lonza; 
Allendale, NJ) including 0.5% HS (heat-inactivated horse serum; Invitrogen Corp., Grand Island, 
NY), 1000 IU/ml penicillin, and 1000 μg/ml streptomycin (Invitrogen Corp.). Neurite process 
outgrowth was stimulated in all cultures using a concentration of 75 ng/ml nerve growth factor 
(NGF; Invitrogen Corp.).  This protocol achieved superior neurite outgrowth among PC12 cells 
in a 2D culture compared to other medium regimens and therefore was used in all culture types. 
2.2.1.1 2D static cultures 
2D static control cultures were maintained in tissue-culture treated 100 mm Petri dishes (BD 
Biosciences; San Jose, CA).  Dishes were first coated with 5µg/mL collagen type I (from rat tail 
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sterile filtered solution; BD Biosciences) dissolved in 0.02 N acetic acid for 1 hour in 5 % CO2 
humidified incubator at 37°C.  Dishes were then washed with Dulbecco’s phosphate buffered 
saline solution (PBS; Invitrogen Corp).  1x106 PC12 cells were plated in each dish at a density of 
127 cells/mm2 in low serum medium without NGF.  Throughout rest of culture period medium 
with NGF was replaced once daily.  N= 5 dishes were seeded for each experiment.  These 2D 
static cultures were replicated in triplicate. 
2.2.1.2 3D static collagen gel cultures 
3D static control cultures were possible using collagen type I (rat tail, BD Biosciences) 
hydrogels (gels).  Collagen gels were fabricated and cultured within tissue culture-treated 12 well 
plates with a 1 mL volume gel within each well.  Collagen gels were prepared using the 
following components quickly added in the given order: 100 uL 10X PBS (Invitrogen Corp.), 
PC12 cells with 500-600 uL RPMI medium containing 0.5% HS and 1% Pen/Strep (enough to 
bring final volume to 1 mL), 250-350 uL collagen type I sterile solution (amount varied with 
manufacturer stock concentration, final concentration of collagen in gel 1 mg/mL), and 6 uL 1 N 
NaOH.  Collagen gel solutions can then undergo fibrillation and gel formation after addition of 
NaOH for final pH approximately 7.4 and plates placed in 5% CO2 humidified incubator at 
37°C.  Collagen gel formation completed within 15 minutes and 1.5 mL RPMI with low serum 
was added to each well.  Collagen gels were detached from the well edges using a sterile scalpel 
in order to maintain gel cultures as “free-floating” to improve nutrient exchange from fresh 
medium on entire surface area of gels.  Collagen gel dimensions within the 12 well plates 
resulted approximately in 20 mm diameters and 2 mm in height.  Gel plus liquid medium layer 
height never exceeded 6 mm from bottom of well in order to not further limit gas diffusion into 
gel constructs.  Medium was completely replaced in each well once daily (every 24 hours).  
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During each experiment a total of 9 collagen gels were made within a 12 well plate for n = 3 gels 
at each of three densities: 1x103 cells/mm2 (1x106 total cells), 2.5x103 cells/mm2 (2.5x106 total 
cells), and 5x103 cells/mm2 (5x106 total cells).  These 3D static collagen gel cultures were 
replicated in triplicate. 
 
2.2.1.3 3D dynamic hollow fiber-based bioreactor cultures 
The hollow fiber-based bioreactors used in this work are the laboratory scale devices previously 
designed and used by our lab as described by Gerlach et al. [116-118, 137, 221-223].  The 
bioreactor contains four separate compartments as shown in Figure 1.  Two woven bundles of 
porous, hydrophilic polyethersulfone hollow fiber membranes with molecular weight cutoff of 
400 kD and maximum pore size 0.5 µm ± 0.1 µm (Membrana, Wuppertal, Germany) compose 
two of the compartments which are arranged to allow countercurrent medium perfusion.  The 
third compartment is composed of a bundle of hydrophobic polypropylene hollow fibers (MHF; 
Mitsubishi, Tokyo, Japan) used for integral gas exchange of oxygenation and CO2 removal 
within bioreactor.  These three separate fiber bundles are inter-woven layer by layer throughout 
compartment 4 of the bioreactor forming the volume used to culture cells.  Cells are able to fill 
the 3D volume within this extra-fiber compartment and use the perfusion fibers as scaffolds to 
form tissue around.  The medium perfusion and oxygenation fibers therefore mimic the in vivo 
configuration of blood supply through capillary network beds in order to maintain dynamic 
homogeneous nutrition and gas exchange in order to allow tissue formation.   
Figure 1b shows a photograph of the actual 8 mL lab scale bioreactors used here that 
have been fabricated and produced at the company Stem Cell Systems (Berlin, Germany).   The 
hollow fiber bundles are embedded in a fiber-compatible two component polyurethane (Pur 725, 
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Morton, Bremen, Germany) utilizing dialyzer potting techniques to seal the ends of the bundles 
and retain the inner cell compartment to have an extra-fiber volume of approximately 8 
milliliters.  This polyurethane housing creates flow heads at the ends of the fiber bundles that 
each lead to their own ports.  There are nine ports total: two for medium inlet tubing connections 
leading to each PES fiber bundle, two for medium outlet tubing connections leading from each 
PES fiber bundle, two ports connect the inlet and outlet flow through the gas polypropylene fiber 
bundle, two ports sit directly at the top and bottom of the housing that directly connect to the cell 
compartment (used for pre-cell inoculation degassing), and the last port used for cell inoculation 
which leads into small diameter silicone tubes that allow distribution of cells throughout the 
extra-fiber cell compartment. 
 
Figure 1. 8 mL hollow fiber-based bioreactor: a) diagram of displaying three separate fiber bundles 
running through inner cell compartment; b) photograph of 8 mL bioreactor placed in heating chamber with perfusion 
tubing circuit connected at each flow head port. 
 
The bioreactor becomes a dynamic system when the ports are connected to the tubing 
circuits used to perfuse medium and gas with pump systems.  The 8 mL hollow fiber-based 
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bioreactor is shown in Figure 2 within the perfusion system used for these experiments.  The 
pump on the bottom left is a roller style pump that enables pulsatile flow through the 
recirculation loop of the medium perfusion circuit through the perfusion fibers of the bioreactor.  
The perfusion circuits used here in these experiments used tubing made of medical-grade 
polyvinyl chloride (PVC; B. Braun Medical Inc., Melsungen, Germany).  The medium and gas 
perfusion tubing circuits are shown in the diagram of Figure 3. 
 
Figure 2. Photograph of bioreactor system used for 8 mL hollow fiber-based bioreactor experiments with 
bioreactor connected to tubing circuit within heating chamber.  Shown on the top right are the rotameters used to 
control air and CO2 gas flow rates. The top left shows the feed pump and bottom left the recirculation roller pump.  
The feed and waste bottles are shown connected to the medium perfusion tubing circuit. However, the feed medium 
bottle is kept within a mini-fridge above the system at 4°C. 
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Figure 3. Diagram of tubing circuit used for medium and gas perfusion through 8 mL hollow fiber-based 
bioreactor. Red lines indicate arterial side tubing with medium flow leading into bioreactor. Blue lines indicate 
venous side tubing with medium flow leading out of bioreactor.  This diagrams the tubing connections allowing 
medium flow in through the feed line, through the bioreactor in the recirculation loop, and out through the waste 
line. Yellow lines indicate pump tube segments connected to roller pumps.  The sample port for recirculation 
medium daily samples is shown as the blue filter. 
 
A total of six PC12 cell (Neuroscreen-1 cell line) bioreactor experiments were completed.  
Notation used to identify each bioreactor experiment in an abbreviated form with the example of 
the first experiment noted by RNS-1; where the first initial is the species being rat, the second 
and third initial correspond to the cell type (in this case Neuroscreen-1), and the number giving 
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the order within the six experiments (RNS-1 through RNS-6).  All six RNS bioreactor 
experiments included inoculation of the bioreactor with PC12 cells suspended in a collagen gel 
solution.  Two separate 10 mL collagen gel solutions were made; one including all cells and one 
for flushing behind to further disperse cell solution throughout bioreactor.  A 10 mL collagen 
solution was made similarly to the 3D static gel cultures by adding the following components to 
a 50 mL conical tube in the given order: 1 mL 10X PBS, 5-6 mL media (RPMI 1640 with 10% 
HS and 1% Pen/Strep) (including cells in first solution), 2.5-3.5 mL collagen type I (amount to 
achieve final 1 mg/mL concentration; BD), and 40 µL 0.2 N NaOH.  Solutions were withdrawn 
into two separate 20 mL syringes for inoculation into bioreactor through the cell injection ports.  
The syringe containing cells plus gel solution was first connected to cell injection port.  Media 
was first withdrawn from bioreactor into syringe to remove any air bubbles from line.  Solution 
plus cells was then slowly injected into bioreactor cell compartment.  Finally, the second 10 mL 
gel solution-containing syringe was connected and injected to further distribute cells in collagen 
solution throughout cell compartment volume.   
The extra-fiber cell compartment volume is only 8 mL, but the 20 mL collagen solution 
allows for an approximate 1 mg/mL final concentration of collagen within the formed gel due to 
the solution mixing first with the medium initially in the compartment before injection.  Also, 
any excessive collagen injected into the cell compartment can penetrate the medium perfusion 
fiber walls and be diluted into the circuit volume without any detrimental effects.  In all 
experiments, cells were injected with gel solution with recirculation flow rate being kept on to 
prevent collagen gel formation within lumens of fibers.  Also, tubing connecting top and bottom 
cell compartment ports remained clamped (closed) during inoculation and entire culture period to 
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confine the cells and gel to the bioreactor cell compartment (compartment can be opened to flush 
debris, but this was never performed in these experiments using the gel system). 
RNS-1 was the first Neuroscreen-1 PC12 bioreactor experiment performed (original 
PC12 bioreactors: RPC-1 and RPC-2).  Using the original PC12 cell line, cells were only 
maintainable even with NGF under high serum conditions (not below 10% HS).  Therefore, 
when continuing to the Neuroscreen-1 cell line a high serum of 10% HS was also used for the 
RNS-1 bioreactor experiment throughout the culture period.  However, serum levels were then 
tested on control Neuroscreen-1 2D cultures and found that cells achieved maximal neurite 
outgrowth with 0.5% HS concentrations and bioreactor experiments RNS-2 through RNS-6 were 
continued using this low serum level.  It was not possible to maintain any of these lines with no 
serum present in the medium.  RNS-2 through RNS-6 bioreactors were cultured using the 
medium regimens described in section 2.2.1 for the six day culture period. 
The numbers of cells inoculated into each bioreactor are listed below in Table 3.  Cell 
numbers were increased initially and varied among bioreactor experiments in order to optimize 
cell density within the bioreactor to have high density neurite network formation and subsequent 
increased synapse formation between cells.  Due to the contact inhibition properties of these 
PC12 cells, bioreactors were not able to be repeated exactly even with RNS-5 and RNS-6 having 
the same initial cell inoculation number.  Therefore, we have instead completed a series of 















RNS-1 700 2.5 8.75x104 
RNS-2 200 1 2.5x104 
RNS-3 1000 3 1.25x105 
RNS-4 700 2.5 8.75x104 
RNS-5 300 1 3.75x104 
RNS-6 300 1 3.75x104 
 
2.2.2 Metabolic measurements 
Medium samples were infused into single use CG4+ cartridges or G Glucose cartridges to 
measure the following metabolic parameters: lactate, pH, pCO2, pO2, and glucose; using the i-
STAT® clinical blood analyzer system (Abbott, East Windsor, NJ).  3D static gel cultures were 
maintained each day during culture period by collecting 1.5 mL of culture medium (previously 
replaced 24 hours earlier) and analyzing metabolic parameters.  Medium from bioreactor cultures 
was collected via syringe withdrawal from the sample port within the recirculation segment of 
the tubing circuit (medium flowing through recirculation tubing and bioreactor perfusion fibers 
at flow rate 30 mL/min).  Bioreactor glucose and lactate concentrations have been inserted into 
formulas incorporating feed medium flow rate to give consumption and production values 
averaged between two measurements.  The formula used is shown below in Figure 4. 
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Figure 4. Equation used to obtain daily glucose consumption or lactate production values of samples taken from the 
recirculation medium perfusion circuit during bioreactor culture experiments. 
2.2.3 Fluorescent immunohistochemistry visualized with confocal microscopy 
Static control cultures used for immunohistochemistry were first washed with PBS three times 
and fixed with 4% paraformaldehyde for 30 minutes and then washed with PBS again 3 times.  
Bioreactor fiber layer samples were transferred immediately after opening to tissue cassettes and 
placed in 4% paraformaldehyde for 1 hour.  Samples were then washed with PBS three times, 15 
minutes each. 
Immunostaining procedure was first carried out by blocking in a 5% horse serum/PBS 
solution containing 0.3 % triton X-100 (LabChem Inc., Pittsburgh, PA) for 1 hour.  All samples 
were first stained with mouse monoclonal primary antibody against class III neuronal specific β-
tubulin (Covance CRP Inc.; Princeton, NJ) 1:500 dilution in 3% HS/PBS solution containing 
0.3% triton-X for 1.5 hours.  Samples were then washed five times with PBS each for 10 
minutes.  Goat-anti-mouse secondary antibody Alexa Fluor 488 (Molecular Probes, Invitrogen 
Corp.) was then added at dilution 1:1000 in 3% HS/PBS solution containing 0.3% triton-X for 
1.5 hours.  Samples then received washes five times with PBS each for 10 minutes.  Double 
immunostaining was carried out on all samples with the same previous protocol but with one of 
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the following antibodies: anti-Synapsin I polyclonal rabbit primary antibody (Covance CRP Inc.) 
1:200 dilution, anti-phosphorylated Synapsin I (site Ser 553) polyclonal rabbit primary antibody 
(Santa Cruz Biotechnology, Inc.; Santa Cruz, CA) 1:200 dilution, and anti-phosphorylated 
Synapsin I (site Ser 9) rabbit polyclonal primary antibody (Cell Signaling Technology, Inc.; 
Danvers, MA) 1:200 dilution.  Goat-anti-rabbit secondary antibody Cy3 (Molecular Probes, 
Invitrogen Corp.) was then added at dilution 1:1000 in 3% HS/PBS solution containing 0.3% 
triton-X for 1.5 hours.  Samples then received final washes five times with PBS each for 10 
minutes.  All samples were counterstained with DAPI (Sigma Aldrich, St. Louis, MO) for 
nuclear localization.  Two 3D static gel and 3D dynamic bioreactor samples were used as 
immunostaining controls by performing the above staining protocol with deletion of primary 
antibody step with addition of Cy3 secondary antibody to check for residual secondary antibody 
within the gel or tissue samples. 
Fluorescent confocal microscopy was used to visualize the immunohistochemical 
staining of all samples (inverted Olympus Fluoview 1000; Center Valley, PA).  2D samples 
cultured on tissue culture treated dishes were imaged by cutting the bottom surface out of the 
dish and sealing with gelvatol and glass coverslip.  3D gel and bioreactor samples were imaged 
by wet mounting with directly placing the sample onto a glass coverslip in order to image both 
sides of sample.  To image cell morphology and neurite outgrowth images were taken using a 
20X oil objective (final magnification 200X) and a 40X or 100X objective for imaging Synapsin 
staining (final magnification 400X or 1000X, respectively).  All images were taken as z-stacks 
with 0.5 µm or 1 µm thick sections at 10 µm depth for 2D samples and approximately 50 µm 
depths for 3D gel and bioreactor samples.  Stacked section images were reconstructed into 
maximum intensity projection representations in a single image or avi movie file to demonstrate 
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30 degree rotation showing 3D characteristics using Metamorph software (Molecular Devices; 
Downington, PA).  When imagining synapsin I-Cy3 staining, microscope laser and imaging 
software settings were changed to optimize actual staining and minimize background noise (laser 
intensity and gain were minimized with offset set to 40%). 
2.2.4 Quantitative RT-PCR gene expression analysis 
3D static gel and 3D dynamic bioreactor samples for RNA collection were immediately 
immersed in RNA Protect reagent (QIAGEN, Valencia, CA) and stored at 4°C for less 
than two weeks before RNA collection.  For RNA collection, samples were first 
centrifuged to pellet cell, gel, and/or fiber material with removal of supernatant.  Total 
RNA was isolated from all samples with an mRNA isolation kit including on-column 
DNAse digestion (QIAGEN, Valencia, CA).  The first step was carried out by placing the 
samples in the first buffer solution of the kit and using a disposable pestle the sample was 
ground to mechanically digest the collage gel tissue.  cDNA was synthesized by a 
conventional reverse transcription process (Promega, Madison, WI).  The master mixture 
contained 5 mmol/L MgCl2, 1x Reverse Transcription Buffer, 1 mmol/L deoxynucleotide 
triphosphate mixture, 1unit/µL recombinant RNasin® ribonuclease inhibitor, 0.75U/µL 
AMV reverse transcriptase, and 1µg of random hexamer Primers.  Two micrograms of 
total RNA were prepared in sterile H2O to a final volume of 20µL.  The reaction mixture 
was incubated at 42°C for 60 minutes, followed by heat inactivation of the enzyme at 
95°C for 5 minutes. After cooling on ice for 5 minutes, the cDNA was stored at –20°C 
until analysis. Quantification of mRNAs using real-time polymerase chain reaction (qRT-
PCR) analysis was performed using an ABI PRISM 7000.  The pre-designed TaqMan 
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probe and primer sets for Syn1 (Rn00569468_m1), Gap43 (Rn00567901_m1), and 
GAPDH (Rn99999916_s1) were selected from TaqMan Gene Expression Assays 
(Applied Biosystems, Foster City, CA). 
2.2.5 Western Blot protein analysis 
Protein collection from samples was first attempted by digestion of collagen gel from 3D static 
gel and 3D bioreactor samples using 30 units/ mL collagenase type II (Worthington Biochemical 
Corp.; Lakewood, NJ) for 1 hour at 37°C.   Digestion was then stopped using RPMI 1640 
medium with 10% HS and samples centrifuged to pellet cells.  Cells were resuspended in 300 µL 
MPER cell lysis buffer (Pierce Biotechnology; Rockford, IL) including 3 µL protease inhibitor 
cocktail (Sigma Aldrich) and heavily vortexed.  The samples were kept in lysis buffer on ice for 
30 minutes with repeated vortexing to completely lyse cells.  Samples were finally centrifuged to 
pellet membrane protein fractions and keep the supernatant containing the cytoplasmic protein 
fraction.  These supernatants and pellets were stored separately at -80°C.  The standard protein 
quantification method using a BCA Protein Assay kit (Pierce Biotechnology) was implemented 
to measure protein concentrations of each sample.  Using this protein collection method, Western 
blots were performed to determine ability to collect synapsin proteins from PC12 cells efficiently 
within the supernatant fraction only. 
After the bioreactor experiment RNS-2, a second protein collection method was then 
applied on further bioreactor experiments as well as completely restarting control 2D static and 
3D static gel cultures in order to preserve the synapsin proteins in their active phosphorylated 
states.  This method was executed using a cell lysis buffer solution of 300 µL TGN cell lysis 
buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 50 mM NaF, 1% Tween 20, 0.2% NP-40) 
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containing 3 µL protease inhibitor cocktail. For the 2D static cultures this method was executed 
by directly placing the lysis buffer solution onto the 2D plate and collecting lysate using a cell 
scraper.  Protein was collected from the 3D samples by placing the entire cell containing gel 
(plus fibers in the case of the bioreactor samples) into a 50 mL conical tube containing the TGN 
lysis buffer solution.  Gels were first disrupted mechanically with disposable pestle.  Then 
protein collection method was completed as above with samples on ice for 30 minutes with 
intermittent vortexing.  Supernatants after centrifugation were then collected from each sample 
and stored at -80°C.  This protein collection method differs from the first method by excluding 
collagen gel digestion, which results in some collagen proteins contaminating the final collected 
cell lysate protein sample.  The BCA assay was implemented before Western blotting to give an 
estimate of cell lysate protein concentration (since the BCA assay used recognizes both the cell 
proteins and collagenous proteins from collagen gel matrix).  Western blots were performed 
multiple times in order to optimize loading of all nine sample types via trial and error to achieve 
final blot containing all samples together with equal loading (according to control protein bands). 
Western blots were performed using the Bio-Rad Mini Trans-Blot cell system with SDS-
PAGE (Bio-Rad Laboratories Inc.; Hercules, CA).  Collected protein samples at 10-20 µg were 
loaded into wells of 7.5% Tris-HCL Ready Gel (Bio-Rad Laboratories).  Precision Plus Protein 
Kaleidoscope standard ladder was used (Bio-Rad Laboratories).  Samples were run through gel 
with constant voltage of 125V for 75 minutes in Ultra Pure Tris/Glycine/SDS running buffer 
(National Diagnostics; Atlanta, GA).  Protein was transferred onto trans-blot transfer membrane 
(Bio-Rad Laboratories) from gel using Bio-Rad system at constant current of 250A for 90 
minutes in Ultra Pure Tris/Glycine transfer buffer.  Membrane was then blocked with 5% milk 
solution (5% dry milk powder in 1X PBS with 0.1% Tween 20) with shaker for 2 hours.  Primary 
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antibodies used were: synapsin I polyclonal rabbit primary antibody (Covance CRP Inc.) 1:2000 
dilution, anti-phosphorylated Synapsin I (site Ser 553) polyclonal rabbit primary antibody (Santa 
Cruz Biotechnology, Inc.; Santa Cruz, CA) 1:1500 dilution, anti-phosphorylated Synapsin I (site 
Ser 9) rabbit polyclonal primary antibody (Cell Signaling Technology, Inc.; Danvers, MA) 
1:1000 dilution, and anti-synaptophysin monoclonal mouse primary antibody (Covance CRP 
Inc.) 1:1000 dilution.  Membrane was incubated with primary antibody in 1% milk/PBS/0.1% 
Tween 20 solution with shaking overnight at 4°C.  Membrane was washed several times with 
PBS/Tween 20.  Secondary antibody goat-anti-rabbit HRP or goat-anti-mouse HRP (Jackson 
ImmunoResearch Laboratories Inc., West Grove, PA) was incubated on membrane at dilution in 
1% milk/PBS/Tween 20 solution for one hour with shaking.  Antibody was washed off several 
times with PBS/Tween 20 for 30 minutes.  Protein detection was carried out by blotting 
membrane with ECL Plus western blotting detection system (GE Healthcare Amersham; 
Piscataway, NJ) and X-ray film developing system using Hyper film ECL (GE Healthcare).  
Loading for cell protein among all samples was checked by stripping membrane (1 hour at 37°C) 
and re-blotting for control GAPDH protein (using primary anti-GAPDH antibody; Santa Cruz 
Biotechnology) which is an abundant house keeping gene product present at same levels in all 
cells.  Dilution used for GAPDH primary antibody was 1:8000 incubated only for one hour on 
membrane and then with a secondary antibody goat-anti-mouse HRP. 
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2.3 RESULTS 
2.3.1 Metabolic activity of 3D cultures 
2.3.1.1 3D static gel cultures 
Figure 5 shows the results of measuring daily glucose and lactate concentrations throughout the 
period of culturing PC12 cells at three different densities in 3D collagen gels cultured under 
static conditions.  Media on these cultures was replaced entirely each day, so that the daily 
readings measure concentration produced over the past 24 hours within the culture.  The baseline 
concentrations are shown on Day 0 at 1900 mg/L glucose and 0 mmol/L lactate.  The curves to 
the left on Figure 5 represent the metabolic data for 1 million PC12 cells cultured in a 1 mL gel 
(density is 1x103 cells/mm3).  These curves for 1 million cells/gel culture show steadily 
increasing glucose consumption and lactate production over the six day culture period.  Also, the 
pH within this culture remained between 7.3 – 7.4 with pCO2 ranging 17-25 mmHg and pO2 
ranging 140-150 mmHg.  These values are within normal limits of desired and baseline values of 
pH 7.4, pCO2 17 mmHg, and pO2 140 mmHg. 
The curves in the middle of Figure 5 represent the glucose and lactate concentrations 
measured from the culture of 2.5 million PC12 cells in 1 mL collagen gel.  There is a large 
decline in glucose concentration to 0 mg/L by culture day 3, where the cells proliferated enough 
to consume all the glucose before the media could be replaced again for the rest of the culture 
period.  The lactate for this culture did steadily increase, but the pH dropped to 7.0 by culture 
day 3 and reached as low as 6.7 at the end of the culture period.  The pCO2 values of this culture 
reached a maximum on day 3 of 30 mmHg, but remained between 15-20 mmHg for the rest of 
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the culture period.  The pO2 also reached a minimum of 106 mmHg on day 3, but remained above 
120 mmHg for the rest of the culture period.   
The curves on the right of Figure 5 show the results of glucose and lactate concentrations 
measured from the culture of 5 million PC12 cells in 1 mL collagen gel under static conditions.  
Within this culture there is a rapid decrease of glucose to 0 mg/mL and a high lactate 
accumulation by culture day 2 with a corresponding pH value of 6.8.  The lactate concentration 
sustained a plateau between 15-16.6 mmol/L for the duration of the culture period.  Even with 
the pH measuring 7.0 and 6.8 on the first two culture days the pCO2 remained within the baseline 
limits of 16-17 mmHg. 
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Figure 5. 3D static gel culture metabolic data plotting daily glucose and lactate concentration 
measurements over culture period for each density of cells cultured in 1 mL collagen gels. 
2.3.1.2 3D dynamic bioreactor cultures 
With all bioreactor experiments, however, the PC12 cells experienced significant proliferation as 
evidenced by increasing glucose consumption and lactate production during bioreactor culture 
described in the plots of Figure 7 and macroscopic tissue formation seen in Figure 6 below.  
Figure 7 plots the glucose consumption and lactate production according to averaging the daily 
concentration measurements between two days with subtracting the baseline concentration value 
and multiplying by the amount of fresh medium supplied due to the feed flow rate over the 
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previous 24 hours.  These plots heavily relying on the feed flow rate, which was increased 
differently throughout all experiments, shows similar trends for metabolic activity of all 
bioreactors (except RNS-4 where there was a clear significant drop in activity after Day 3).  
Therefore, it is more interesting to observe the trends shown in Figure 8 with the plots of actual 
glucose and lactate measurements taken each day over the culture period.  It is only in these plots 
that the glucose concentration reaching zero is observable, which occurred in RNS-3 on culture 
day 3. 
 
Figure 6. Photograph of 8 mL bioreactor housing opened to obtain tissue samples including fiber layers; 
shown here is RNS-1 with macroscopic tissue formation within collagen gel between fibers. 
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Figure 7. Metabolic data for all six bioreactor experiments plotting glucose consumption on the left axis 
and lactate production on the right axis averaged between each daily measurement including dilution due to change 
in feed flow rate. 
 
The glucose and lactate concentration plots shown in Figure 8 demonstrate that for RNS-
1, with high serum conditions, there was an immediate increase of lactate concentration above 10 
mmol/L within the first 24 hours of culturing.  The lactate concentration maintained a plateau of 
10-12 mmol/L for the duration of the culture period.  Unlike the 3D static gel cultures, this 
plateau of lactate concentration (and therefore possibly cell number) was not due to limitations of 
nutrition or medium acidity.  The RNS-1 bioreactor maintained glucose concentrations above 
200 mg/L and a pH above 7.275.  This result (along with the description of the more rounded cell 
morphology of RNS-1 samples in section 2.3.2) necessitated the change in medium regimen to 
using very low serum concentrations.  RNS-2 was then cultured with medium containing only 
0.5% HS while also lowering the inoculation cell number to only 200x106 cells.  The glucose and 
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lactate concentrations for RNS-2 both slowly decreased and increased, respectively, representing 
a more gradual proliferation of PC12 cells within the bioreactor. 
Cell morphology within samples from RNS-2 showed healthy and adequate neurite 
outgrowth from the PC12 cells, but cell density throughout the bioreactor was not uniform.  
There were regions varying between high and low densities (seen below in section 2.3.2).  This 
and other results from Western blot analysis of RNS-2 (described in section 2.3.3.3) lead to the 
continuation of RNS-3 with a higher initial cell inoculation number with low serum conditions to 
achieve a maximum density of cells and therefore neurites within the bioreactor to obtain the 
highest possible capacity for synapse formation between cells.  However, lactate concentrations 
for RNS-3 did quickly plateau at only culture day 2.  These PC12 cells do hold the property of 
contact-inhibition, where the cells will not proliferate past confluent densities, and therefore 
RNS-3 is suspected to have reached a maximum density.  The cell morphology within RNS-3 
showed confluent clusters of rounded cells, therefore the density for inoculation of RNS-4 was 
decreased to 700x106 cells.  Also, to avoid the possibility of complete glucose depletion during 
the culture period, the baseline glucose concentration of the medium was doubled to 4000 mg/L.  
Most other bioreactor experiments performed by our group uses the control of CO2 flow rate 
through the gas perfusion to maintain a healthy pH values, whereas RNS bioreactors are 
maintained already with 0 mL/min CO2.  The pH has to instead be regulated in these experiments 
by increasing the feed flow rate in order to flush the high accumulation of lactate.  This method 
unfortunately makes it hard to predict ability to accurately predict the necessary increase in feed 
flow rate to maintain a healthy pH value.  Including the higher glucose concentration in the 
baseline medium for RNS-4 made it even hard to predict the needed increase in feed rate.  
Culture day 1 and 2 for RNS-4 had feed flow rates already at 10 and 13 mL/hour, respectively, 
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while most other RNS bioreactors the feed flow rate was under 6 mL/hour for those culture days.  
However, the lactate concentration for RNS-4 on culture day 2 reached 17.9 mmol/L, which 
created a pH value of 6.8.  The feed flow rate was then increased to 20 mL/hour to attempt to 
maintain the pH on culture day 3, but for the duration of the experiment the lactate concentration 
decreased possibly due to death of the cells based on the unacceptable environment.  Upon 
opening of RNS-4 there seemed to be a significant amount of tissue formation, but again with the 
cells attaining rounded and clustered cell morphology (data not shown). 
The cell inoculation numbers for RNS-3 and RNS-4 were then concluded to be too high 
for the cells to not reach confluency during the six day culture period, but the optimal density 
desired within the bioreactor by the end of the culture still was believed to be higher than the 
inoculation number for RNS-2 of 200x106 cells.  Therefore, the next experiment of RNS-5 was 
inoculated with 300x106, only a slight increase in cell number compared to the increase used for 
RNS-3 and RNS-4.  Seen Figure 7 and Figure 8 the trends in glucose and lactate concentration 
are much more gradually increasing, similarly to that of RNS-2.  Also, the pH values for RNS-5 
were maintained between 7.2-7.4.  The morphology of RNS-5 samples consequently had 
extensive neurite outgrowth with a high density throughout the volume of the cell compartment 
in the bioreactor (discussed below in section 2.3.2).  Therefore, RNS-6 was performed to attempt 
replication of RNS-5 with a cell inoculation number of 300x106 cells.  However, RNS-5 seemed 
to reach a plateau of lactate concentration on culture day 2 instead of day 3 for RNS-6.    
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Figure 8. Bioreactor metabolism plots of actual daily measurements taken for glucose and lactate 
concentrations not accounting for feed flow rate. 
2.3.2 Comparison of cell morphology and neurite outgrowth 
PC12 cells are used as model neurons in tissue engineering specifically due to their ability to 
generate substantial neurite outgrowth when stimulated with NGF.  The 2D control cultures of 
PC12 cells were traditionally plated on 2D tissue cultured treated polystyrene plates coated with 
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collagen type I at 5 µg/cm2 with 0.5% horse serum (HS) starvation for one day and then NGF 
supplementation at 75 ng/mL for 5 days.  These PC12 cells cultured for six days are shown in 
Figure 9 with immunocytochemical staining of neuronal class III β-tubulin (Tuj1 clonal 
antibody) with AlexaFluor 488 secondary antibody (green) and counterstained with DAPI for 
nuclear staining (blue) at magnification of 200X.  β-III-tubulin within the PC12 cells shows up 
throughout the entire cytoskeleton of these cells and is a good marker representing the cell 
morphology and neurite outgrowth.  Figure 9 demonstrates the ability of the PC12 cells to 
generate extensive neurite outgrowth within the control 2D culture and represents the motivation 
for use of these cells as a model neuron. 
 
Figure 9.  Cell morphology of 2D control PC12 cells cultured for 6 days on collagen coated dishes at a 
density of 127 cells/mm2 with NGF stimulation showing β-III-tubulin neurite staining (green) and DAPI nuclear 
staining (blue) (confocal z-stack single image reconstructions 10 µm depth at magnification 200X). 
 
3D static control cultures consisted of PC12 cells encapsulated in collagen type I 
hydrogels, where the cells are mixed with the 1 mL collagen solution and gelled in traditional 
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12-well tissue culture plates.  The gels take the shape of the well with the approximate 
dimensions of 20 mm diameter and 2 mm height.  The gels are kept in the 12 well plates, but 
free-floating in the culture media so that diffusion of nutrients can occur through all surfaces of 
the gel.  The gels have a final collagen concentration of 1 mg/mL, which is the lowest possible 
collagen type I concentration in order to maintain a cohesive hydrogel.  Gels made with lower 
collagen concentrations either do not completely form a hydrogel or degrade before the end of 
the necessary six day culture period (data not shown but these concentrations have been tested).  
Also, the lowest possible collagen concentration was used so that the PC12 cells are able to 
sprout their neurites throughout the porous gel and not be inhibited by a dense collagen matrix.  
Krewson et al. demonstrated that lower density collagen gels allow better neurite outgrowth from 
PC12 cells stimulated with NGF [224]. 
Figure 10 shows confocal fluorescent images representing the cell morphology of PC12 
cells stimulated with NGF encapsulated in collagen type I hydrogels cultured with static 
conditions in a tissue culture plate in a 5% CO2 humidified incubator with immunostaining of β-
III-tubulin and DAPI.  Figure 10a is representative of the growth of PC12 cells seeding 1x106 
cells in the 1 mL gel volume with density 1x103 cells/mm3 after culture for six days.  This 
density according to metabolic data in Figure 5 allows steady growth of the cells within the gel 
also with healthy conditions of pH and gas partial pressures.  The image demonstrates the ability 
of these cells under adequate conditions to sprout long neurites in 3D throughout the collagen 
gel.  Also demonstrated is the sparse final cell density with cells far apart in the representative 
image with seeding at the low 1x103 cells/mm3 initial density which prevents cells having close 
neighboring cells in all three directions for potential synapse formation.   
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Figure 10b is a representative image of the PC12 cells in the 3D static collagen gel with 
an initial seeding density of 2.5x106 cells for a density 2.5x103 cells/mm3.  This image, however, 
does not demonstrate an increased number of cells present at this region of the gel compared to 
the lower density gel.  It does demonstrate the decreased neurite outgrowth from the cells at this 
lower local density.  The image in Figure 10b only represents a region of the gel near the edge 
where the best neurite outgrowth occurred, due to increased nutrient and gas diffusion for 
improved culture conditions.  Figure 5 demonstrated that the metabolic activity of this density 
culture was high, but created unfavorable conditions with acidic pH values.  The center of the gel 
had an increased local density, but the images shown in Figure 10 demonstrate representative 
images of the best neurite outgrowth within each culture. 
Figure 10c represents the PC12 cell growth and neurite outgrowth of the cells seeding 
5x106 cells in the 1 mL gel with initial density 5x103 cells/mm3.  This image demonstrates the 
increased cell density within the gel compared to the other cultures where cells have neighboring 
cells in all three surrounding dimensions.  However, due to the poor environment occurring from 
culturing this high density of cells under static conditions in the gels, as revealed in Figure 5, the 
representative image here shows little neurite outgrowth from the cells with most cells obtaining 
a rounded morphology instead.  With the high density culture depleting its glucose every day and 
lactate accumulation producing a very acidic pH the effects are shown by preventing healthy 
neurite outgrowth from the cell. 
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Figure 10. Cell morphology of 3D static controls of PC12 cells cultured for 6 days within 1 mg/mL 
collagen gels with NGF stimulation showing β-III-tubulin neurite staining (green) and DAPI nuclear staining (blue) 
at different densities: a) 1x103 cells/mm3, b) 2.5x103 cells/mm3 , c) 5x103 cells/mm3 (all confocal z-stack single 
image reconstructions approximately 50 µm depths at magnification 200X). 
 
Six experiments were performed culturing the PC12 cells in the hollow-fiber based 
bioreactor maintaining dynamic flow conditions with decentralized oxygenation.  Medium 
supplemented with 75 ng/mL NGF was circulated through the PVC tubing circuit, which 
perfused through the hollow fibers of the bioreactor to allow convective transport of nutrients to 
the cell compartment.  Figure 11 illustrates the PC12 cells encapsulated in the collagen gel 
surrounding the extra-fiber space of the cell compartment of the 8 mL bioreactor of experiment 
RNS-2.  The images demonstrate considerable neurite outgrowth from the PC12 cells throughout 
the collagen gel of the 3D cell compartment including dynamic homogeneous nutrition and 
oxygenation.  Confocal fluorescent images representing cell morphology of the cells in regions 
with the best neurite outgrowth of most of the bioreactor cultures are shown in Figure 12.  
Images of RNS-3 and RNS-4 are not shown here, but look similar to the morphology shown in 
Figure 12a for experiment RNS-1 with most cells having a rounded morphology.  RNS-1, RNS-
3, and RNS-4 due to their high initial cell inoculation number (all over 700x106 total cells) 
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resulted in poor neurite outgrowth from the cells due to the contact inhibition that these cells 
maintain.  RNS-3 and RNS-4 both reached deficient conditions of either glucose depletion or 
acidic pH values during the culture period and could be the reason for the rounded cell 
morphology within these experiments, however RNS-1 never achieved unfavorable culture 
conditions and the medium even contained higher serum content.  It is likely that the reduced 
neurite outgrowth of these bioreactors is due to their overpopulation within the cell compartment 
with the contact inhibition properties preventing further overlap of the cells with neurites. 
The bioreactor experiments RNS-2, RNS-5, and RNS-6 with the lower initial cell 
inoculation densities (fewer than 400x106 cells) were able to maintain substantial neurite 
outgrowth under the 3D dynamic perfused culture environment within the hollow fiber-based 
bioreactor.  Figure 12b, c, and d represent the morphology of the PC12 cells in regions of these 
bioreactors, respectively, with the maximal neurite outgrowth.  Throughout the culture period of 
RNS-2 there was a steady increase in metabolic activity from the cells.  The image of Figure 12b 
demonstrates the morphology within a region of the bioreactor samples that had a moderate local 
density; however this was approximately representative of one third of the entire cell 
compartment.  The other two-thirds of the cell compartment volume were at slightly lower and 
higher local densities (with the lower local density regions shown in Figure 11).  Therefore the 
density within the bioreactor cell compartment for RNS-2 was not uniform and lead to increasing 
the initial inoculation cell number for the subsequent experiments.  Conversely, the image shown 
in Figure 12c is representative of the morphology of the PC12 cells throughout the entire 
bioreactor culture space for RNS-5 with remarkable neurite outgrowth from cells in close 
proximity to each other.  All images within this section for the 3D cultures are single images of 
z-stack reconstructions where the image shown is a compilation of the maximum intensity 
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projection of 50 images taken in the z-direction to represent the cells within the 50 µm depth of 
the 3D space imaged.  Therefore, the images do represent the substantial 3D neurite outgrowth 
from the PC12 cells achieved under dynamic perfusion conditions with the hollow fiber-based 
bioreactor.  The culture of RNS-5 and RNS-6 allowed sustainment of very high density PC12 
cell cultures with extensive neurite outgrowth between cells.  RNS-6 attempted to repeat the 
experiment of RNS-5 with the same initial conditions, but the cells within this bioreactor did not 
distribute evenly throughout the cell compartment and resulted in dispersed macroscopic tissue 
masses with low cell densities in between.  The image shown in Figure 12d is representative of 
the cell morphology within one of the large tissue masses, but not representative of the entire cell 
compartment of the RNS-6 culture.  Therefore, the overall cell morphology with extensive 
neurite outgrowth from PC12 cells maintained at a uniform high density was only achievable in 





Figure 11. Confocal images (z-stack single image reconstructions with approximate 50 µm depths) of 
fluorescently immunostained PC12 cells (with antibodies against β-III-tubulin-green and DAPI-blue) at end of six 
day culture period within hollow-fiber based bioreactor (RNS-2) demonstrating neurite outgrowth from cells within 
collagen gel a) around medium perfusion hollow fiber and b) between two medium perfusion hollow fibers (arrows 
point to fibers; magnification 200X). 
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Figure 12. Cell morphology of 3D dynamic bioreactor cultures of PC12 cells with NGF stimulation 
showing immunostaining with antibodies against β-III-tubulin neurite staining (green) and DAPI nuclear staining 
(blue) for four of the different bioreactor experiments: a) RNS-1, b) RNS-2, c) RNS-5, d) RNS-6 (all confocal z-
stack single image reconstructions approximately 50 µm depths at magnification 200X). 
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2.3.3 Comparison of neuronal network formation 
2.3.3.1 Synapsin I protein localization 
Due to the significant neurite outgrowth achieved within the PC12 cells cultured with dynamic 
conditions in the 3D culture space of the bioreactor as well as in the 2D static control cultures we 
have further investigated the properties of the neurite networks formed.  In order to observe 
synapse formation between PC12 cells after stimulation with NGF that have undergone neurite 
outgrowth after six days, we have detected synapsin I protein within the cells.  Synapsin I 
localization within cells was observed using immunohistochemical staining with anti-synapsin I 
antibodies and visualized with confocal fluorescence microscopy.  An example of synapsin I 
staining within a 10 µm thick section of a rat cortical brain slice is shown in Figure 13.  Figure 
14 displays the synapsin I (red) immunostaining throughout the 10 µm thick layer of cells with 
neurite networking  cultured on the 2D collagen coated plate.  Figure 14a displays the staining at 
low magnification where most cells stain positively for synapsin I, but the staining shows up 
mostly as diffuse speckles throughout the cell bodies.  In Figure 14b at a higher magnification, 
the synapsin I in the PC12 cells cultured on 2D plates reveals more about the localization of the 
synapsin I protein.  Both diffuse staining throughout the cell body can be seen as well as more 
clustered brighter staining within some nerve terminals and presynaptic terminal forming a 
synapse on a neighboring cell (white arrows in figure).  This localization reveals the control 
cultures on traditional 2D plates have synapsin I not just localized the nerve terminals and 
therefore is not just a marker for synapse formation within 2D PC12 cell cultures. 
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Figure 13. Fluorescent microscopic image of synapsin I immunostaining with Cy3 (red) in a rat cortical 
brain section with DAPI nuclear counterstaining (blue) at magnification 200X. Image depicts abundant red punctate 
staining with synapsin I staining in the brain. 
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Figure 14.  Confocal fluorescent images representative of  2D positive control PC12 cell cultures 
stimulated with NGF at the end of the six day culture period immunostained with antibodies against Synapsin I with 
Cy3 (red), β-III-tubulin with AlexaFluor 488 (green), and nuclear DAPI (blue) at magnifications of a) 400X, b) 
1000X, and c) same image as b without green channel. In b, arrows point to brighter punctuate staining of Synapsin 
I clustered at nerve terminals while arrowhead points to diffuse Synapsin I staining throughout cell somata (single 
image z-stack reconstructions throughout entire 10 µm depth of 2D culture). 
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Immunostaining of samples from PC12 cells cultured in 3D collagen gel within the 
dynamically perfused bioreactor environment of the hollow fiber-based bioreactor reveals 
different staining patterns than the 2D cultured cells.  Figure 15-16 display confocal fluorescent 
images of regions within the successful bioreactor cultures with the best synapsin I staining (the 
images are not necessarily representative of the entire culture space).  Figure 15a-b depicts the 
synapsin I staining in bioreactor experiment RNS-1 which is representative of regions in these 
samples where there was more neurite outgrowth.  As described earlier, RNS-1 was cultured 
with high serum containing medium which lead to an increased proliferation of the cells over 
more neurite outgrowth, with Figure 12a showing many cells with a rounded morphology.  
However, where there was substantial neurite outgrowth from the PC12 cells within RNS-1, 
there was significant synapsin I staining as multiple bright puncta in many cells (revealed in 
Figure 15b).  In bioreactor experiment RNS-2, the density of PC12 cells was lower and variable 
throughout the cell compartment.  Figure 15c-d is an example of synapsin I staining in regions of 
RNS-2 where there was a higher cell density with increased neurite networking.  This high 
density neurite networking within these regions of the bioreactor culture created numerous 
synapsin I+ puncta.  In control samples testing for residual secondary fluorescent antibody within 
the sample by performing staining with deletion of primary antibody, no signal was seen 
throughout the samples with the 594 nm laser excitation (red signal for Cy 3 secondary 
antibody). 
Subsequent bioreactor experiments were conducted to increase the cell density and 
therefore neurite networking density in order to achieve higher synapsin I expression within the 
3D dynamic bioreactor cultures.  Images of synapsin I staining within the cultures of bioreactors 
RNS-5 and RNS-6 are shown in Figure 16-16.  RNS-5 culture samples achieved extensive 
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neurite outgrowth throughout the entire cell compartment.  As a result synapsin I staining as 
bright puncta was observed throughout these samples.  However, there were a few cells detected 
with diffuse synapsin I staining throughout the cell body as seen in one cell of Figure 16a.  Most 
importantly, confocal fluorescent images of Figure 17 were taken immediately after the images 
seen in Figure 14b with the exact same laser intensity and image software settings.  However, 
even with increasing signal intensities for synapsin I staining in the RNS-5 bioreactor samples, 
diffuse speckle pattern staining could not be found in most cells.  This is demonstrated by there 
being only one cell within Figure 16a showing diffuse staining within the cell body with all other 
cells only possibly containing punctate staining. 
PC12 cells cultured in bioreactor experiment RNS-6 experienced significant high 
densities and neurite outgrowth within certain distinct regions of the bioreactor where cells 
seemed to not distribute well upon cell inoculation.  Despite the increased neurite outgrowth 
within these accumulated areas there was not as much bright punctate staining of synapsin I and 




Figure 15.  Confocal fluorescent images of 3D dynamic bioreactor  cultures of PC12 cells stimulated with 
NGF at the end of the six day culture period for experiments RNS-1 in a and RNS-2 in c immunostained with 
antibodies against Synapsin I with Cy3 (red), β-III-tubulin with AlexaFluor 488 (green), and nuclear DAPI (blue) at 
magnficiations of 400X; b and d repeats the images of the first column without the green layers of β-III-tubulin 




Figure 16. Confocal fluorescent images of 3D dynamic bioreactor  cultures of PC12 cells stimulated with 
NGF at the end of the six day culture period for experiments RNS-5 in a and RNS-6 in c immunostained with 
antibodies against Synapsin I with Cy3 (red), β-III-tubulin with AlexaFluor 488 (green), and nuclear DAPI (blue) at 
magnficiations of 600X; b and d repeats these images of the first column without the green layers of β-III-tubulin 





Figure 17. Confocal fluorescent images of 3D dynamic bioreactor cultures of PC12 cells stimulated with 
NGF at the end of the six day culture period for experiment RNS-5 immunostained with antibodies against Synapsin 
I with Cy3 (red puncta), β-III-tubulin with AlexaFluor 488 (green), and nuclear DAPI (blue) at magnification of 
1000X (single image z-stack reconstructions throughout a 50 µm depth of the 3D samples). 
2.3.3.2 Synapsin I quantitative gene expression 
Immunostaining with anti-synapsin I antibodies allowed localization of this protein, but further 
analysis was conducted to quantify this synapsin I expression in PC12 cells across culture 
methods.  Gene expression data for PC12 cells cultured in bioreactor experiments RNS-1 
through RNS-4 was not performed because RNA was not collected from these cultures.  Figure 
18 displays the results of quantifying Synapsin I gene expression using quantitative RT-PCR 
(reverse transcriptase polymerase chain reaction, quantifies mRNA transcripts produced in cells 
corresponding to the activity of synapsin I genes being transcribed).  The first two bars on the 
graph show the difference in Synapsin I gene expression from PC12 cells in their normal 
chromaffin phenotype untreated with NGF compared to the neuronal phenotype after NGF 
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stimulation for five days during the culture period.  Synapsin I gene expression between the 
PC12 cells cultured in 3D static collagen gels shows no significant differences between the cells 
cultured at the three different densities.  There is a significant difference of Synapsin I gene 
expression of PC12 cells cultured at the low density in the 3D static collagen gels compared to 
the cells cultured on a 2D surface with NGF stimulation (p-value <0.05).  The Synapsin I gene 
expression of cells cultured in the bioreactor RNS-5 is approximately equal to the 2D cultured 
cells with NGF stimulation.  The expression within the RNS-6 bioreactor culture was, however, 
substantially lower. 
 
Figure 18. Quantitative RT-PCR results comparing gene expression ratios for synapsin I among different 
PC12 cell culture types (for 2D and gel cultures bars represent means n = 3 replicate cultures with error bars 
representing standard deviation). 
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2.3.3.3 Synapsin I protein quantification 
We have implemented the Western blot assay in order to further quantify detection of the 
synapsin I proteins within the different culture methods of PC12 cells.  The Western blots were 
carried out using the same anti-synapsin I antibody used for immunostaining results of section 
2.3.3.1.  Samples for bioreactor experiment RNS-1 were not possible because protein from this 
experiment was not collected from the cells.  Western blots for samples from bioreactor 
experiments RNS-3 and RNS-4 were performed and showed no band for synapsin I detection 
since these bioreactors did reach unhealthy culture conditions (data not shown).  Figure 19 shows 
the results of blotting for synapsin I as well as the loading control protein GAPDH with all 
samples run on the same gel and developed together with the same exposure time for each 
antibody.  The control rat cortical brain whole cell lysate is shown on the farthest right lane 
loading only 1.5 µg protein.  Even with this small amount of brain protein loaded synapsin I is so 
abundant in brain tissue that the blot shows up as a smear down the lane.  The second to last lane 
contained a control ladder with known molecular weight standards showing that the synapsin I 
bands close to the 75 kDa marker.  Synapsin I should be present as a 77-80 kDa molecular 
weight protein, which it does here as well in the PC12 cell samples.  However, normal rat brain 
synapsin I shows up as a doublet at 77 and 80 kDa representing synapsin Ia and Ib isoforms.  
Within the PC12 cells it shows up as a singlet around these molecular weights.   
 The differences in protein detection between PC12 cells cultured on 2D plates without 
and with NGF stimulation are seen in the first and second lanes, respectively.  Again, along with 
the results of qRT-PCR quantification of synapsin I expression in these two groups shows only a 
small increase due to NGF stimulation.  There is a high level of protein already existing within 
the untreated non NGF-stimulated 2D cultured control PC12 cells of the chromaffin phenotype.  
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Lanes 3-5 represent the synapsin I protein detection of PC12 cells cultured statically in a 3D 
collagen gel at the lowe density of 1x103 cells/mm3, medium density of 2.5x103 cells/mm3, and 
high density of 5x103 cells/mm3.  Protein collected from PC12 cells cultured in the 3D dynamic 
bioreactor of experiments RNS-2, RNS-5, and RNS-6 are shown in lanes 6-8, respectively.  The 
bands detecting synapsin I for all NGF treated samples (which only excludes the first lane with 
control untreated PC12 cells)  display approximately the same quantities of synapsin I protein 
within the samples.  However, some samples such as the 2D NGF stimulated samples and all 
bioreactor samples display darker bands of lower molecular weights.  These bands correspond to 
the banding pattern similar to synapsin IIa, IIb, and III.  The sample for RNS-2 shows an 








Figure 19. Western blot of all samples detecting synapsin I (~78 kDa). Samples include 2D cultured PC12 
cells without (Neg) and with (Pos) NGF stimulation, 3D static collagen gel samples (3D Static) at the three different 
densities tested, bioreactor experiment samples from RNS-2, RNS-5, and RNS-6, and control rat cortical brain 
lysate.  Some samples display multiple bands with a banding pattern similar to the lower molecular weights for 
Synapsin IIa, IIb, and III. Cortical rat brain lysate displays smearing of detection through the lane due to the 
abundance of synapsin I within the brain at the same sample loading as the PC12 cells. Also, with loading control 
GAPDH (36 kDa). 
 
We have also detected synaptophysin by Western blot with the protein collected from the 
different PC12 cell cultures.  The same Western blot above is shown in Figure 20 with re-
blotting for synaptophysin.  Synaptophysin is present as a synaptic vesicle associated protein 
within normal nerve tissue.  However, for the PC12 cells synaptophysin is highly present within 
the normal untreated chromaffin phenotype cells.  Upon NGF stimulation within the 2D cultures 
there is a decrease in synaptophysin expression, as shown in lane 2 compared to lane 1.  The 
intensity of the bands for the PC12 cells cultured in the 3D static collagen gels shows an increase 
in synaptophysin with increasing density of cells cultured within the gels under static conditions.  
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The sample collected from bioreactor experiment RNS-2 displays very little synaptophysin 
detection, whereas the samples collected from bioreactor experiments RNS-5 and RNS-6 display 
a high detection of synaptophysin. 
 
Figure 20. Western blot of all samples detecting synaptophysin (40 kDa). Samples include 2D cultured 
PC12 cells without (Neg) and with (Pos) NGF stimulation, 3D static collagen gel samples (3D Static) at the three 
different densities tested, bioreactor experiment samples from RNS-2, RNS-5, and RNS-6, and control rat cortical 
brain lysate. Also, with loading control GAPDH (36 kDa). 
2.3.3.4 Phosphorylated Synapsin I localization  
In order to further investigate synapsin I within PC12 cells with different culture methods we 
have continued by attempting to look at the phosphorylated active form of synapsin I.  Synapsin 
I can be phosphorylated at least at six different sites, which are at serine residues and is the 
active form when phosphorylated.  We have used antibodies specifically detecting synapsin I that 
is under current phosphorylation at two different sites.  The first antibody used detected synapsin 
I phosphorylated serine 553 residue (Ser 553).  The results of localization of this phosphorylated 
synapsin I and PC12 cells cultured on collagen coated 2D plates stimulated with NGF after the 
six day culture period is shown in Figure 21.  These images represent areas within the 2D sample 
of the most significant staining detected.  Within 2D cultured PC12 cells stimulated with NGF, 
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the phosphorylated synapsin I is detected mostly as small red puncta correlating with nerve 
terminals.  However, there is still some phosphorylated synapsin I staining shown as diffuse 
speckling pattern throughout parts of the cell bodies in some of the cells.  Therefore, this 
antibody more accurately shows active synapsin I within the PC12 cells, but is still not an 
exclusively specific marker for only synaptic transmission of a nerve terminal.   
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Figure 21. Confocal fluorescent images of 2D static cultures of PC12 cells stimulated with NGF at the end 
of the six day culture period immunostained with antibodies against phosphorylated-Synapsin I (site Ser553) with 
Cy3 (red puncta), β-III-tubulin with AlexaFluor 488 (green), and nuclear DAPI (blue) at magnficiation of 1000X 
(single image z-stack reconstructions throughout the 10 µm depth).  Images shown on right are same images on left 
excluding green channel allowing visualization of all phosphorylated synapsin I (Ser 553) staining. 
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Figure 22a represents a region within a sample from bioreactor experiment RNS-5 with 
significant phosphorylated synapsin I immunostaining.  The image in Figure 22b is 
representative of staining seen throughout most of the RNS-5 tissue samples.  Again, the staining 
for synapsin I phosphorylated at the serine 553 residue is detected as strong bring punctate 
staining with no diffuse speckle patterns throughout the cytoplasm.  Later phosphorylated 
synapsin I staining was not performed on samples from bioreactor cultures RNS-1 and RNS-2 
because all samples were already previously stained.  Since synapsin I staining in samples from 
bioreactor culture RNS-5 were superior to that of RNS-6, these RNS-6 samples were not 
continued to be stained for phosphorylated synapsin I antibodies. 
 
Figure 22. Confocal fluorescent images of 3D dynamic bioreactor cultures of PC12 cells stimulated with 
NGF at the end of the six day culture period for experiment RNS-5 immunostained with antibodies against 
phosphorylated-Synapsin I (site Ser553) with Cy3 (red puncta), β-III-tubulin with AlexaFluor 488 (green), and 
nuclear DAPI (blue) at magnification of 400X (single image z-stack reconstructions throughout a 50 µm depth of 
the 3D samples). 
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2.3.3.5 Phosphorylated Synapsin I protein quantification 
It was not possible to accurately detect phosphorylated synapsin I in RNS-2 bioreactor samples 
due to the protein collection method using a first step of collagenase digestion and lysis buffer 
not compatible with preserving phosphorylated protein states.  Protein from PC12 cells was first 
collected using collagenase digestion step in order to remove collagenous proteins from samples 
leaving protein samples with mostly cell lysate.  However, Synapsin I has a collagenase sensitive 
tail and digestion with collagenase might not allow complete recovery of cells with extensive 
neurite processes intact during centrifugation before the cell lysis step [213].  Control 3D static 
collagen gels were repeated in order to test the Ser 553 phosphorylated synapsin I antibody on 
the two different collection methods used.  The first being collagenase digestion and cell lysis 
with MPER buffer and the second using TGN buffer added directly to entire collagen gel-cell 
construct treated like tissue.  The results of this experiment are not shown, but proved that using 
the 3D static collagen gel cultures with protein collected via collagenase digestion and MPER 
lysis buffer were not able to detect phosphorylated synapsin due to no bands up for the western 
blot.  However, we decided to include the RNS-2 protein sample the Western Blot shown in 
Figure 23 detecting phosphorylated synapsin I (Ser 553). 
Figure 23 depicts the results of the Western blot detecting site Serine 553 phosphorylated 
synapsin I among samples from different culture methods of PC12 cells.  In the last lane to the 
far right, a positive control sample of cortical brain lysate is shown marking the accurate 
molecular weight of approximately 80 kD for this protein.  All protein samples used for this 
Western Blot, except for that of RNS-2, were collected immediately at end of culture with the 
lysis buffer preserving phosphorylated proteins.  Therefore, the intensity of the band for the 
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RNS-2 bioreactor culture sample is not accurately accessable because the actually 
phosphorylated protein within this sample could have been higher. 
The loading for this Western blot was not exactly equal across all samples as shown by 
different intensities of some GAPDH bands.  Quantification of the intensities of the bands of 
Figure 23 was performed using free NIH Image J software.  The results of expressing the relative 
intensity of the bands for p-synapsin I (Ser 553) to their respective GAPDH bands is show in 
Figure 24.  Plotting this data shows an increase in phosphorylated synapsin I (Ser 553) found in 
samples from 2D PC12 cell cultures stimulated with NGF over the untreated non-NGF 
stimulated PC12 cells.  The relative intensities for the 3D static collagen gel cultures demonstrate 
lower amounts of active phosphorylated synapsin I than either 2D NGF stimulated cultures or 
RNS-5 3D bioreactor culture with a further decrease among the 3D static cultures with 
increasing cell density.  The 3D static gel with the highest initial cell density of 5x103 cells/mm3 
contains the lowest amount of active phosphorylated synapsin I (Ser 553) demonstrating a large 
increase in cell density of cultures under static conditions does not allow increased active 
synapsin I.  However, when comparing the samples of 2D cultured PC12 cells with NGF 
stimulation to the samples of 3D dynamic bioreactor cultures of RNS-5 and RNS-6 show equal 
detection of phosphorylated synapsin I (Ser 553). 
Figure 25 demonstrates the Western blot using an antibody specific for site I 
phosphorylation on synapsin I on the serine 9 residue (Ser 9).  The antibody used here was raised 
against a synthetic human phosphorylated synapsin I peptide.  The antibody detected 
phosphorylation at site I of all isoforms of synapsin, including synapsin I, IIa, IIb, and III, 
corresponding to the four top bands appearing in Figure 25.  This is only an example of the 
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banding pattern for p-synapsin Ser 9 and cannot be used to directly compare the 2D PC12 cell 
culture and bioreactor culture RNS-5 because loading was not checked with GAPDH. 
 
Figure 23. Western blot of all samples detecting Synapsin I phosphorylated at the Ser 553 site (~78 kDa). 
Samples include 2D cultured PC12 cells without (Neg) and with (Pos) NGF stimulation, 3D static collagen gel 
samples (3D Static) at the three different densities tested, bioreactor experiment samples from RNS-2, RNS-5, and 
RNS-6, and control rat cortical brain lysate.  Also, with loading control GAPDH (36 kDa). 
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Figure 24. Quantification of Western blot for synapsin I phosphorylated at serine 553 (Ser 553) by 
measuring band intensities with NIH software ImageJ and plotting ratio of p-synapsin I (Ser 553) to GAPDH to 
normalize samples accounting for unequal loading (Gels are shown labeled as the three different densitites tested). 
 
Figure 25. Example of Western blot using antibody detecting Synapsin I phosphorylated at the Ser 9 site; 
this antibody should be specific but instead shows a multiple band pattern similar to that of all four synapsin proteins 




For PC12 cells cultured under static conditions within 3D collagen gels, only very low densities 
were effectively able to be maintained.  The culture of 2.5x106 cells/1 mL gel was not able to 
maintain sufficient nutrition and acceptable pH values.  The culture of 5x106 cells/1 mL gel 
reached conditions of depleted glucose as soon as culture day 2 also with pH levels mostly below 
7.0.  Cell morphology visualized with confocal fluorescence microscopy revealed only cultures 
at low density within static 3D collagen gels provided conditions necessary for extensive neurite 
outgrowth from the cells.  This metabolic data seems to indicate that the acidity of the culture 
medium is due to the lactate accumulation rather than the limitations on gas diffusion within the 
static culture.  Cullen et al. describe cultures of rat embryonic cortical neurons with postnatal 
astrocytes at densities above 5x103 cells/mm3 under static conditions in 3D had significantly 
reduced viability of cells [225].  They also observed delayed cell death at low density cultures, 
possibly due to the lack of available neuron-neuron interactions.  This work along with the 
literature demonstrates the need for dynamic conditions in order to sustain high density neuronal 
cell cultures in thick 3D configurations.  Also, very thick 3D tissue formation will eventually 
also be limited by gas transport through a tissue maintained in a scaffold only having dynamic 
perfusion of medium.  This problem is as easily solvable as increasing medium flow rates using 
the hollow fiber-based bioreactor designs used here.  These limitations are outlined in the below 




Figure 26. Diagram describing differences in culture conditions between a) 3D static conditions with cells 
encapsulated within an ECM hydrogel scaffold maintained in a Petri dish and b) 3D dynamic conditions with cells 
within the cell compartment of the 8 mL hollow fiber-based bioreactor (yellow tubes indicating gas perfusion fibers 
and red and blue tubes indicating counter-current flow through medium perfusion fibers). 
 
Using lactate concentration as an indicator of cell number, the metabolic data from 3D 
static and 3D dynamic bioreactor cultures demonstrates the ability of the PC12 cell line to 
proliferate at different rates depending on the surrounding cell density.   The lactate curve for the 
1x106 cells/gel culture only reaches a maximum of 3 mmol/L by the end of the culture which is 
approximately only 20% of the concentration reached by the other density cultures, which both 
reach the same concentration at 16.5 mmol/L.  This is in contrast to initial reports of NGF effects 
on PC12 cultures where proliferation ceases upon NGF stimulation and neurite outgrowth 
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begins[191, 192, 226, 227].  It is only under higher serum conditions that PC12 cells have a 
doubling time of 48-96 hours [227].   
The culture of PC12 cells within the hollow fiber-based bioreactor maintaining dynamic 
flow conditions with perfusion of the cell compartment allowing homogeneous and decentralized 
nutrition and oxygenation allowed significant neurite outgrowth in three dimensions throughout 
the collagen gel.  In bioreactor experiments such as RNS-5, significant neurite outgrowth was 
visualized throughout the entire 8 mL cell compartment of the bioreactor.  Macroscopic tissue 
formation was seen in all bioreactor experiments.  Traditional two dimensional culture plates 
allow extensive neurite outgrowth between PC12 cells, but the only method able to produce 
extensive neurite outgrowth especially at high densities throughout 3D collagen gels was using 
dynamic conditions in the hollow fiber-based bioreactor. 
We have observed synapsin I expression in PC12 cells among the different culture types 
using immunohistochemical staining visualized with confocal fluorescence microscopy, Western 
blot, and qRT-PCR.  Within control 2D static PC12 cell cultures, Western blot and qRT-PCR 
revealed an initially high level of synapsin I expression within untreated non-NGF-stimulated 
PC12 cells.  Also, the qRT-PCR data presented here revealed a very small increase in synapsin I 
gene expression in NGF treated PC12 cells over untreated.  Romano et al. described a low level 
of synapsin I expression detected with Western blot from untreated PC12 cells, with a significant 
increase in detection of NGF treated PC12 cells [214].  Das et al. plotted a curve representing a 
significant increase in synapsin I over the course of 6 day NGF stimulation in PC12 cells [220]. 
We expected a higher increase in synapsin I expression in the control 2D cultures between non-
NGF stimulated cells and NGF stimulated cells in order to see a range of expression according to 
increased neuronal phenotype of the PC12 cells over their non-neuronal phenotype.  However, 
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the cells used in these studies are Neuroscreen-I cells, a sub-cloned population of the original 
PC12 cell line used in other previous studies and could be the reason for discrepancies between 
our results with previous reports.  Other inconsistencies have risen using the PC12 cell line 
between initial cell line use and more recent reports including PMNT activity and epinephrine 
synthesis [228].  Eaton et al. purport discrepancies to be due to lack of cell line subcloning to 
achieve homogeneous populations and that initial reports were most likely using a very 
heterogeneous population of cells [228].   
The lower increase in synapsin I expression demonstrates an inadequacy of the PC12 cell 
line to perfectly model real neurons.  As described earlier, real neurons of the developing 
nervous system display an increase of synapsin I expression correlating with neurite outgrowth 
and synaptogenesis.   Romano et al. also claims synapsin I detection by Western blot was 
independent of cell density [214].  If synapsin I quantification is not density dependent within 
PC12 cells, it cannot correlate with synaptogenesis.  This implies synapsin I is not a useful 
marker to delineate the stage of the chromaffin phenotype of the PC12 cell to the neuronal 
phenotype after NGF stimulation, especially referring to synaptogenesis.  Therefore, our results 
of Western blot quantification and qRT-PCR do not necessarily show that the 3D dynamic 
bioreactor cultures of PC12 cells are only equal in synapse formation compared to control 2D 
static cultures based on comparing synapsin I expression. 
Normal non-neoplastic cells of the medullary regions of the adrenal gland are chromaffin 
cells.  The normal function of chromaffin cells in the adrenal gland is to store catecholamines, 
including dopamine and epinephrine, and release them upon stimulation by the sympathetic 
nervous system directly into the blood and not through typical synapses [228].  These chromaffin 
cells do not express synapsin I, but the neoplastic aspect of the PC12 cell line makes them very 
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different from their non-transformed chromaffin cell counterparts [214, 228]  The chromaffin 
cells secrete the catecholamines via abundant membrane-bound dense granules which are only 
transported along microtubules to the cell surface [228].  The functions of chromaffin cells 
closely resemble that of neurons, which have the same function of neurotransmitter secretion 
except via specialized synapses.  PC12 cells potentially very closely resemble neurons even at 
the untreated chromaffin like phenotype without NGF stimulation.  Again, use of this cell line to 
specify enhanced neuronal phenotypes comparing treated vs. nontreated controls may not allow 
enough change expression of proteins useful in synaptic transmission due to the similarities of 
vesicle transport and catecholamine secretion in both phenotypes with and without NGF 
stimulation.  It is possible that the subcloned population available as the Neuroscreen-I line of 
the PC12 line, is already a more neuronal-like phenotype population than the original PC12 line 
and a reason for the increase in synapsin I expression. 
Localization of synapsin I with immunohistochemistry and confocal fluorescent 
microscopy revealed that NGF stimulated static 2D cultures had diffuse staining throughout the 
cell bodies of cells and brighter clustered staining only at nerve terminals, especially those 
forming synapses with neighboring cells as seen in Figure 14.  The results of Foster-Barber and 
Bishop display synapsin I staining in PC12 cells stimulated with NGF as bright diffuse staining 
throughout the entire cytoplasm of all cells [229].  It is possible that the non NGF-stimulated 
PC12 cells maintain diffuse levels of synapsin I throughout the cytoplasm and after NGF 
stimulation the synapsin I partially relocates to the nerve terminals and presynaptic endings of 
the neurites formed.  This theory would imply the importance of synapsin I localization using 
immunostaining with fluorescence microscopy instead of whole cell lysate protein collection and 
quantification by Western blot.   
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Surprisingly, immunostaining of samples from 3D dynamic bioreactor cultures for 
synapsin I mostly showed bright punctate staining.  It was only in some cells of samples from 
experiment RNS-6, where qRT-PCR synapsin I expression was lower, that diffuse synapsin I 
staining throughout a cell body was ever seen in bioreactor samples.  Images shown in Figure 15 
and Figure 17 display this staining as bright red puncta of varying sizes.  Brigadski et al. 
discusses secretion of neurotrophins from synapsin I positive presynaptic terminals in 
hippocampal neurons displaying immunostaining for synapsin as similar bright immunoreactive 
dots [230].  Results of Gitler et al. also show similar fluorescent punctate staining of synapsin I 
in neurons as bright varying sized dots [212].   Unfortunately, here in our work the confocal 
microscopic images display a substantial amount of broken neurites.  This is due to the sample 
retrieval methods after opening the bioreactor, where the samples including the hollow fibers are 
cut out using a scalpel as seen in Figure 6.  Therefore, it is difficult to precisely localize the 
bright punctate staining of synapsin I in the bioreactor samples only to nerve terminals and 
synapses.   
However, it is possible that this punctate staining does express a significant difference in 
synapsin I of PC12 cells cultured with dynamic conditions in three dimensions within the 
bioreactor over the 2D static control cultures.  Z-stacks of confocal images displayed as rotating 
3D reconstructions among only some images where the neurites are more intact, especially from 
samples of RNS-1, reveals the bright red punctate staining can be localized to nerve terminals.  
This is only observable by 30 degree rotation of the 3D reconstructed image to demonstrate the 
synapsin I red puncta around the surface of a cell membrane.  An example of this staining in an 
image from bioreactor experiment RNS-1 is shown in Figure 27 below.  The variable size of the 
immunoreactive red puncta can be explained with varying sizes of synaptic vesicle clusters 
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(SVCs).   Bloom et al. demonstrated with transmission electron microscopy the localization of 
synapsin I to SVCs as individual dots within the clusters of vesicles at a very high magnification 
[207].  Figure 28 is a diagram from this report demonstrating the visualization of an SVC by 
reconstructing the TEM serial sections.  This depicts the bright red puncta in immunostained 
images with our work to correspond to a collection of synapsin I proteins throughout an SVC, so 
the brighter the puncta the larger the SVC is containing more vesicles.  The larger, brighter 
synapsin I puncta staining within the 3D dynamic bioreactor cultures of PC12 cells over the 2D 
control cultures possibly infers there are larger SVCs generated within some of the PC12 cells 
cultured with  dynamic 3D perfusion conditions.  Also, due to the lack of diffuse synapsin I 
staining throughout the cell bodies of the 3D bioreactor samples it is likely that these cells have 
further matured and undergone complete synaptogenesis with present synapsin I collecting in 
SVCs to function more like real neurons for synaptic vesicle trafficking instead of the more 
chromaffin like phenotype of granule secretion directly through the cytoplasm. 
Tao-Cheng et al. have demonstrated very similar results comparing synapsin I and 
synaptic vesicle clustering comparing 2D cultured NGF treated PC12 cells with both NGF 
stimulation and K-ras oncogene overexpression [231].  These authors demonstrated with electron 
microscopy that synapsin I+ synaptic vesicles clustered with larger numbers of synaptic vesicles 
and at higher frequencies with the additional treatment of ras overexpression.  Even with these 
differences observed the two treatment groups from imaging synapsin I expression they observed 
no difference when quantifying synapsin I with Western Blot.  The doubly treated cells had the 
same overall quantification of synapsin I compared with the NGF treated cells.  Therefore, these 
results support our hypothesis that the increased punctate immunostaining of synapsin I within 
the PC12 cells cultured within the 3D dynamic bioreactor correlates with more synaptic vesicle 
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clustering compared to the 2D cultures.  Also, these authors discuss synaptophysin expression 
among the PC12 cells explaining that with electron microscopy synaptophysin is localized not 
just to synaptic vesicles within normal untreated PC12 cells, but as well as other organelles such 
as Golgi apparatus.  They demonstrate that there is a re-localization of synaptophysin within 
PC12 cells after NGF stimulation to the synaptic vesicles of the nerve terminals.  However, there 
is an overall decrease in synaptophysin expression within normal 2D cultured samples.  Here, we 
see this increase in synaptophysin among the 3D statically cultured collagen gels with higher 
densities, correlating with the poor differentiation of these cells to the neuronal phenotype.  
However, the increase of synaptophysin within the RNS-5 bioreactor sample could correlate with 
an increase in the synaptophysin that is localized to the nerve terminals.  Further work to clarify 
this with synaptophysin immunostaining and confocal fluorescent microscopy could therefore 





Figure 27. Confocal fluorescent images of 3D dynamic bioreactor  cultures of PC12 cells stimulated with 
NGF at the end of the six day culture period for experiments RNS-1 immunostained with antibodies against 
synapsin I with Cy3 (red), β-III-tubulin with AlexaFluor 488 (green), and nuclear DAPI (blue) at magnficiation 
400X. Image to right is duplicate of image on left without the green layers of β-III-tubulin revealing all Synapsin I 
staining in red (single image z-stack reconstructions throughout a 50 µm depth of the 3D samples).  Arrows point to 
red punctate staining of synapsin I that localizes to the surface of the PC12 cells shown, which is further 





Figure 28.  From Bloom et al. a 3D reconstructed diagram of a synaptic vesicle cluster. Synaptic vesicles 
are shown as red spheres with white dots representing synapsin I tethering the vesicles in the cluster. The plasma 
membrane marking the border dividing the presynaptic cleft at the top portion and postsynaptic dendrite to the 
bottom is shown in green. An actin rich cytomatrix is shown in yellow surrounding the SVC. 
 
 In order to further investigate synapsin I within PC12 cells with different culture methods 
we have continued by attempting to look at the phosphorylated active form of synapsin I.  
Synapsin I can be phosphorylated at least at six different sites, which are at serine residues.  The 
protein undergoes conformational changes after phosphorylation that decreases the binding 
affinity for tethering the synaptic vesicles together.  Hosaka et al. demonstrated that 
phosphorylation of the synapsins at site I or serine residue 9 dissociates synapsins from synaptic 
vesicles and shows this site phosphorylation significance for participating in synaptic 
transmission within normal neurons [206].  However, Romano et al. and Hall et al. discovered 
that NGF stimulation of PC12 cells phosphorylated synapsin I at a novel specific site, that of 
serine residue 553 [209, 232].  We have therefore used antibodies directed towards both 
phosphorylation sites in order to investigate active synapsin I protein within the PC12 cells 
among the different culture methods.  The Western blot using the site I Ser 9 antibody detected 
 95 
this site within all four synapsin isoforms and therefore made it unable to easily quantify this 
detection.   
 Since the site Ser 553 is more relevant within NGF stimulated PC12 cells, we have 
focused on the use of the antibody directed towards this site.  Immunostaining results with this 
antibody showed very few bright puncta of active synapsin I within control 2D cultured PC12 
cells with NGF stimulation.  Immunostaining with this antibody on bioreactor cultured PC12 
cells for experiment RNS-5, however, contained numerous bright puncta throughout the tissue 
samples.  However, again quantification with Western Blot of the phosphorylated synapsin I at 
Ser 553 evidenced in Figure 24 showed approximately equal levels of active protein within the 
PC12 cells cultured in the 3D dynamic conditions of the bioreactor in RNS-5 compared with the 
control 2D cultured NGF stimulated cells.  This Western blot also showed a decrease in active 
synapsin I of the PC12 cells cultured at a high density within 3D statically cultured collagen gels 
that underwent poor culture conditions due to accumulating lactate concentrations.   
 Only confocal imaging has been able to reveal significant differences of synapsin I 
expression between PC12 cells cultured on 2D surfaces compared to 3D dynamic bioreactor 
culture.  Imaging revealed larger synaptic vesicle clustering within some of the PC12 cells 
cultured with 3D dynamic conditions in the bioreactor, but with some cells showing no positive 
staining for synapsin I.  Almost all PC12 cells cultured on 2D surfaces demonstrate synapsin I 
immunostaining, however most of the staining is displayed as diffuse speckled pattern 
throughout the cytoplasm.  This explains why the quantification of synapsin I of samples 
containing collection of protein or mRNA from all cells shows no overall differences between 
2D and 3D dynamic bioreactor cultures. 
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 Results of Xue et al. revealed diffuse immunostaining pattern of synapsin I with site I Ser 
9 phosphorylation within untreated non-NGF stimulated control PC12 cells [233].  Also, here 
using the antibody for phosphorylated synapsin I (Ser 553) also still detects some diffuse 
synapsin throughout the cell bodies as active phosphorylated proteins and therefore again makes 
it impossible to accurately quantify synapse formation among the PC12 cell cultures.  This 
implies that the untreated chromaffin phenotype of PC12 cells have active synapsin I 
participating in vesicle transport through their adrenal-type movement directly through the 
cytoplasm instead of through the neuronal synaptic transport of vesicles.  Immunostaining of our 
treated NGF stimulated 2D cultured PC12 cells shows bright puncta at active nerve terminals 
indicating synaptic vesicle transmission, but some diffuse speckling throughout the cytoplasm 
with this synapsin participating in the non-neuronal vesicle transmission.  Immunostaining of the 
PC12 cells cultured in the 3D dynamic bioreactor reveals only bright punctate staining implying 
a more mature neuronal phenotype participating in vesicle transport only through typical 
synaptic transmission. 
2.5 CONCLUSIONS 
Initial experiments demonstrated the original PC12 cell line forms large tissue aggregates within 
high density 3D cultures under dynamic conditions.  However, the Neuroscreen-1 subcloned cell 
line allows superior observation of the neurite outgrowth within the different culture types.  The 
data presented using the Neuroscreen-1 cell line with NGF stimulation among different culture 
conditions leads to the conclusion that in order to maintain high density neurite networking of 
Neuroscreen-1 cells with active synaptic transmission in three dimensions, a dynamic culture 
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system like that demonstrated here of the hollow fiber-based bioreactor is necessary.  It is also 
likely that the 3D dynamic culture described here allowed enhanced synaptic transmission 
among the Neuroscreen-1 cells with larger synaptic vesicle clusters containing active synapsin I 
at nerve terminals.  Within the optimized bioreactor culture in experiment RNS-5 it is possible 
that some of the Neuroscreen-1 cells were able to differentiate into a more mature neuronal 
phenotype with only synaptic transport of vesicles compared to the 2D cultured NGF stimulated 
cells.  This work has initiated discussion of improving synapse formation among in vitro 
neuronal cultures to more accurately reflect the in vivo situation.  However, significant 
differences comparing 2D statically cultured Neuroscreen-1 cells to those cultured in a 3D 
dynamic situation were difficult due to the Neuroscreen-I cell line used here maintaining the 
property of contact inhibition.  This work leads to the hypothesis that it might be possible to 
achieve more significant synapse formation using primary neurons cultured within the 3D 
dynamic environment able to form neuronal tissue structures compared with traditional culture 
methods on 2D surfaces. 
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3.0  TESTING ECM SCAFFOLDS FOR ENHANCING NEURAL STEM CELL 
SURVIVAL AND DIFFERENTIATION WITHIN HOLLOW FIBER-BASED 
BIOREACTORS 
3.1 INTRODUCTION 
3.1.1 Neural stem cells (NSCs) 
Proliferating neural cells were discovered in the adult rat brain in the late 1960s [37].  Reynolds 
and Weiss, in 1992, were the first to demonstrate that neural stem cells could be isolated from 
the adult and embryonic mouse brain able to clonally self-renew or differentiate into the three 
major cell types of the central nervous system (neurons, astrocytes, and oligodendrocytes) [234, 
235].  Today, neural stem/progenitor cells can be isolated from both fetal central nervous system 
(CNS) ganglionic eminence(s) in the embryo and adult CNS locations at the subventricular zone 
(SVZ) of the lateral ventricles or the subgranular zone (SGZ) of the hippocampal dentate gyrus 
(DG), and throughout areas of the spinal cord [37, 236].   
Protocols for expanding these cells in culture have been refined to allow significant 
expansion of the neural progenitors while maintaining their “stemness” or ability to self-renew 
producing many progeny and differentiate into the three major central nervous system cell types 
[237].  The cells are usually grown as cell clusters termed neurospheres in serum-free media 
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containing epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF/FGF2) [37].  
Adult mouse neurospheres can easily be expanded in suspension culture whereas adult rat 
neurospheres are grown in 96 well plates utilizing the walls of the wells for attachment.  Adult 
NSCs have been shown to divide less frequently than the embryonic/fetal NSCs leaving a 
possible advantage to the fetal derived NSCs [20].  Therefore, we have continued the work in 
this chapter utilizing the commercially available source of mouse neurospheres obtained from the 
striatum of the embryonic mouse brain from the company Stem Cell Technologies Inc. 
(Vancouver, B.C., Canada).  Neural stem/progenitor cells isolated from these regions can 
differentiate into astrocytes, oligodendrocytes, and neurons after withdrawal of EGF and addition 
of serum [37].  The neurospheres in culture are a combination of progenitor cell populations 
capable of differentiating into all three lineages to neurons, astrocytes, and oligodendrocytes.  
Lobo et al. has described rat neurospheres generated in vitro to consist of at least two different 
cell types [238].   Figure 29 depicts the relationships between these different progenitor cell 
populations and their progeny of terminally differentiated neuronal cell types [37, 239-241].   
The final terminal differentiation of a neural stem cell through the progenitor cell types 
leads to a neuron, astrocyte, or oligodendrocyte.  Neurons are the primary functioning cell type 
of the nervous system allowing signal propagation and communication within the brain and the 
rest of the body.  Neurons are therefore the most desired cell type with neural stem cell 
differentiation to enable replacement of functional tissue within the damaged or diseased nervous 
system.  Astrocytes were thought to only perform supporting roles to neurons acting as 
scavengers and forming the blood brain barrier to maintain and regulate a healthy environment in 
the nervous system tissue [242].   Reactive astrocytes are major contributors to the glial scar 
formed after spinal cord injury, preventing nerve regeneration, but recent investigations have 
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shown astrocytes can also provide support and guidance for neurons during regeneration [243].  
Davies et al. have demonstrated glial restricted progenitor cells treated with different 
neurotrophic factors have differential effects on spinal cord injury repair [244].  Therefore the 
control over improving nerve regeneration by addition of astrocytes could be beneficial, but 
needs refining in order to have a positive outcome.  Oligodendrocytes are the cells of the central 
nervous system that create insulation of signal propagation through neurons by wrapping their 
cytoplasmic processes around the axons of neurons forming a myelin sheath, a dielectric 
phospholipid layer.  It is this myelin sheath of oligodendrocytes that is damaged in the disease 
multiple sclerosis, contributing improper signal transduction and further degeneration of axons.  
Therefore, the oligodendrocytes are also a highly sought after population of cells derived from 
neural stem cell differentiation. 
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Figure 29. Diagram describing neural progenitor cell populations arising from the astrocytic neural stem 
cells found in the neurogenic regions of the brain.  The transit amplifying nestin positive progenitor cells are the 
EGF responsive cell type able to generate neurospheres in culture.  All progenitor populations of the neural stem 
cells are able to terminally differentiate into the post-mitotic three major cell types of the central nervous system: 
neurons, astrocytes, and oligodendrocytes.  Looped arrows imply cell type can symmetrically divide to self-renew 
itself.  Straight arrows imply cells can asymmetrically divide into the specified more differentiated cell type. 
 
Neural stem cells in vivo have very specific niches within the brain.  These neural stem 
and progenitor cell niches are distinct regions having specific cellular, molecular, and structural 
components in order to maintain both long term preservation of the stem cell populations and 
regulation of differentiation for neural cell repopulation.  Embryonic neural stem cells, used in 
this work instead of adult derived cells, are derived from the entire embryonic striatum which 
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includes the adult subventricular zone (SVZ).  Doetsch et al. first described the cellular 
organization of neural progenitor cells within the SVZ niche of the adult mammalian brain [245].  
This group demonstrated that the progenitor populations reside inside the lateral wall ependymal 
cell lining of the lateral ventricles.  Within this layer, the type A neuroblast populations reside in 
migratory tracts lined by type B1 and B2 stem cells with intermittent clusters of the transit-
amplifying progenitor type C cells.  Multiple groups have described that the neural stem cell 
population within the SVZ are actually a specific type of astrocytes [239, 246].  In 2003, Doetsch 
described that the quiescent type B1 astrocytes are the actual stem cells of the SVZ which give 
rise to the more rapidly proliferating type C cells which undergo asymmetric division into 
neuroblasts [241].  Recently, Mirzadeh et al. discovered that the B1 astroctyic neural stem cells 
have a pinwheel organization with direct apical endings touching the ventricle plus a long basal 
process reaching throughout the subventricular zone ending on blood vessels [247].  Doetsch et 
al. also describes the location of neural stem cells of the SGZ in the hippocampal formation of 
the adult mammalian brain [241].  The same type B1 astrocytes reside within this niche lining 
blood vessels and give rise to type D immature dividing cells that can asymmetrically divide into 
polysialylated neural cell adhesion molecule, PSL-NCAM, positive granule neurons.  Doetsch et 
al. have also demonstrated that it is the type C transit amplifying population of neural progenitor 
cells within the SVZ in vivo that give rise to the EGF responsive population able to generate 
neurospheres in vitro [240].  Ependymal cells from the SVZ region have been demonstrated by 
Capela et al. to not be the cell population able to generate neurospheres in vitro [248]. 
Mercier et al. have investigated the ECM components of the SVZ niche for neural stem 
and progenitor cells of the adult mammalian brain [249, 250].  They describe fractal patterned 
extensions of capillary basal laminae, termed fractones, folding throughout the sub-ependymal 
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layer tracts of neuroblast type A cells bounded by type B stem cell astrocytes.  These basal 
lamina fractones were distinguished with laminin immunoreactivity.  Also, there were specific 
random regions within the fractones containing collagen type I.  More recently, these fractones 
of adult rat, mouse, and human SVZ regions have been shown to contain laminin β1 and γ1, 
collagen IV, nidogen, and perlecan, but not laminin-α1 [251].  This work also demonstrated that 
proliferative cells specifically localized with regions of fractones containing heparin sulfate 
proteoglycans (HSPG) binding FGF2.  The interconnection of the basal laminae within this 
neurogenic SVZ region is possible because there is a rich plexus of capillaries throughout where 
the cells are highly organized around the blood vessels [252, 253].  As described above, the type 
B1 astrocytic neural stem cells have a basal process extending from the ventricle to capillaries 
surrounded by the fractones extensions from these capillaries.  Tenascin-R has been found to 
inhibit neural stem cell-derived neuroblasts in vitro and surrounds the neuroblast migratory tracts 
in vivo [254, 255]. 
Cell surface receptors able to bind laminins are integrins (especially integrin subunits α6 
or β1), dystroglycan, and syndecans [247].  The type B1 neural stem cells have been shown to 
highly express the α6β1 integrin heterodimer just like many other non-neural stem cell types 
[247].  These integrins on the NSCs allow the cells to bind and interact with the laminins of the 
basal lamina fractones in vivo.  Neurospheres generated from transgenic mice with subsequent β1 
integrin knockout contained fewer nestin positive cells with decreased proliferation and 
increased apoptosis, but was partially recovered with addition of exogenous growth factors 
[256].  Within the in vivo neurogenic niche, growth factors are able to be captured and stored by 
the basal lamina fractones reaching from SVZ capillaries and CSF of the ventricles.  Cell surface 
receptors on neural stem cells for soluble growth factors, cell-cell contacts (especially E-
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cadherins), and cell-ECM contacts (especially α6 or β1 integrins) interacting with the niche 
microenvironment allow control over the fate of neural stem cells in vivo.  It is currently 
hypothesized that disruption of the cell-ECM contacts of β1 integrins and laminins may lead to 
changes in the state of the neural stem cells in directing them to either proliferate, migrate, or 
differentiate [257, 258].  Integrins can also regulate growth factor signaling to further control 
stem cell fate [257].  In a review by Campos, the changing neurogenic niche over development is 
described in terms of laminin, fibronectin, and expressed integrins [258].   Laminin α2 is 
abundant throughout a thick layer of the ventricular zone during embryonic development.  
Further into development, this laminin α2 layer becomes thinner and eventually is confined to 
only a small lining of the ventricle with the rest of the subventricular zone containing mostly 
fibronectin.  Tate et al. has demonstrated that blocking α6β1 integrins prevents migration of 
neural stem cells in vitro on laminin and blocking α5β1 prevents migration on fibronectin [259].  
Yoshida et al. have demonstrated a decrease in α5β1 integrin expression with neuronal 
differentiation of neural progenitor cells [260].  Therefore, these integrins play special roles in 
the ability of the neural progenitor cells to be maintained in vivo and properly migrate away from 
the subventricular zone, but further clarification is still needed on the exact temporal expression 
of these receptors for enhancing neural stem cell proliferation and differentiation in vitro. 
Other important ECM components involved in neural tissue development and present 
within adult neural tissue are glycoconjugates, including proteoglycans, glycoproteins, and 
glycolipids.  The ECM of the neural stem cell niche was described above to be comprised 
significantly of basement membranes.   Large components of basement membranes within 
tissues are proteoglycans.  The chains of proteoglycans are present throughout the laminin and 
fibronectin components.  Heparan sulfate proteoglycans (HSPG) is a major contributor within 
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many tissues, including neural tissue, which regulates growth factor binding and presentation to 
cells within the ECM.  Specifically within the neural stem cell niche, HSPG can bind bFGF for 
regulating neural stem cell proliferation [251, 261].  Another proteoglycan important in 
regulating growth factor presentation within the neural stem cell niche is nerve/glial antigen 2 
(NG2) [261].  Chondroitin sulfate proteoglycans (CSPG) are a group of proteoglycans extremely 
important in regulationg neural tissue function.  Some important CSPGs within neural tissue are 
neurocan, brevican, versican, aggrecan, and phosphacan [262].  CSPGs have been demonstrated 
to be highly synthesized by astrocytes within the CNS [262].  Kabos et al. have demonstrated the 
increase of CSPGs synthesized by neural stem cells during proliferation and neurosphere 
formation with a decrease in CSPG expression during differentiation in culture [263].  CSPGs 
have been shown to be present within both embryonic and adult neural stem cell niches of the 
ventricular and subventricular zones [262].  Also, CSPGs have been demonstrated to directly 
affect neural stem cell proliferation and decreased neuronal differentiation in culture [262].  
However, CSPGs have also been demonstrated as a major component of the glial scar within 
adult CNS tissue after injury preventing axonal regeneration [262].  Some forms of CSPGs are 
also present within the developing nervous system as inhibitory molecules that line tracts guiding 
neuroblast migration and axonal growth pathways [262]. 
Another important glycosaminoglycan present throughout developing tissues, including 
the central nervous system, is hyaluronic acid (or hyaluronan; HA).  HA is present within the 
developing mouse brain diffusely in gray matter and along axonal tracts in white matter.  It has 
also been detected as present lining the migratory tracts of neuroblasts allowing migration of 
these cells [262].  In culture, HA has been shown to inhibit astrocyte proliferation and injection 
of hyaluronidase in vivo causes proliferation of astrocytes within the spinal cord [262].  HA 
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along with CSPGs have been shown to be overexpressed within the site of CNS injuries and glial 
lesions.  Reactive astrocytes staining positive for GFAP within CNS lesions highly express 
CD44, a specific receptor for cell attachment to HA.  It is possible that HA is upregulated within 
the tissue of the lesion formed after a CNS injury for the ability of reactive astrocytes, with HA 
receptors, to migrate throughout the site to perform their functions of protecting and maintaining 
the spared neural tissue [262]. 
3.1.2 Obstacles using neural stem cells in vivo for potential therapy development 
Neural stem cells (NSCs) hold the foremost potential to be used as a cell source for treating 
various nervous system injuries and diseases with cell therapies.  Some of the major nervous 
system diseases and disorders able to potentially be corrected with neural stem cell 
transplantation were described earlier in section 1.1.  Transplantation of NSCs has been 
demonstrated to be free of tumor growth after long-term engraftment in vivo, unlike embryonic 
stem cells.  Progress in reaching this goal has been hindered by a number of factors.  Many in 
vivo reports of testing NSC types for cell therapy transplantation in animal models have 
encountered significant problems of low cell survival rate with poor neuronal differentiation.  
Cao et al. demonstrated that transplantation of neurospheres into normal adult rat spinal 
cords led to high survival and neuronal differentiation, but when transplanted into rats with 
injured spinal cords differentiation was inhibited resulting in very few neurons [264].  The 
significance of this particular study was that the neurospheres used for transplantation were pre-
treated and induced to become neuronal restricted progenitor cells.  Most previous studies show 
a high degree of astrocyte differentiation of transplanted neural stem cells into injured spinal 
cord animal models [264-266].  Human NSC neurospheres were demonstrated by Cummings et 
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al. to survive and differentiate into oligodendrocytes and neurons with few astrocytes,  contribute 
to locomotor recovery, and form synapses with mouse host neurons after transplantation into 
spinal cord-injured NOD-scid mice [266].  They specifically showed that the neurons created by 
the NSCs directly contributed to the functional recovery by selective destruction of these cells 
and subsequent loss of the recovered function.  This report shows the promise of using neural 
stem cells to treat spinal cord injuries, but the lack of positive outcomes using rodent derived 
NSCs within rodent spinal cord injury models might illustrate a larger problem using immuno-
deficient animals for accurately assessing human neural stem cells in vivo.  As described above 
in section 1.1.2, the injured spinal cord possesses a very hostile environment with a reactive 
immune response contributing to glial scar formation.  Ricci-Vitiani et. al. have hypothesized 
that it is the inflammatory environment of spinal cord injuries that pushes the NSCs to 
differentiate into astrocytes by showing in vitro differentiation of the cells into the astrocytes 
after stimulation with tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and 
interferon-gamma (IFN-gamma) [267].  To date there has only been a handful of successful 
reports on functional recovery in rodent models of acute spinal cord injury treated by 
transplantation of neural stem cells [266, 268-271].  Cummings et al. have been the only group to 
prove neural stem cell incorporation into the host neural circuitry, while most of these reports 
cite functional improvement due to the “bystander effect” where the neural stem cells provide 
trophic support and prevent worsening due to secondary complications in SCI [37]. 
In a review by Martino and Pluchino, the authors hypothesize that recruitment of 
endogenous neural stem cells in the brain to repair diseased cells and tissue is limited by the 
addition of inflammatory conditions with many nervous system diseases and injuries [37].  
Multiple sclerosis (MS) is a specific nervous system disease that is caused by autoimmune 
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reactivity.  Lesions in patients with MS are frequently seen as wedge-shaped with a broad base 
along the ventricular lining.  These lesions most likely occur from infiltration of immune cells 
through the rich blood supply to the SVZ.  This emphasizes the poor surrounding conditions the 
endogenous neural stem cells have to overcome in order to repopulate brain tissue within lesions 
due to MS.  However, in 2003 these same authors reported their results of mouse neural stem cell 
transplantation abolishing functional impairment of mouse MS model, experimental autoimmune 
encephalomyelitis (EAE) [272].  Jeong et al. have demonstrated improvement in rats with an 
experimental stroke model with transplantation of human neural stem cells into the brain [273].  
Zhang et al. have demonstrated an increase in neural stem cell repopulation of the brain after 
induction of stroke within rat brains [274].  Some groups have been able to demonstrate 
improved outcomes from fetal or adult neural progenitor cell transplantation into animals having 
an experimental model of Parkinson’s disease [275-278].  However, it is likely that the positive 
outcomes of these studies have occurred considerably by the mechanism of the neural stem cells 
acting through immune modulation and neuroprotection by trophic factor secretion instead of 
differentiation and integration for functional cell replacement. 
There are a number of ongoing clinical trials for the treatment of different CNS diseases 
such as stroke, multiple sclerosis (MS), lupus erythematosus, cancer, and traumatic brain injury 
using transplant cell therapies, but these so far have focused on adult autologous stem cells such 
as bone marrow-derived cells (www.clinicaltrials.gov).  Stem Cells Inc. has been the first 
company to generate a human fetal brain-derived neural stem cell product (HuCNS-SC) used for 
transplantation cell therapies [13].  The first clinical trial using the HuCNS-SC cells was initiated 
in 2006 in order to test the safety of the cells transplanted into patients with neuronal ceroid 
lipofuscinosis or Batten’s disease, where the complications arise from the lack of specific 
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enzyme production from neurons.  The HuCNS-SCs have been demonstrated to produce the 
enzymes lacking in Batten’s disease after transplantation into pre-clinical animal models.  The 
company hopes to prove the safety of the neural stem cell transplantations in order to continue 
with future clinical trials using the cells for other nervous system diseases such as SCI, 
demyelinating disease, stroke, and Alzheimer’s disease. 
3.1.3 Biomaterials for enhancing neural stem cell survival and differentiation 
Compatibility and control of neural stem cells using biomaterials has only recently been studied 
within the past few years.  This is due mostly to the fact that protocols for long-term culture of 
neural stem cells were only developed in 1996, but it has only recently been recognized that 
improvements are needed to produce a more promising strategy for clinical use of these cells 
[279].  It is known that in vitro neural stem cells have the ability to differentiate into functional 
neurons on a two dimensional surface coated with laminin, but the ability to achieve this 
differentiation in a 3D organization has recently been of interest.  Laminin is a protein 
component of the extracellular matrix within tissues highly present within basal lamina basement 
membranes in a thin layer.  Laminin has multiple active domains useful in binding other ECM 
proteins like fibronectin in order to form a matrix, however currently it is not possible to form a 
3D hydrogel completely from natural unmodified laminin molecules.  The neural stem cells 
differentiation very well on laminin due to functional domains on laminin able to enhance 
neuronal survival and neurite outgrowth [280, 281].  The whole laminin molecule has binding 
domains for many integrin receptors (especially β1 integrins), which include the sites on laminin 
having the amino acid sequence RGD and YIGSR [281].  The IKVAV peptide sequence found in 
laminin has been able to mimic the neurite outgrowth enhancing activity of laminin [281].  
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However, we have been interested in culture of the neural stem cells within a 3D matrix instead 
of the traditional 2D laminin coated surface. 
 Martinez-Ramos et al. examined neuronal differentiation of adult rat neural stem cells on 
different polymeric biomaterials, but described the increase in neuronal differentiation on some 
of the materials due most likely to the increased ability of the material to adsorb laminin [282].  
Ma et al. have described functional synapse formation between embryonic rat neural precursor 
cells within 3D collagen hydrogels in vitro [283].  Very recently these authors described further 
differentiation of the rat neural precursor cells within collagen gels maintained in a rotating wall 
vessel bioreactor [284].  Some groups have described testing of biomaterial compatibility with 
neural stem cells using printing of the materials in arrays for screening NSC behavior on 
multiple materials [285].  The results of this work showed an increase in neuronal differentiation 
on fibronectin and ProNectin L, a recombinant polymer consisting of multiple fibronectin RGD 
(arginine-glycine-aspartic acid amino acid sequence) cell attachment domains.   
Most in vivo studies incorporating biomaterial enhancement of neural stem cell 
transplants have been used in spinal cord regeneration.  Prang et al. have developed an alginate 
based hydrogel scaffold allowing incorporation of NSCs for transplantation for improvement in 
recovery of spinal cord injury models [286].  Wu et al. have attempted to improve spinal cord 
regeneration with the implantation of rat fetal hippocampal neural progenitor cells encapsulated 
by delivery within an alginate hydrogel, but most cells still differentiated into astrocytes rather 
than neurons [287].  Another study investigating improvement of rat spinal cord injuries by 
spinal cord-derived NSC transplantation including a hydrogel, has been performed by Vacanti et 
al. [288].  These authors demonstrated coordinated hindlimb movements with recovery in 
animals transplanted with the NSCs with hydrogel scaffold while the animals receiving only the 
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NSCs had scar formation with little behavioral improvement.  These reports comprise the 
majority of the papers described in a comprehensive review published very recently by Little et 
al. entitled “Engineering Biomaterials or Synthetic Neural Stem Cell Microenvironments” [289].  
This demonstrates the need for more investigation on the proper biomaterials for enhancing 
control and manipulation on the neural stem cell environment either in vitro or in vivo. 
 The in vivo neural stem cell niche is highly organized including a variety of ECM 
molecules and growth factors for controlling neural stem cell behavior and therefore poses the 
difficulty in attempting to recreate the proper environment to permit NSC survival and neuronal 
differentiation.  There are two major clinical goals for research involving neural stem cells.  The 
first goal has been to use these cells as a cell therapy as described in the previous section.   
However, due to the limited success of neural stem cell transplantation to replace lost functional 
neurons from disease and trauma, investigation into additional factors enhancing the 
environment and delivery of these cells used as cell therapies is relevant for improving the neural 
stem cell survival and differentiation after transplantation.  The other goal is to better understand 
the endogenous neural stem cell niche and its control over the cell behavior.  Information from 
understanding the natural mechanisms and environment for NSCs might allow further 
manipulation to enhance endogenous neural stem cell repopulation in central nervous system 
injuries and diseases rather than transplantation of engineered non-autologous neural stem cells. 
 The research necessary in achieving both of these goals can be pursued with the ability to 
recreate a synthetic neural stem cell niche in vitro.  Attempting to achieve this goal could enable 
insight into the natural mechanisms for controlling neural stem cell behavior.  Once a 
reproducible in vitro system is available, allowing high density tissue configurations, the 
application of such a system for in vitro studies for therapeutic development can be expected.  
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We have initiated the work here in order to develop such a 3D dynamic in vitro system allowing 
manipulation of the microenvironment for optimizing neuronal differentiation of mouse 
embryonic neural stem cells.  Our initial studies in achieving this goal have focused on testing 
different injectable extracellular matrix (ECM) hydrogel-based scaffolds allowing assessment of 
neurosphere differentiation within a 3D configuration.  Further work included use of hollow 
fiber-based bioreactors as tools for recreating an in vivo-like dynamic environment allowing 
investigation of neuronal differentiation within this environment after delivery of neural stem 
cell neurospheres suspended within the different injectable hydrogels.   
 The ECM hydrogels investigated here consist of commercially available products: 
collagen type I (BD Biosciences), high concentration growth factor-reduced Matrigel (BD 
Biosciences), and HyStem (cross-linked hyaluronan; Glycosan Biosystems Inc.).  There are 
many FDA approved collagen products currently used clinically as dermal fillers for cosmetic or 
reconstructive purposes [290].  There are also many hyaluronan or hyaluronic acid products used 
clinically as either dermal fillers or joint fillers for osteoarthritis [291-293].  Matrigel, however, 
is not a synthetic material useful for actual cell therapies in clinical treatments, but is an 
injectable hydrogel with naturally occurring endogenous ECM proteins that can provide an initial 
framework for analyzing scaffolds to modulate neural stem cell behavior.  Matrigel contains 60% 
laminin and could prove useful in directing neural stem cell differentiation in 3D.  Laminin is a 
large component of the natural basement membrane matrix present in many tissues, and highly 
present within the nervous system tissue, but it is only an adhesive protein able to link other 
proteins of the basal lamina together forming a matrix [294].  It is not currently possible to form 
a hydrogel purely out of whole unmodified laminin molecules and therefore we have specifically 
investigated Matrigel which has a very high percentage of laminin. 
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 Our objectives within this chapter were to begin studies of mouse neural stem cell 
cultures within 3D dynamic in vitro culture systems.  The ultimate desired goal is to develop an 
in vitro culture system allowing studies of neural stem cell expansion, migration, and 
differentiation within a 3D configuration under dynamic conditions.  Such a system could allow 
pursuit of the two goals mentioned above: synthetic recreation of the in vivo neural stem cell 
niche to further elaborate on the environment naturally allowing control of endogenous neural 
stem cells and using the system as a tool mimicking the in vivo 3D dynamic environment for 
testing strategies improving development of cell therapies using neural stem cells.  In order to 
obtain this system we have initially investigated the three injectable hydrogel scaffolds allowing 
a 3D space for neural stem cell cultures.  We have also investigated the use of these scaffolds 
within two different hollow fiber-based bioreactor systems for further culture of the neural stem 
cells under dynamic conditions within the 3D scaffolds.  These studies have allowed further 
understanding of the behavior of mouse neural stem cells in vitro under 3D dynamic conditions.  
We have been able to achieve differences in neuronal differentiation with modulation of the 3D 
scaffold used.  Also, we have demonstrated the complexity of the environment necessary for 
manipulating neural stem cell behavior, which includes further investigations of soluble factors 
within the medium formulations in order to further control the cells.  We believe the system 
being developed here could enhance in vitro studies for improving neural stem cell research. 
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3.2 METHODS 
3.2.1 Mouse neural stem cells and culture conditions 
Mouse neural stem cells were purchased as passage 1 neurospheres isolated from the striata of 
embryonic day 14 (E14) mouse brains from Stem Cell Technologies (Stem Cell Technologies 
Inc., Vancouver, B.C., Canada).  Cells were expanded according to Stem Cell Technologies 
protocols using Neurocult® Basal Media with Neurocult® Proliferation Supplements (Stem Cell 
Technologies, Inc.) and the addition of 20 ng/mL recombinant human epidermal growth factor 
(rhEGF; Stem Cell Technologies Inc.) within Costar 162 cm vented cap flasks (40 mL medium 
in each flask).  Basic fibroblast growth factor (bFGF) was not included in the proliferation 
medium, because mouse embryonic neural stem cells do not require the growth factor for 
expansion.  Neurospheres were expanded until sphere size was quite large and passaging was 
carried out by mechanical dissociation by trituration 5-15 times using a fire-polished glass 
Pasteur pipette.  The fire-polishing narrows pipette tip opening.  Trituration consists of aspirating 
cells into pipette and holding tip angled at bottom of conical tube cells and expelling 
neurospheres through narrow tip to dissociate into smaller clusters.  Trituration 20-30 times 
creates single cell suspensions with this method and initial sphere size.  Cells used in all 
experiments were expanded 8 times to reach passage 9 neurospheres in order to obtain enough 
cells for entire experiment including bioreactor culture (except in initial testing of different cell 
differentiation protocols). 
Initial testing of different neural stem cell differentiation protocols on 2D laminin coated 
surfaces included testing neurosphere dissociation methods, single cell suspension vs. whole 
neurospheres, and seeding density effects on differentiation.  All differentiation protocols were 
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tested on laminin coated tissue culture treated dishes.  Dissociation methods tested were the 
traditional mechanical trituration method as described above and chemical dissociation (kit from 
Stem Cell Technologies Inc.).  Chemical dissociation kit was performed according to 
manufacturer’s protocol.  These methods were used to dissociate neurospheres into a single cell 
suspension.  These cells were also compared to differentiation of whole neurospheres.  Also, 
mechanical trituration was utilized to partially dissociate neurospheres resulting in smaller 
diameter neurospheres.  Later, partially triturated smaller neurosphere differentiation was tested 
at varying sphere seeding densities of 0.1x103 cells/mm2,  0.25x103 cells/mm2, 0.5x103 
cells/mm2 (Stem Cell Technologies Inc. recommended density), 1x103 cells/mm2, 2.5x103 
cells/mm2, and 5x103 cells/mm2. 
Traditional differentiation protocols using neural stem cells require cells seeded onto 
laminin (extracellular matrix protein with properties enhancing neurite outgrowth) coated 2D 
tissue culture dishes.  Most of these protocols, including that of Stem Cell Technologies Inc., 
describe initial coating of culture dish with poly-L-lysine to improve laminin adsorption.  
Therefore, positive control mNSC 2D static cultures were performed within 6 well tissue culture 
treated plates first coated with 50 µg/mL poly-L-lysine (Sigma Aldrich) for one hour and then 
coated with 20 ug/mL laminin (Invitrogen) overnight at 37°C in a humidified 5% CO2 incubator.  
There is currently no commercially available product able to obtain a 3D hydrogel matrix made 
of 100% laminin.  We have therefore proceeded to test commercially available hydrogels for the 
3D differentiation of mNSCs.  We have also included 2D static control cultures of the three 
hydrogel matrices tested, which included either an adsorbed diluted layer of the ECM molecule 
or a thin gel coating. 
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3.2.2 Preparation of mNSC-ECM 3D hydrogel constructs 
Each ECM 2D coating and 3D hydrogel was prepared according to the manufacturer’s standard 
protocol.  2D static control cultures were maintained in tissue-culture treated 12 or 6 well plates 
(BD Biosciences; San Jose, CA).  For 2D cultures, cells were seeded as partially triturated 
neurospheres at either 0.5x106 cells/well in a 12 well plate or 1x106 cells/well in a 6 well plate 
for a density of 1.5x103 cells/mm2 (including laminin coated positive control cultures).  2D 
cultures were seeded and maintained with Neurocult Differentiation medium with medium being 
replaced every other day for the 14 day cultures.  Dishes used for 2D collagen cultures were first 
coated with 5µg/mL collagen type I (from rat tail sterile filtered solution; BD Biosciences) 
dissolved in 0.02 N acetic acid for 1 hour in 5 % CO2 humidified incubator at 37°C.  Dishes were 
then washed with Dulbecco’s phosphate buffered saline solution (PBS; Invitrogen).  Matrigel 
(high concentration growth factor reduced; BD Biosciences) 2D cultures were prepared by first 
thawing the Matrigel vial overnight on ice at 4°C.  Matrigel was handled by keeping on ice to 
avoid hydrogel solidification.  2D coatings were prepared by diluting high concentration 
Matrigel 1:10 with ice cold Neurocult Differentiation medium and was aliquoted 1 mL into each 
well of a 6 well plate or 0.5 mL into each well of a 12 well plate.  Dishes were then placed in a 5 
% CO2 humidified incubator at 37°C for 30 minutes. Excess solution was then aspirated off and 
fresh medium was replaced.  2D cultures on HyStem (cross-linked hyaluronic acid (HA); 
Glycosan Biosystems Inc., Salt Lake City, UT) were performed using two different methods.  2D 
coatings were prepared by diluting the HA component of HyStem in PBS 1:1 and using solution 
to completely cover wells of 12 well plate.  Plates were placed in a 5 % CO2 humidified 
incubator at 37°C for 1 hour.  Also, 1 mm thick hydrogel layers were formed on 12 well plates 
adding 0.5 mL of the hydrogel solution into each well (cells were later seeded on top of the 
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hydrogel layer instead of encapsulated into the 3D gel).  At least n=6 wells of 12 or 6 well plates 
were prepared each time for 2D mNSC cultures with each of the three ECM coatings tested and 
were replicated in triplicate. 
3D ECM hydrogel cultures were performed by preparing 1 mL of each of the ECM 
hydrogel solutions with the addition of 1x106 neural stem cells (as partially triturated 
neurospheres) and placing the 1 mL solution plus cells into a well of a 12 well tissue culture 
plate.  Collagen type I hydrogels were prepared using the following components quickly added 
in the given order: 100 µL 10X PBS (Invitrogen Corp.), PC12 cells with 500-600 µL RPMI 
medium containing 0.5% HS and 1% Pen/Strep (enough to bring final volume to 1 mL), 250-350 
µL collagen type I sterile solution (amount varied with manufacturer stock concentration, final 
concentration of collagen in gel 1 mg/mL), and 6 µL 1 N NaOH.  Collagen gel solutions can then 
undergo fibrillation and gel formation after addition of NaOH for final pH approximately 7.4 and 
plates placed in 5% CO2 humidified incubator at 37°C.  Collagen gel formation completed within 
15 minutes and medium was placed on hydrogel construct.   
Matrigel 3D ECM hydrogels were prepared by handling Matrigel on ice as described 
above to prevent early matrix gelation.  1 mL of undiluted high concentration (approximately 19 
mg/mL) Matrigel solution was pipetted into each well of a 12 well culture plate.  Neurospheres 
were then pipetted into the solution and quickly mixed into gel solution using pipette tip to create 
uniform cell suspension.  Plates were then placed in 5% CO2 humidified incubator at 37°C.  
Initial Matrigel used for neural stem cell cultures was the original 7-8 mg/mL concentration 
Matrigel product, but using this solution for the 3D hydrogel cultures even under static 
conditions for the 14 day culture period resulted in partial hydrolytic degradation of the gels 
preventing possible analysis of intact 3D cell-gel constructs.  Therefore, all further experiments 
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utilized high concentration Matrigel product, which is recommended for in vivo studies having 
dynamic conditions. 
HyStem 3D ECM hydrogels (Glycosan Biosystems Inc.) were prepared according to the 
manufacturer’s protocol.  The HyStem kit contains two components, thiol-modified hyaluronan 
(HA) and reactive polyethylene glycol diacrylate (PEG-DA) used to cross-link the hyaluronan 
molecules in order to form a hydrogel.  In order to create 2.5 mL of hydrogel solution, sterile 
water, provided with HyStem kit, was used to reconstitute the two components by adding 1 mL 
of water to each of two HA component vials and 0.5 mL water to one PEG-DA vial.  Then the 
vials are further reconstituted as liquid solutions by placing within 37°C water bath for 30 
minutes.  Finally, the solutions of the 3 vials (two HA vials and one PEG-DA vial) were 
combined together and quickly mixed with pipetting.  1 mL of solution was placed into each well 
of a 12 well culture plate and neurospheres were then added directly to gel solution within plate 
and the pipette tip was used to uniformly mix the cells into the gel solution.  Plates were then 
placed in 5% CO2 humidified incubator at 37°C. 
3D hydrogel dimensions within the 12 well plates resulted approximately in 20 mm 
diameters and 2 mm in height.  1.5 mL Neurocult Differentiation medium was placed in each 
well after gelation of each ECM hydrogel was complete after 30 minutes within incubator.  Gel 
plus liquid medium layer height never exceeded 6 mm from bottom of well in order to not 
further limit gas diffusion into gel constructs.  Medium was completely replaced in each well 
once daily (every 24 hours).  12 well plates containing 3D ECM hydrogel plus cell constructs 
were maintained under static culture conditions within a 5% CO2 humidified incubator at 37°C.  
At least n=6 wells of 12 or 6 well plates were prepared each time for mNSC cultures within each 
of the three 3D ECM hydrogels tested and were replicated in triplicate. 
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3.2.3 Hollow fiber-based bioreactor cultures 
A total of five bioreactor experiments testing mouse neural stem cell differentiation were 
completed.  Notation used to identify each bioreactor experiment in an abbreviated form with the 
example of the first experiment noted by MNS-1; where the first initial is the species being 
mouse, the second and third initial correspond to the cell type (in this case neural stem), and the 
number giving the order among the five experiments (MNS-1 through MNS-5).  MNS-1, 2, and 
4 were conducted using the 8 mL laboratory scale hollow fiber-based bioreactor.  MNS-3 and 5 
were conducted using the four compartment analytical scale bioreactor.  All five bioreactor 
experiments included inoculation of the bioreactor with mouse neural stem cells suspended in 
one of the three extracellular matrices (ECM) gel solutions investigated.  These ECM gel 
solutions were prepared with the same methods described above in section 3.2.2 for making gel 
solutions used for 3D static control cultures.  All bioreactor experiments were maintained for the 
entire 14 day culture period necessary for differentiation of mouse neural stem cells. 
3.2.3.1 8 mL laboratory scale bioreactors 
There were a total of three 8 mL hollow fiber-based bioreactor experiments performed to 
differentiate mouse neural stem cells in a 3D space under dynamic conditions.  One 8 mL 
bioreactor was used for each of the three ECM hydrogels tested.  These experiments were 
performed similarly to those described in section 2 using the 8 mL hollow fiber-based bioreactor 
and perfusion systems shown in Figure 1-3.  Each ECM hydrogel solution was prepared exactly 
as specified in the above section 3.2.2.  Within each experiment, 1x108 mouse neural stem cells 
as passage 9 partially triturated neurospheres were suspended in 10 mL of the ECM hydrogel 
solution and inoculated into the bioreactor.  Next, 5-10 mL of the ECM hydrogel was inoculated 
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to further distribute the neurospheres within the bioreactor.  For these experiments, culture 
conditions were maintained with medium pH between 7.2-7.4 by varying the CO2 flow rate 
through the gas perfusion system.  Feed medium flow rate in all experiments was set to 2 mL/hr, 
which is the lowest possible flow rate using the pumps used.  Medium used for entire bioreactor 
set up and culture was Neurocult Differentiation medium. 
Perfusion tubing circuits used for these 8 mL bioreactor experiments were made from 
medical-grade PVC (circuit produced by Stem Cell Systems, tubing manufactured by B. Braun 
Medical Inc.).  Poor outcome due to experiment MNS-1 necessitated testing of bioreactor and 
tubing material compatibility with neural stem cell cultures.  Therefore, during setup of 8 mL 
bioreactor experiment MNS-2, Neurocult differentiation medium was used to pre-fill the 
bioreactor plus tubing circuit and circulated through the circuit for 24 hours and then collected.  
A second batch of medium then replaced into the circuit volume and circulated for a second 24 
hour period.  Both batches of medium were collected in order to test circulated medium on 
control mNSC cultures.  This was performed to test if any detrimental particles/reagents leached 
into the medium during circulation from any of the materials used in the bioreactor or tubing 
circuit.  For experiment MNS-2, these control cultures testing medium were performed by 
seeding neurospheres onto Matrigel coated plates with the collected medium from each time 
point and compared to mNSCs differentiating in control fresh medium.  For experiment MNS-4 
this material testing was performed again, but tested on control mNSC cultures differentiating on 
tissue culture plates coated with control laminin coatings (for optimal cell survival and 
differentiation). 
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3.2.3.2 Four chamber analytical scale bioreactors 
A photograph of the four chamber analytical-scale hollow fiber-based bioreactor is seen in 
Figure 30.  This bioreactor is a scaled down version of the 8 mL hollow fiber-based bioreactor 
containing only a single layer of parallel hollow fibers used for gas and medium perfusion.  This 
allows a system providing dynamic conditions to the cell compartment, but allows visualization 
of the cultures using microscopy during the culture period.  The hollow fiber layer is bounded on 
the top and bottom within each chamber by a plastic coverslip.  This allows placement of the 
entire bioreactor onto the stage of an inverted microscope in order to image cells during 
bioreactor culture. 
Four chambers are seen surrounded by the bioreactor polyurethane housing.  Perfusion 
hollow fibers run horizontally through the polyurethane housing.  Each of the four chambers is 
separated by the polyurethane housing sealing the fibers around each chamber.  Each chamber 
has its own white cap port for cell and hydrogel solution inoculation into each chamber 
individually.  Medium passing through each row of two chambers flows directly into the other, 
but medium is then ultimately diluted into the same perfusion circuit tubing volume (one tubing 
circuit for the entire bioreactor.  Red ports at ends of fiber bundles are used to connect medium 
perfusion circuit tubing for medium flow through hollow fibers under counter-current flow 
through each chamber.  White ports are at ends of gas fiber bundles used to connect the gas 
perfusion tubing circuit.  A diagram of this perfusion tubing circuit used for the four chamber 
bioreactor experiments is shown in Figure 32.  The perfusion systems used for these experiments 
is shown in Figure 34. 
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Figure 30. Photograph of four chamber analytical-scale hollow fiber-based bioreactor. 
 
Figure 31. Diagram describing flow patterns through each chamber of the four chambered hollow fiber-
based analytical scale bioreactor.  Also shown are the analytical capabilities possible with microscopic visualization 
of the cell compartments with this bioreactor design. 
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Figure 32. Diagram of tubing circuit used for medium and gas perfusion through four chamber analytical 
scale hollow fiber-based bioreactor. The tubing segments outlined in the dotted black box indicated the same circuit 
design used for the 8 mL bioreactor experiments.  Differences in this tubing circuit are just the lengths of the 
segments leading to the bioreactor, which are longer allowing movement of the bioreactor to the microscope stage.  
Also, there are no tubing segments connecting the perfusion circuit to the cell compartments of the individual 
chambers within the bioreactor. Instead cells are inoculated through ports directly connected to each chamber. 
 
MNS-3 and MNS-5 bioreactor experiments were performed using this four chamber 
analytical scale bioreactor design.  The chambers within the bioreactor were inoculated with 
5x106 mNSCs (as partially triturated neurospheres) in each chamber.  Each chamber within the 
bioreactor was inoculated with a different ECM hydrogel out of the three different matrices 
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investigated within this work.  All 5x106 mNSCs for each chamber were suspended into 
collagen, Matrigel, or HyStem solutions in a 1 mL volume of each gel solution.  The orientation 
of chambers with different ECM hydrogels for each experiment is seen in Figure 33. 
 
Figure 33. Diagram of orientation of mNSC plus ECM hydrogel solutions inoculated into the separate 
chambers of the four chambered bioreactor within each of the two experiments performed.  Black lines indicate 
direction of perfusion hollow fibers through the chambers.  The “x” through the bottom right chamber of MNS-3 
indicates that this chamber was not used (the port connector leading to the inoculation tubing line of this chamber 
came off during bioreactor-tubing assembly). 
 
MNS-3 and MNS-5 were maintained with a feed medium flow rate of 2 mL/hr and 
recirculation medium flow rate of 8 mL/hr.  The pH of the medium was maintained between 7.2-
7.4 by controlling the CO2 and air flow rate mixtures.  The gas perfusion flow rate through the 
gas perfusion circuit was maintained at 2.5 mL/min.  Both of these experiments were performed 
using the newer version four rotameter perfusion systems from Stem Cell Systems (Berlin, 
Germany). A photograph of this perfusion system is seen in Figure 34.  The tubing perfusion 
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circuit used for experiment MNS-3 used the original medical-grade PVC tubing used for all 
previous experiments.   
Due to poor outcome of testing medium perfused through bioreactor and tubing circuit on 
control cultures, further tests were performed by testing only the tubing perfusion circuit.  
Perfusion tubing circuits were made including only a single loop of tubing with one pump tube 
segment and two three-way stopcock connectors.  Two different tubing circuits were made for 
this test and sterilized with ethylene oxide gas.  The first was comprised of the original medical 
grade polyvinyl chloride (PVC) tubing previously used in all bioreactor experiments and the 
second of Tygon 2275 (Saint-Gobain, Valley Forge, PA).  For this test, Neurocult Differentiation 
medium was perfused through each tubing circuit for two consecutive 24 hour periods within the 
perfusion system at 37°C and then collected and tested on control laminin coated culture dishes 
seeded with mNSC neurospheres with the medium.  Cultures were compared to control wells 
using fresh medium.  Due to the outcome of this test MNS-5 was performed using the newer 




Figure 34. Photograph of latest version of perfusion system (from Stem Cell Systems) used for MNS-3 and 
MNS-5 four chamber bioreactor experiments.  Shows an 8 mL bioreactor placed on the top within the plexiglass 
heating chamber with tubing circuit connected and configured within the two roller pumps.  Chamber is heated 
using the light bulbs plus fans seen at the top left.  Four rotameters to the right control the gas flow rates: gas 
mixture going into bioreactor and individual air, CO2, and N2 components (N2 not used in these experiments). 
3.2.4 Bioreactor metabolic measurements 
Medium samples were infused into single use CG4+ cartridges or G Glucose cartridges to 
measure the following metabolic parameters: lactate, pH, pCO2, pO2, and glucose; using the i-
STAT® clinical blood analyzer system (Abbott, East Windsor, NJ).  3D static gel cultures were 
maintained each day during culture period by collecting 1.5 mL of culture medium (previously 
replaced 24 hours earlier) and analyzing metabolic parameters.  Medium from bioreactor cultures 
was collected via syringe withdrawal from the sample port within the recirculation segment of 
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the tubing circuit (medium flowing through recirculation tubing and bioreactor perfusion fibers 
at flow rate 30 mL/min).  Bioreactor glucose and lactate concentrations have been inserted into 
formulas incorporating feed medium flow rate to give consumption and production values 
averaged between two measurements.  The formula used for this is shown below in Figure 35. 
 
Figure 35. Equation used to obtain daily glucose consumption or lactate production values of samples taken from 
the recirculation medium perfusion circuit during bioreactor culture experiments. 
3.2.5 Fluorescent immunohistochemistry visualized with fluorescent microscopy 
One sample was used to observe living cells versus dead cells using the Live/Dead Cell Viability 
Assay (Molecular Probes, Invitrogen) and these samples therefore were not fixed.  This kit 
includes calcein AM staining live cells with a green fluorescent signal and ethidium homodimer-
1 (EthD-1) staining dead cells with a red fluorescent signal.  Samples were directly incubated 
with solutions at 2 µm calcein AM and 4 µm EthD-1 and imaged within 30 minutes. 
Static control cultures used for immunohistochemistry were first washed with PBS three 
times and fixed with 4% paraformaldehyde for 30 minutes and washed with PBS again 3 times. 
Fiber layer samples from 8 mL bioreactor experiments were transferred immediately after 
opening to tissue cassettes and placed in 4% paraformaldehyde for 1 hour.  Samples were then 
washed with PBS three times, 15 minutes each.  For bioreactor experiment MNS-3, using the 
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four chamber analytical bioreactor, the entire four well compartments were used for 
immunohistochemical staining and therefore the entire bioreactor was perfused with 4% 
paraformaldehyde through the perfusion circuit and cell compartment for one hour followed by 
PBS washing.  The bioreactor wells were opened by cutting through the bottom plastic coverslip 
of each well and removing the fiber-gel layer.  
Immunostaining procedure was first carried out by blocking all samples in a 5% horse 
serum/PBS solution containing 0.3 % triton X-100 (LabChem Inc., Pittsburgh, PA) for 1 hour.  
All samples were first stained with mouse monoclonal primary antibody against class III 
neuronal specific β-tubulin (Covance CRP Inc.; Princeton, NJ) 1:500 dilution in 3% HS/PBS 
solution containing 0.3% triton-X for 1.5 hours.  Some samples were instead stained with anti-
nestin mouse monoclonal primary antibody (Stem Cell Technologies Inc.) at 1:100 dilution. 
Samples were then washed five times with PBS each for 10 minutes.  Goat-anti-mouse 
secondary antibody Alexa Fluor 488 (Molecular Probes, Invitrogen Corp.) was then added at 
dilution 1:1000 in 3% HS/PBS solution containing 0.3% triton-X for 1.5 hours.  Samples then 
received washes five times with PBS each for 10 minutes.  Double immunostaining was carried 
out on all samples with the same previous protocol but with one of the following antibodies: anti-
GFAP (glial fibrillary acidic protein) polyclonal rabbit primary antibody (Stem Cell 
Technologies Inc.) 1:400 dilution, anti-O4 polyclonal rabbit primary antibody (Stem Cell 
Technologies Inc.) 1:100 dilution.  Goat-anti-rabbit secondary antibody Cy3 (Molecular Probes, 
Invitrogen Corp.) was then added at dilution 1:1000 in 3% HS/PBS solution containing 0.3% 
triton-X for 1.5 hours.  Samples then received final washes five times with PBS each for 10 
minutes.  All samples were counterstained with DAPI (Sigma Aldrich) for nuclear localization. 
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2D samples cultured on tissue culture treated dishes were imaged by cutting the bottom 
surface out of the dish and sealing with gelvatol and glass coverslip.  These 2D samples were 
imaged using an Olympus Provis light microscope with fluorescence capabilities (Olympus; 
Center Valley, PA) with a 40X oil objective for final magnification of 400X. 
Fluorescent confocal microscopy was used to visualize the immunohistochemical 
staining of 3D static gel and 3D dynamic bioreactor samples (inverted Olympus Fluoview 1000; 
Center Valley, PA).  These 3D samples were imaged by wet mounting with directly placing the 
sample onto a glass coverslip in order to image both sides of sample.  All images taken to 
observe neural stem cell differentiation were taken using a 40X oil objective (final magnification 
400X).  All images were taken as z-stacks with 1 µm thick sections at approximately 50 µm 
depths for 3D gel and bioreactor samples.  Stacked section images were reconstructed into 
maximum intensity projection representations in a single image or avi movie file to demonstrate 
30 degree rotation showing 3D characteristics using Metamorph software (Molecular Devices; 
Downington, PA). 
3.2.6 Quantitative RT-PCR gene expression analysis 
3D static gel and 3D dynamic bioreactor samples for RNA collection were immediately 
immersed in RNA Protect reagent (QIAGEN, Valencia, CA) and stored at 4°C for less than two 
weeks before RNA collection.  For RNA collection, samples were first centrifuged to pellet cell, 
gel, and/or fiber material with removal of supernatant.  Total RNA was isolated from all samples 
with an mRNA isolation kit including on-column DNAse digestion (QIAGEN, Valencia, CA).  
The first step was carried out by placing the samples in the first buffer solution of the kit and 
using a disposable pestle the sample was ground to mechanically digest the collagen gel tissue.  
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cDNA was synthesized by a conventional reverse transcription process (Promega, Madison, WI).  
The master mixture contained 5 mmol/L MgCl2, 1x Reverse Transcription Buffer, 1 mmol/L 
deoxynucleotide triphosphate mixture, 1unit/µL recombinant RNasin® ribonuclease inhibitor, 
0.75U/µL AMV reverse transcriptase, and 1µg of random hexamer Primers.  Two micrograms of 
total RNA were prepared in sterile H2O to a final volume of 20µL.  The reaction mixture was 
incubated at 42°C for 60 minutes, followed by heat inactivation of the enzyme at 95°C for 5 
minutes. After cooling on ice for 5 minutes, the cDNA was stored at –20°C until analysis. 
Quantification of mRNAs using real-time polymerase chain reaction (qRT-PCR) analysis was 
performed using an ABI PRISM 7000.  The pre-designed TaqMan probe and primer sets for 
Tubb3 (Mm00727586_s1), Gfap (Mm01253033_m1), Mbp (Mm01262037_m1), and GAPDH 
(Rn99999915_g1) were selected from TaqMan Gene Expression Assays (Applied Biosystems, 
Foster City, CA). 
3.3 RESULTS 
3.3.1 Properties of mouse neural stem cells 
Mouse embryonic neural stem cells (mNSCs) were purchased as passage 1 neurospheres from 
Stem Cell Technologies Inc.  Cells were expanded to passage 9 using Neurocult Proliferation 
medium including 20 ng/mL rhEGF in order to obtain enough cells for bioreactor experiments 
and therefore performed most experiments using neurospheres at passage 9.  Only initial 
neurosphere differentiation tests were performed using lower passage cells.  Figure 36 represents 
the nestin immunostaining of the passage 9 neurospheres after expansion demonstrating cells 
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could be expanded within our laboratory maintaining the cells in an undifferentiated state, 
correlating with high positive staining for nestin, while preventing too much spontaneous 
differentiation of the cells.  When the neurospheres expand and reach a sphere size that is too 
large to be maintained, the cells will begin to spontaneously differentiate and attach to the 
bottom of the culture flask.  A neurosphere in the initial stage of this process with low nestin 
staining is seen in the middle of the image on the right in Figure 36. 
 
Figure 36. Confocal fluorescent images representative of mouse neural stem cell neurospheres expanded to 
passage 9; immunostained with antibody against nestin (neural stem cell marker) with AlexaFluor 488 (green) and 
nuclear DAPI (blue) at magnification 200X (single image z-stack reconstructions through 50 µm depth of 
neurospheres). 
 
For differentiation of the neurospheres, cells are seeded on dishes coated with an 
adhesive surface for the neurospheres to attach and cultured using Neurocult Differentiation 
medium.  Standard protocol for optimal neural stem cell differentiation is by seeding the cells 
onto laminin coated tissue culture plates.  When mNSCs are seeded onto adhesive laminin coated 
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tissue culture plates as neurospheres, the neurospheres attach and begin to migrate away from the 
neurosphere in order to properly differentiate.  After 24 hours of neurosphere seeding onto 
laminin coated plates, the cells completely attach and form a confluent layer on the surface of the 
laminin coated substrate with different morphologies (some cells already resemble neurons with 
phase bright bodies and multiple processes). 
Other factors could contribute to determining enhanced differentiation conditions of the 
cells as well and therefore we tested the effects of neurosphere dissociation and seeding density 
on mNSC differentiation.  The results of these tests are shown using passage 3 mNSCs in Figure 
37.  The top row of this figure depicts examples of seeding mNSCs as a single cell suspension by 
dissociating the neurospheres with two different methods: mechanical trituration or chemical 
enzymatic digestion.  Both images demonstrate a low percentage of differentiation of the mNSCs 
into neurons (green β-III-tubulin staining).  Therefore, all further experiments were performed by 
seeding mNSCs as neurospheres instead of in a single cell suspension.  Also, cells were seeded 
as neurospheres so that autocrine factors produced by the cells could help maintain support of the 
cells especially after inoculation into the bioreactor.  Most in vivo studies testing neural stem cell 
transplantation as cell therapy treatments use the cells as whole intact neurospheres for this same 
reason.   
The bottom row of Figure 37 shows the results of varying the seeding density of the 
neurospheres and the effects on differentiation at the different densities.  The images shown are 
the differentiated cells seeded at the two highest seeding densities tested of 2.5x103 cells/mm2 
and 5x103 cells/mm2 after 14 days of differentiating (other densities not shown).  The percentage 
of mNSCs differentiated into neurons did not appear to change, but a higher number of cells 
would seem to imply the ability to attain more neurons within a culture.  However, at these 
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higher densities on a 2D surface, the cells did not have enough surface area to completely attach 
onto the surface from the neurospheres (as seen in the images as brighter GFAP (red) stained 
clusters).  In order for the neurospheres to have the proper surface area to completely spread out 
from the spheres to confluency on the 2D surfaces, all 2D cultures were performed with an initial 
seeding density of 1.5x103 cells/mm2. 
The mNSCs have the ability to differentiate into neurons and astrocytes as well as 
oligodendrocytes.  These cells are an important and desired lineage of differentiation for the 
mNSCs, but the percentage of cells differentiating within the control 2D laminin coated cultures 
towards the oligodendrocyte lineage was very low.  An example of O4 immunostaining 
(immature olidgodendrocyte marker) is shown in Figure 38 with cells differentiated for 14 days 
on a laminin coated dish.  Since the detection of immature oligodendrocytes was observed to be 
very low under optimal differentiation conditions and ability to perform triple immunostaining 
on a single sample is complicated, differentiation on most samples was observed by double 
immunostaining for only β-III-tubulin labeling neurons and GFAP labeling astrocytes together.  
Also, a very high percentage of the mNSCs differentiate mostly into astrocytes even with the 
optimal culture conditions, and the desired goal was to vary culture conditions for improving 
neuronal differentiation which is also by preventing astrocyte differentiation. 
Figure 39 is representative of the differentiation achieved in positive control cultures of 
mNSCs after 14 days in Neurocult Differentiation medium on laminin coated dishes.  The cells 
were seeded in these cultures using the same neurosphere preparation protocol as all further 
experiments.  Cells were expanded to passage 9 and neurospheres were mechanically dissociated 
by partial trituration to obtain smaller diameter neurospheres.  All 2D cultures were seeded at the 
same density of 1.5x103 cells/mm2, which is the same density for the cultures shown in Figure 
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39.  This density was chosen because on the laminin coated surface, this density allows complete 
attachment and spreading of the cells from the neurospheres to attain a confluent monolayer of 
cells.  The seeding of cells as partially triturated (5-10 times trituration) smaller diameter 
neurospheres allowed this complete migration of cells out onto the 2D surface from the spheres, 







Figure 37. Fluorescent microscopic images of passage 3 mouse neural stem cells differentiated on 2D 
laminin coated tissue culture treated dishes for 14 days.  Immunostaining with antibodies against β-III-tubulin 
(neuron specific) with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; astrocyte specific), and nuclear 
DAPI (blue).  Top row depicts neuronal differentiation after seeding single cell suspension testing neurosphere 
dissociation techniques: a) chemical dissociation (enzymatic kit from Stem Cell Technologies Inc.) and b) 
mechanical trituration with fire polished Pasteur pipette (magnification 400X).  Bottom row depicts neuronal 
differentiation after seeding partially triturated neurospheres testing seeding density effects on differentiation: c) 
2.5x103 cells/mm2 seeding density and d) 5x103 cells/mm2 seeding density (magnification of 200X). 
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Figure 38. Example of fluorescent microscopic image detecting mNSC differentiation into 
oligodendrocytes by immunostaining with antibody against O4, an immature oligodendrocyte marker, with 
AlexaFluor 488 (green) (magnification 200X). 
 
Figure 39. Fluorescent microscopic images of passage 9 mouse neurospheres differentiated on 2D laminin 
coated tissue culture treated dishes for 14 days.  Immunostaining with antibodies against β-III-tubulin (neuron 
specific) with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; astrocyte specific) with Cy3 (red), and 
nuclear DAPI (blue) (magnification 400X).  Displays optimal differentiation of control mNSC cultures with cells 
expanded to passage 9 and seeded as semi-dissociated smaller neurospheres and differentiated with Neurocult 
Differentiation media. 
 137 
3.3.2 Light microscopic analysis of mNSC differentiation on 2D and 3D ECM hydrogel 
cultures 
Imaging of neural stem cells during the differentiation culture period testing the effect of varying 
the ECM was performed using an inverted light microscope.  Figure 40a shows the results of 
mNSC neurosphere differentiation on collagen coated 2D tissue culture plates at day 5 of the 
differentiation culture period.  The image shows spheres attached to the collagen coated surface 
with cells only forming structures between the attached spheres.  However, many single cells 
migrated out from the neurospheres attaching to the collagen coated substrate throughout the 
entire surface area of the plate by culture day 1 (24 hours after neurosphere seeding) (image not 
shown), but these cells had died and lifted from the plate by culture day 3.  Therefore, only the 
cells left by culture day 8 are the surviving cells that were able to attach onto each other within 
structures instead of attaching to the collagen coated surface.  Images of Figure 40 b and c show 
the results of cell viability using a live/dead (green/red) staining on this same culture showing 
most of the cells remaining within the structures by culture day 8 were alive. 
 
Figure 40. Mouse neurospheres differentiating for 8 days on 2D collagen coated dishes: a) light 
microscopic image showing neurosphere structure formation; b) cell viability staining of these structures showing 
live cells (green); and c) cell viability staining of these structures showing dead cells (red) (magnification 100X). 
 138 
Figure 41a depicts the morphology of mNSCs differentiating on Matrigel coated tissue 
culture plates at culture day 5.  Some single cells were able to attach from the spheres onto the 
Matrigel coated surface forming multiple processes from the cells out of the spheres and towards 
each other.  However, by culture day 14 as shown in Figure 41b, many cells did not survive the 
full differentiation culture period when differentiating on the 2D Matrigel coated surfaces.  
Seeding neurospheres onto 2D coatings of HyStem, either as coatings of HA component or 1 mm 
thick hydrogel layer, resulted in no neurospheres attaching to this ECM substrate after 24 hours.  
This therefore prevented possible 2D cultures of mNSC differentiation on HyStem. 
 
Figure 41. Mouse neurospheres differentiating on 2D Matrigel coated dishes: a) light microscopic image 
showing neurosphere differentiation on culture day 5, b) light microscopic image showing neurosphere 
differentiation on culture day 14 (magnification 100X). 
 
Figure 42 depicts examples of light microscope imaging of mNSC neurospheres 
differentiating within the three different 3D ECM hydrogels maintained under static culture 
conditions at culture day 2.  The first image (a) represents the neurospheres within the collagen 
type I hydrogel showing few processes protruding from neurospheres into the surrounding 
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collagen hydrogel.  The image in (b) represents the morphology of mNSCs differentiating within 
the Matrigel hydrogels.  Neurospheres within the Matrigel acquired multiple processes extending 
from the spheres within the first two days of culture.  These processes and spheres stayed in tact 
within the Matrigel 3D hydrogels for the entire duration of the 14 day culture period. 
When prepared with the manufacturer recommended ratio of HA component to PEG-DA 
cross-linker component, the HyStem product enables formation of a more rigid hydrogel when 
compared to the collagen and Matrigel hydrogels.  The mNSC cultures using the 3D HyStem 
hydrogels cultured under static conditions led to an acidic medium pH of 6.9 after the first 24 
hours of culture.  The image in Figure 42c depicts the neurospheres encapsulated within the 
HyStem hydrogel at culture day 2.  Most cells within the neurospheres are seen instead as 
individual rounded cells broken apart from the intact neurosphere, implying cells are dead.  Cells 
continued to appear with this same morphology throughout the entire culture period.  Also, 
morphology of mNSCs within 3D HyStem hydrogel cultures incorporating 100 µg/mL laminin 
looked exactly the same as the image shown in Figure 42c for the unmodified 3D HyStem 
hydrogel cultures. 
 
Figure 42. Light microscopic images of mouse neurospheres differentiating within 3D ECM hydrogels on 
culture day 2 under static conditions: a) collagen type I; b) high concentration growth factor-reduced Matrigel; and 
c) HyStem (cross-linked hyaluronic acid) (magnification 100X). 
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3.3.3 mNSC neuronal and astrocytic differentiation on 2D ECM coated plate cultures 
Immunostaining for detection of neurons and astrocytes of the mNSCs cultured and 
differentiated for 14 days on the 2D ECM coated tissue culture plates are shown in Figure 43-
Figure 45.  Images in Figure 43 show examples of neuron and astrocyte differentiation of 
mNSCs on the 2D collagen coated surfaces.  As described above the cells completely spreading 
out from the neurospheres and attaching to the coated plate died and lifted from the plate by the 
end of the 14 day culture period, but the cells left intact that were able to form structures and 
differentiate on top of each other were able to undergo substantial neuronal differentiation.  More 
neurons are seen around the edges of intact neurospheres attached to the surface.  It seems that 
this neuronal differentiation was possible where cells were able to attach on top of underlying 
astrocytes, as seen in the bottom right image. 
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Figure 43. Fluorescent microscopic images of mouse neurospheres differentiated on 2D collagen coated 
tissue culture treated dishes for 14 days.  Immunostaining with antibodies against β-III-tubulin (neuron specific) 
with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; astrocyte specific) with Cy3 (red), and nuclear 
DAPI (blue) (a and c magnification 200X, b and d magnification 400X). 
 
Since attachment and spreading of cells from neurospheres onto collagen coated 2D 
surfaces was poor, the culture medium was altered to include 20 ng/mL of bFGF (basic fibroblast 
growth factor) for enhancing cell survival.  This growth factor was incorporated because Gobbel 
et al. demonstrated increased neuronal differentiation from rat neurospheres with the addition of 
bFGF at this concentration when kept in the differentiation medium [295].  Also, O’Shaughnessy 
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et al. achieved functional neuronal differentiation from rat neurospheres differentiating within 
3D collagen hydrogels using a medium formulation including bFGF [172].  The results of our 
mouse neurospheres differentiating on either laminin or collagen coated 2D surfaces with 
incorporation of bFGF into the differentiation medium improved cell survival, but decreased 
neuronal differentiation of the cells especially on the collagen as seen in Figure 44.  Therefore, 







Figure 44. Fluorescent microscopic images of mouse neurospheres differentiated for 14 days testing effects 
of addition of 20 ng/mL bFGF on neuronal differentiation.  Immunostaining with antibodies against β-III-tubulin 
(neuron specific) with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; astrocyte specific) with Cy3 
(red), and nuclear DAPI (blue, only in top right image) (magnification 400X).  Left column shows neurospheres 
seeded on laminin coated dishes and right column shows neurospheres seeded on collagen coated dishes.  Top row 
shows these cultures with no added growth factors while bottom row shows these cultures with the addition of 20 
ng/mL bFGF to the Neurocult Differentiation media. 
 
Differentiation of the mNSC neurospheres onto Matrigel coated 2D tissue culture plates 
resulted in more attachment of cells onto the Matrigel coated surface, but the differentiation of 
these cells resulted in mostly astrocytes as seen in Figure 45.  Also, most of the cells that did 
stain positive for β-III-tubulin, indicating neuronal differentiation, also partially stained positive 
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for GFAP, usually indicating astrocyte differentiation.  This double positive staining was never 
observed within any other mNSC cultures on other ECM substrates.  The arrows of Figure 45 
indicate these double stained cells. 
 
Figure 45. Fluorescent microscopic images of mouse neurospheres differentiated on 2D Matrigel coated 
tissue culture treated dishes for 14 days.  Immunostaining with antibodies against β-III-tubulin (neuron specific) 
with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; astrocyte specific) with Cy3 (red), and nuclear 
DAPI (blue) (magnification 400X).  Arrows indicate cells staining positive for both β-III-tubulin and GFAP. 
3.3.4 mNSC neuronal and astrocytic differentiation within 3D ECM hydrogel cultures 
Confocal fluorescence imaging with immunostaining was used to observe differentiation of the 
mNSCs cultured within the different 3D ECM hydrogels tested.  Figure 46 shows the results of 
confocal imaging of different stains of mNSCs differentiated within 3D collagen hydrogels 
cultured under static conditions.  The image in Figure 46a represents the cell viability live/dead 
staining showing that most cells within the collagen hydrogels at the end of the 14 day culture 
period are alive.  The image in Figure 46b shows the results of immunostaining these samples 
with nestin, the neural stem cell marker, indicating that most cells still located within the 
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neurospheres are still nestin positive and remain as undifferentiated stem cells.  The image in 
Figure 46c shows that very few of the cells cultured within the collagen hydrogels differentiate 
either into neurons or astrocytes.  Very few cells were stained positive with the β-III-tubulin or 
GFAP markers. 
 
Figure 46. Confocal fluorescent microscopic images of mouse neurospheres within 3D collagen hydrogels 
after 14 days of differentiation under static conditions: a) cell viability staining with live cells (green) and dead cells 
(red) (magnification 200X); b) immunostaining with antibody against nestin (stem cell marker; green) and nuclear 
DAPI (blue) counterstaining (magnification 400X); and c) immunostaining with antibodies against β-III-tubulin 
(neuron specific) with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; astrocyte specific) with Cy3 
(red), and nuclear DAPI (blue) (magnification 400X). 
 
Enhancement of neurospheres differentiated within 3D collagen hydrogels was attempted 
by modifications incorporating either bFGF into the medium or incorporation of laminin within 
the collagen hydrogel solution before gelation.  The results of these cultures are shown in Figure 
47.  The image in Figure 47a depicts the results of culturing the neurospheres in the collagen 
hydrogel including bFGF in the medium, showing similar results as the 2D cultures with this 
modification where migration of cells out from spheres into the surrounding collagen hydrogel is 
not enhanced.  However, the modification of adding laminin into the collagen hydrogel did 
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increase neuronal differentiation in these cultures substantially and in a dose-dependent manner.  
The images in Figure 47b-c demonstrate the increasing amounts of incorporated laminin further 
enhanced neuronal differentiation within the collagen hydrogels and imply the importance of the 
effects of laminin on the differentiation of mNSCs. 
 
Figure 47. Confocal fluorescent microscopic images of mouse neurospheres within 3D collagen hydrogels 
including modifications after 14 days of differentiation under static conditions: a) 20 ng/mL bFGF included in 
medium; b) incorporation of 50 µg/mL laminin within collagen gel solution; and c) incorporation of 100 µg/mL 
laminin within collagen gel solution.  Immunostaining with antibodies against β-III-tubulin (neuron specific) with 
AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; astrocyte specific) with Cy3 (red), and nuclear DAPI 
(blue) (magnification 400X).  Staining protocol for these samples was modified to incubate with primary antibodies 
overnight at 4°C to improve neurosphere staining, but resulted in inability to completely wash out all excess 
antibody and therefore gave non-specific staining across entire samples.  
 
Figure 48 show images of confocal fluorescent microscopy of immunostaining mNSCs 
differentiated within 3D Matrigel hydrogels cultured under static conditions.  The images depict 
some astrocyte differentiation of the cells having processes extending from the neurospheres.  
Also, a higher number of β-III-tubulin positive cells are seen within these 3D Matrigel cultures 
as compared to the 2D Matrigel coated cultures.  However, again these cells staining positive for 
the neuronal marker again are mostly also positive for the GFAP astrocyte marker, indicated in 
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the images with arrows.  There are many cells within these cultures that do not stain positive for 
either neurons or astrocytes, but nestin immunostaining on the mNSCs cultured within 3D 
Matrigel hydrogels is shown in Figure 49.  Few cells stained positive for nestin within this image 
indicating remaining stem cells within the Matrigel cultures is rarer than what is implied by the 
amount of cells not staining positive for the other markers, but these stains were performed on 
separate samples. 
 
Figure 48. Confocal fluorescent microscopic images of mouse neurospheres within 3D Matrigel hydrogels 
after 14 days of differentiation under static conditions.  Immunostaining with antibodies against β-III-tubulin 
(neuron specific) with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; astrocyte specific) with Cy3 




Figure 49. Confocal fluorescent microscopic images of mouse neurospheres within 3D Matrigel hydrogels 
after 14 days of differentiation under static conditions.  Immunostaining with antibody against nestin (neural stem 
cell marker) with AlexaFluor 488 (green) and nuclear DAPI (blue) counterstaining (magnification 400X). 
 
Even though light microscopic images of mNSC differentiation within HyStem cultures 
revealed possible cell death within this ECM hydrogel, samples were immunostained and imaged 
using confocal fluorescence microscopy.  Figure 50 shows that there was no staining of the cells 
within these cultures for the differentiation markers.  This image also shows very few intact 
nuclei with DAPI staining within a neurosphere with instead leftover fragments of the dead cell 
nuclei.  This image is also representative of the mNSCs cultured within 3D HyStem hydrogels 
incorporating 100 µg/mL laminin within the hydrogel solution before gelation where laminin 
was not able to enhance cell survival or differentiation within this hydrogel (specific image of 
this culture looks similar to Figure 50 with only some DAPI nuclear staining). 
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Figure 50. Confocal fluorescent microscopic image of mouse neurospheres within 3D HyStem hydrogel 
after 14 days of differentiation under static conditions.  Immunostaining with antibodies against β-III-tubulin 
(neuron specific) with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; astrocyte specific) with Cy3 
(red), and nuclear DAPI (blue) (magnification 400X). 
3.3.5 Metabolic activity of bioreactor cultures 
Glucose and lactate measurements were taken daily during the culture of mNSCs within the 8 
mL bioreactor experiments.  The results of the glucose and lactate metabolism throughout these 
three cultures are shown in Figure 51.  The three 8 mL bioreactor experiments were seeded with 
1x108 neural stem cells as neurospheres in each of the three ECM hydrogel solutions.  All three 
of these bioreactor cultures underwent a dramatic decrease in metabolic activity within the first 
five days in culture.  The lactate concentrations dropped by the end of the culture period to 20-
25% of the initial concentrations on culture day 1 for all of the 8 mL bioreactor experiments. 
Decreasing metabolic activity implies cell death within the bioreactor.  Also, after shut down of 
these experiments and opening of the cell compartment it was apparent the many cells had not 
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survived the culture period and very few neurospheres were observed within the samples either 
by light microscopy or confocal fluorescence microscopy after immunostaining. 
Metabolic data for experiment MNS-3 culturing mNSCs within the four chambered 
bioreactor was taken daily, but the results of this data showed no changes within the glucose 
concentrations and no detection of lactate throughout the entire culture period.  The tubing 
circuit used for the 8 mL bioreactors was the same as that used for MNS-3, holding the same 
volume that the glucose and lactate concentrations are sampled from.  However, the four 
chamber bioreactor was seeded with 20% of the total number of cells seeded within the 8 mL 
bioreactors experiments.  This same circuit volume dilutes any observable changes within the 
concentrations measured within the circuit and therefore this data is not shown.  The lactate 
concentrations for MNS-3 and MNS-5 were below the operable detection range of the i-Stat 
device used to measure these concentrations (range = 0.3 -20 mmol/L). 
 
Figure 51. Plots of glucose and lactate metabolism of samples collected daily from the mNSC cultures 
within the 8 mL hollow fiber-based bioreactors. Only metabolic plots for experiments MNS-1 and MNS-4 are 
shown. 
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3.3.6 Live cell imaging during four chamber bioreactor culture 
Unlike the larger 8 mL bioreactor, the four chamber bioreactor allows light microscopic 
visualization of the cells within the chambers during the culture period.  The bioreactor perfusion 
systems for these experiments are placed adjacent to an inverted light microscope, with the 
tubing circuit used for these bioreactors having extensions long enough to maintain the tubing 
connected to the pumps while moving the bioreactor from the perfusion system to the 
microscope stage in order to image.  Images were taken daily of each chamber throughout the 
culture periods of bioreactor experiments MNS-3 and MNS-5.  A montage of the images taken in 
experiment MNS-3 is shown in Figure 52 demonstrating the morphology of the neurospheres on 
culture day 2, 6, and 14.  The chamber with mNSCs encapsulated in collagen shows initial 
process outgrowth from the cells and attachment of cells from the neurospheres within the first 5 
culture days, but by culture day 5 the cells that migrated out appear rounded resembling dying 
cells.  By the end of the 14 day culture the neurospheres within the collagen appeared to have a 
halo formed around the spheres. 
The neurospheres within the Matrigel chamber of experiment MNS-3 remained intact 
with no changes in morphology until culture day 6.  It was only on this culture day that the cells 
within the spheres began to extend processes into the surrounding Matrigel hydrogel.  Also, the 
Matrigel within this chamber seemed to detach between some of the fibers, as seen in the image 
for the Matrigel chamber at culture day 2 as the phase bright horizontal line.  Imaging of the 
Matrigel and collagen containing chambers after culture day 6 revealed pulsatile movements of 
the neurospheres within the gel between fibers in coordination with the pulsatile flow of the 
recirculation pump.  A time lapse movie was taken demonstrating this back and forth movement 
of some of the spheres, but not all neurospheres endured observable movements.   
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The chamber containing mNSCs encapsulated in the HyStem hydrogel of MNS-3 
displayed dramatic morphological changes within 12 hours after bioreactor cell inoculation (as 
seen in Figure 53a).  The cells began to migrate from the neurospheres forming structures 
throughout the HyStem hydrogel.  By culture day 2 as seen in the image of Figure 52, these cells 
formed structures between neurospheres.  By culture day 14 within the HyStem cells continued 
to spread throughout the hydrogel into morphologies that were hard to detect with the light 
microscope.  Individual cells are then difficult to observe within the 3D hydrogels.  However, 
there were some structures that deteriorated over the 14 day culture period within the HyStem 
chamber.  The structures seen in the culture day 2 image of Figure 52 is the same structure at the 
end of the culture period shown in Figure 53c.  The result of this deterioration is later elaborated 
on within the Discussion Section 3.4. 
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Figure 52. Live cell light microscopic imaging of experiment MNS-3 of neurosphere differentiation within 
4 chamber bioreactor through different culture days within chambers containing ECM hydrogels. Top row shows 
neurospheres at culture day 2, middle row at culture day 6, and bottom row at culture day 14.  Left column shows 
neurosphere within collagen type I, middle column within Matrigel, and within HyStem (cross-linked hyaluronic 
(magnification 100X). Neurospheres are seen within ECM gel between non-transparent medium perfusion hollow 
fibers (horizontal black lines). 
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Figure 53. Live cell light microscopic imaging of neurosphere differentiation within chamber of MNS-3 
bioreactor within HyStem cross-linked HA hydrogel through different culture days: a) neurospheres at 12 hours after 
seeding; b) culture day 6; c) culture day 14 (magnification 100X). 
 
The bioreactor experiment MNS-5 was attempted to reproduce the results seen in 
experiment MNS-3.  However, the arrangement of hydrogels within the chambers was changed, 
as described in Figure 33.  MNS-5 included a new hydrogel with the combination of 100 µg/mL 
laminin within the cross-linked HyStem hydrogel, where the two HyStem containing chambers 
were inline with each other.  The collagen and Matrigel chambers were inline together on the 
bottom row of the bioreactor.  The morphology of the cells within the HyStem chamber of 
experiment MNS-5 was dramatically different from what was observed in experiment MNS-3.  
Very few cells spread from the neurospheres within the first two culture days within the HyStem 
chamber.  The neurospheres within this chamber resembled the morphologies of the cells within 
the collagen chamber, where the migrating cells appear rounded and dying by culture day 2.  
However, there seemed to be only a slight improvement of migration of cells from the 
neurospheres.  The neurospheres through culture day 1-5 of the HyStem with laminin chamber 
appeared to have a more flattened morphology of the cells with the neurosphere attaching to the 
surrounding matrix.  However, instead of further attachment throughout the hydrogel and 
differentiation from these cells within the HyStem with laminin chamber, by culture day 7 the 
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morphologies of these cells appeared similar to the cells in the HyStem chamber without added 
laminin.  By culture day 14 within all chambers of bioreactor MNS-5 none of the cells were able 
to maintain any migration from the neurospheres into the surrounding ECM to acquire any 
structure formation. 
 
Figure 54. Live cell light microscopic imaging of experiment MNS-5 of neurosphere differentiation within 
4 chamber bioreactor through different culture days within chambers containing ECM hydrogels. Top row shows 
neurospheres at culture day 2, middle row at culture day 5, and bottom row at culture day 14.  Left column shows 
neurosphere within collagen type I, middle left column within Matrigel, middle right within HyStem (cross-linked 
hyaluronic, and right column within HyStem including 100 µg/mL laminin (magnification 100X). Neurospheres are 
seen within ECM gel between non-transparent medium perfusion hollow fibers (horizontal black lines). 
 
Due to less than desirable results of the 8 mL bioreactor experiments achieving poor cell 
survival within these devices, testing was performed to isolate the materials to test specifically 
the effects of the materials used within the tubing circuits.  Previous tests included testing media 
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circulated through the tubing circuit including the connected 8 mL bioreactor prior to 
experiments MNS-2 and MNS-4.  The results of testing media circulated for 24 hours of the 
bioreactor collected from experiment MNS-2 were tested on control cultures coated on Matrigel.  
The results of this test were misleading because cells did not survive well on the control Matrigel 
coated wells.  This test was repeated with setup of experiment MNS-4 using mNSCs cultured on 
laminin coated plates using the collected media.  Results are not shown here, but the 
neurospheres cultured in the bioreactor system collected medium appeared to attach and 
differentiate similarly to the control cultures on the first culture day, but by culture day 3 most of 
the cells had died and lifted from the plate.  Therefore, further material testing was performed in 
order to isolate the compatibility of the materials used in the system.  The only components of 
the 8 mL bioreactors are the perfusion hollow fibers (both microPES and polypropylene), the 
polyurethane housing, and silicone cell inoculation tubes.  Results in Appendix B previously 
demonstrated substantial rat neural stem cell attachment to the microPES hollow fibers sealed to 
petri dishes using the housing polyurethane and therefore it was assumed that it was not the 
bioreactor materials that were detrimental to the circulating culture medium in the system.   
An experiment was performed testing the perfusion of Neurocult differentiation medium 
through only two tubing circuits made of different materials.  The tubing used was the medical-
grade PVC that has been previously used as the tubing circuits for bioreactor cultures of our 
laboratory for many different cell types for many years.  The other tubing material tested was 
Tygon 275 a more expensive medical grade product useful for many devices used clinically.  The 
results of perfusing the differentiation medium through these two tubing circuits in two separate 
consecutive batches each for a 24 hour period and used to seed and culture mNSCs on laminin 
coated dishes is shown in Figure 55 compared to control cultures with fresh medium.  The 
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control cultures showed excellent neurosphere attachment to the laminin coated dishes with 
multiple cells showing morphologies resembling neurons by culture day 2 (illustrated with 
arrows).  The cultures maintained with medium circulated through the PVC tubing circuit 
resulted in very few neurospheres attaching to the laminin coated dishes.  The second batch of 
medium perfused through the circuit for the second 24 hour period, seemed to have a slight 
increase in neurosphere attachment, but by culture day 2 most of the spheres were seen as 
detached and floating.  The cells cultured in medium circulated through the Tygon 2275 tubing 
circuit, however, appeared to survive similarly to the control cultures achieving morphologies by 
day resembling multiple neurons with phase bright bodies and long processes (arrow point to 
group of neuronal like cells in image using medium perfused through 2275  circuit during the 




Figure 55. Light microscope images of mNSC cultures performed testing Differentiation medium perfused 
through either PVC or Tygon 2275 tubing circuits compared to control cultures with fresh Differentiation medium.  
The first column shows the mNSCs cultured for one day within the medium and the second column shows the same 
cultures after 2 days within culture; medium in this column for tubing types was the batch circulated for the first 24 
hour period through the tubing circuits.  The third and fourth column show the mNSCS at culture day 1 and 2, 
respectively with medium from the second batch circulated through the tubing circuits for the second 24 hour 
period.  Phase bright neurospheres as seen in the PVC tubing cultures are unattached floating spheres. Arrows 
indicate clusters of cells having neuronal-like morphologies. 
3.3.7 mNSC neuronal and astrocytic differentiation within bioreactor cultures 
Example images of fluorescent confocal images of 8 mL bioreactor experiments MNS-1, MNS-
2, and MNS-4 demonstrating immunostaining of samples with β-III-tubulin and GFAP staining 
are shown in Figure 56.  The images shown in this figure are representative of the very few 
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neurospheres able to be located within these samples, revealing minimal cell survival within 
these experiments.  The only neurospheres detected within MNS-1 within collagen hydrogel 
were found attached to the perfusion fibers, as seen in Figure 56a where the perfusion fiber is 
autofluorescent in blue.  The culture within MNS-2 of Matrigel revealed a slightly better survival 
of neurospheres present within the 3D space of the hydrogel, but cells appeared to be dying, with 
staining of the cytoplasm present with no nuclear staining.  The culture of MNS-4 revealed a 
slightly higher increase of neurospheres structures left intact within the samples, an example of 
the differentiation of these spheres is seen in the representative image. 
 
 
Figure 56. Confocal fluorescent microscopic images of neurosphere differentiation within 8 mL laboratory 
scale bioreactors containing 3D ECM hydrogels after 14 days of differentiation within the following experiments: a) 
MNS-1 mNSCs within collagen hydrogel (neurosphere attached to fiber which is autofluorescent in blue), b) MNS-2 
mNSCs within Matrigel hydrogel, and c) MNS-4 mNSCs within HyStem hydrogel.  Immunostaining with 
antibodies against β-III-tubulin (neuron specific) with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; 
astrocyte specific) with Cy3 (red), and nuclear DAPI (blue) (magnification 400X). 
 
 Figure 57 and Figure 58 demonstrate representative images of the neurospheres detected 
from the four chamber bioreactor experiment MNS-3 in which the bioreactor was perfused with 
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paraformaldehyde at the end for the entire samples to be used for confocal fluorescence 
microscopy.  The neurospheres within the collagen containing chamber reveal an increase in 
differentiated cells when compared to the 3D collagen hydrogels cultured statically.  However, 
the spheres left intact completely encapsulated between fibers within the collagen gel were 
smaller in diameter compared to those in the statically cultured collagen hdyrogels.  The 
neurospheres within the Matrigel containing chamber also appeared smaller in diameter, but with 
most cells staining positive for GFAP associated with astrocyte differentiation.  The processes 
from the neurospheres seen in the light microscopic images were not detected with the double 
staining fluorescence microscopic images.  Immunostaining of the structures formed within the 
HyStem containing chamber of experiment MNS-3 revealed a substantial number of cells 
staining positive for β-III-tubulin depicting multiple neurons within these structures.  Also, very 
few cells stained positive for GFAP representing low astrocyte differentiation within the 
structures.  These images show the beneficial enhancement of neuronal differentiation over 
astrocytic differentiation from the neural stem cells cultured in HyStem hydrogels under dynamic 
conditions compared to all other conditions tested. 
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Figure 57. Confocal fluorescent microscopic images of experiment MNS-3 neurosphere differentiation 
within 4 chamber bioreactor containing 3D ECM hydrogels after 14 days of differentiation. Immunostaining with 
antibodies against β-III-tubulin (neuron specific) with AlexaFluor 488 (green), glial fibrillary acidic protein (GFAP; 
astrocyte specific) with Cy3 (red), and nuclear DAPI (blue) (magnification 400X). 
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Figure 58. Confocal fluorescent microscopic images of experiment MNS-3 neurosphere differentiation 
within 4 chamber bioreactor containing HyStem (cross-linked hyaluronic acid) hydrogel after 14 days of 
differentiation. Immunostaining with antibodies against β-III-tubulin (neuron specific) with AlexaFluor 488 (green), 
glial fibrillary acidic protein (GFAP; astrocyte specific) with Cy3 (red), and nuclear DAPI (blue) (magnification 
400X). 
3.3.8 Quantification of neuronal and astrocytic differentiation within ECM hydrogels 
We have further attempted to assess neuronal and astrocyte differentiation of the mNSCs 
cultured on and within the different ECM hydrogels using quantitative RT-PCR.  RNA was 
collected from all samples and cDNA was synthesized and gene expression for β-III-tubulin, 
GFAP, and myelin basic protein (MBP) gene expression was quantified comparing to internal 
control of GAPDH gene expression.  These results of the relative expression ratios of these two 
genes as differentiation markers compared to the internal GAPDH control for the same RNA 
samples are shown in Figure 59 and Figure 60.  The data shown for the “2D” ECM coated plate 
cultures is representative of RNA collected from only one culture, except for the 2D Matrigel 
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including data from two separate cultures.  The data for all “Gel” 3D static cultured hydrogel 
cultures are representative of the mean and standard deviation between three separate cultures of 
each ECM hydrogel tested.  The “Bioreactor” samples within this data are from the RNA 
collected from the 8 mL bioreactor experiments MNS-1 (collagen), MNS-2 (Matrigel), and 
MNS-4 (HyStem).  
 There is a large variation of the β-III-tubulin expression within the 3D hydrogels cultured 
statically.  Some of these samples had very low mRNA expression of β-III-tubulin when 
compared to the control GAPDH mRNA.  Also, quantification of the RNA samples revealed 
very low amounts of RNA collected from all of the mNSC cultures.  This was the case even with 
the 2D laminin coated positive control culture where many cells were present by the end of the 
14 day culture period.  RNA was collected at the end of the 14 day culture period only and 
therefore represents the gene expression only of the cells that survived until the end of this 
culture period.  Therefore, some of these results are potentially misleading when quantifying 
percentage of cells differentiating into either neurons or astrocytes because the same number of 
cells do not survive the entire 14 day culture period among the different culture types.  Many 
cells survive and differentiate on the 2D laminin coated plates, while within the 3D HyStem 
hydrogels barely any cells survived the culture within the first culture day (as described above 
with the imaging results of these static cultures).  It is surprising that there was any β-III-tubulin 
gene expression detected within the 3D HyStem hydrogels cultured statically since imaging of 
these cultures revealed no immunostaining for this protein.  However, the standard deviation for 
this group is very large because two of the 3D static HyStem culture samples detected no mRNA 
presence with only one sample having enough mRNA to analyze the gene expression.  The 
results of this quantitative gene expression for differentiation of mNSCs on and within the 
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Matrigel hydrogels do correlate with the results observed by immunostaining and imaging of 
these cultures demonstrating that Matrigel enhances astrocyte differentiation among the mNSCs. 
In Figure 60, the results of some of the cultures are shown for myelin basic protein (MBP) gene 
expression, which is a marker for cells differentiating towards the oligodendrocyte lineage.  The 




Figure 59. Quantitative RT-PCR results comparing β-III-tubulin (neuron marker) and GFAP (astrocyte 
marker) gene expression of mNSCs cultured with different ECM matrices under the different culture conditions.  
Data represents mean of n=3 samples for “Gel” cultures from 3D hydrogel static cultures.  Error bars on “Gel” 
samples represent the standard deviation between the n =3 samples.  Bioreactor data presented are the results from 
mRNA collected from MNS-1, MNS-2, and MNS-4 performed within the 8 mL bioreactors.  Error bar on 
“Bioreactor Collagen” is the standard deviation between the two RNA samples collected from the 8 mL bioreactor 




Figure 60. Quantitative RT-PCR results comparing β-III-tubulin (neuron marker) and GFAP (astrocyte 
marker) gene expression of mNSCs cultured with different ECM matrices under the different culture conditions.  
Data represents mean of n=2 samples only for samples with error bars. Bioreactor data presented are the results from 
mRNA collected from MNS-1 and MNS-2 performed within the 8 mL bioreactors. 
3.4 DISCUSSION 
We have tested the effects of varying ECM scaffolds on mouse embryonic neural stem cell 
differentiation in vitro in order to determine a suitable matrix for neural stem cell differentiation 
within three dimensions in vitro.  As described in section 3.1.1, the in vivo adult neural stem cell 
niche has been well investigated in terms of the organization of cellular components, 
extracellular matrix components, and cell surface receptor expression.  This organization very 
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specifically defines the cell-cell and cell-ECM interactions between the different neural stem and 
progenitor cell types.  This entire in vivo niche is organized within three dimensions allowing the 
neural stem cells to have the proper morphology enabling growth factor modulation and 
regulation of neural progenitor cell expansion and migration.  Therefore, culturing neural stem 
cells in vitro on a 2D substrate would not allow recreation of this same neural stem cell niche in 
order to investigate the properties that naturally allow neural stem cell migration and 
differentiation. 
Unfortunately, the survival of the mNSCs was low within experiments using the large-
scale 8 mL bioreactors culturing the mNSCs at high densities within the different ECM 
hydrogels under 3D dynamic conditions.  The material testing of medium circulated through the 
PVC tubing circuit, similarly to the circuits used within the 8 mL bioreactor experiments, 
revealed the extremely poor compatibility of this tubing useful for bioreactor medium circulation 
for mouse neural stem cell cultures.  We previously used tubing circuits comprised of this 
medical-grade PVC tubing because it is the same tubing used clinically for dialyzer tubing 
extensions for blood perfusion in patient applications.  Also, this tubing material allowed easy 
production of our custom circuits by welding of the tubing at connection sites.  These PVC 
tubing circuits have previously been used in bioreactor experiments within our laboratory 
culturing multiple stem cell types including mouse and human embryonic stem cells and primary 
human adipose-derived stem cells.  The use of this PVC tubing circuit with the four chamber 
bioreactor of experiment MNS-3 did not produce results as extremely poor as the 8 mL 
bioreactor cultures.  The mNSCs survived and experienced neuronal differentiation within the 
HyStem chamber of this experiment more superior to any other culture performed within this 
work.  It is possible that within the 8 mL bioreactors the very large number of highly woven 
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perfusion fibers within the cell compartment creates a system similar to a filter.  It is possible 
that perfusion in areas of the 8 mL bioreactor cell compartment are not as highly perfused as the 
cell chambers within the four chamber bioreactors and particles and materials leaching from the 
PVC tubing circuit get trapped within the cell chamber without exiting.  For bioreactor 
experiment MNS-5 we produced our own newer version of the tubing circuit used for this four 
chamber bioreactor experiment with the tubing made from the more compatibility material 
Tygon 2275.  We hope that future experiments using this Tygon 2275 tubing circuit will allow 
an increased cell survival and differentiation of the mNSCs within the 8 mL hollow fiber-based 
bioreactors. 
 Results from culture of mNSCs on 2D collagen coated surfaces revealed poor movement 
of cells from neurospheres and attachment onto the collagen substrate, but led to enhanced 
differentiation of cells attached to each other within the structures remaining at the end of the 
culture.  The opposite occurred for mNSCs cultured within 3D collagen hydrogels with most 
cells remaining within the neurospheres still staining positive for the stem cell marker nestin.  
Mercier et al. described fractones of the SVZ mostly consist of the typical basal lamina protein 
laminin, but there were also random locations throughout the fractones where collagen type I 
was detected.  The mNSCs cultured here in collagen type I hydrogels resulted in low attachment 
of cells to the collagen hydrogel with cells remaining within the neurospheres.  In the 3D static 
collagen gel cultures, most intact neurospheres at the end of the two week differentiation period 
were still nestin positive.  It is possible that collagen type I within the localized regions of 
fractones of the SVZ in vivo has a similar function to maintain proliferating progenitor cells and 
preventing differentiation within these locations.  Therefore, collagen type I is not a suitable 
ECM scaffold useful for permitting extensive differentiation of mouse neural stem cells.  
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However, collagen type I hydrogels could be useful in maintaining proliferative populations for 
expansion of neural stem cells.  This could be useful in transplant applications where neural stem 
cells are desired to be maintained in an undifferentiated state in order to act therapeutically as a 
source of neuroprotective factors, termed the “bystander effect” [296]. 
 Conversely, Ma et al. have described production of functional neural circuitry among 
tissue generated from rat neural precursor cells encapsulated in collagen gels cultured in rotating 
wall vessel bioreactors with inclusion of bFGF in the culture media [284].  In our work we have 
shown that addition of bFGF to the Neurocult Differentiation medium (Stem Cell Technologies 
Inc.) used to culture mouse neural stem cells in collagen gels further inhibits neuronal 
differentiation of the cells.  Differences therefore most likely exist within the pathways driving 
differentiation of neural stem cells across species.  Also with our work, incorporation of laminin 
into the collagen gel solution before gelation resulted in increased neuronal differentiation within 
these hydrogels cultured under static conditions in a dose-dependent manner with increasing 
laminin concentrations.  However, Guarnieri et al. have characterized collagen gels with 
incorporation of different laminin concentrations to find laminin forms concentrated aggregates 
within the collagen network instead of a continuous matrix throughout, which also decreases the 
mechanical properties of the hydrogel with increasing laminin concentrations [297]. 
Matrigel is a crude mixture of native basement membrane components isolated from 
cultured mouse EHS tumor cells, which produce these components in abundance [298].  The 
growth factor reduced Matrigel used in these studies consists of approximately 60% laminin, 
30% collagen type IV, 7% entactin, as well as heparan sulfate proteoglycans (HSPG).  
Previously, Matrigel has been used to support neurite extension with primary neuronal cultures 
[299, 300].  Matrigel is the only commercially available 3D matrix composed of such a high 
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concentration of laminin.  We utilized this product since laminin is traditionally preferred as the 
substrate for NSC differentiation on a 2D surface.  However, results using this matrix both in 3D 
static cultures as well as bioreactor cultures showed enhanced astrocyte differentiation from the 
neural stem cells encapsulated in the Matrigel hydrogels.  Original concentration Matrigel was 
first used, but this product was not able to sustain the 14 day culture period as an intact hydrogel 
even under the static culture conditions and therefore high-concentration Matrigel product was 
further used.  Also, we have utilized the high concentration plus growth-factor reduced Matrigel 
product in order to minimize effects of the active growth factor components within the original 
Matrigel.  We attempted to focus on varying only the ECM component of the cultures instead of 
growth factor variation.  However, even this growth factor reduced product still contains low 
amounts of the known active growth factors within Matrigel: 0-0.1 pg/mL bFGF, <0.5 ng/mL 
EGF, 5 ng/mL IGF-1, <5 pg/mL PDGF (platelet-derived growth factor), <0.2 ng/mL NGF, and 
1.7 ng/mL TGF-β. 
Neural stem and progenitor cells are known to proliferate and differentiate in response to 
multiple growth factors in vivo [245, 301-305].  Further investigation of the ECM components of 
the SVZ in vivo has revealed the function of the permissive components, such as laminin and 
HSPG, is to regulate growth factor presentation to the specific cell types [251].  The fractones, 
basal lamina extensions, extend from blood vessels and the ventricle in order to capture growth 
factors from the blood and cerebrospinal fluid (CSF).  Here we utilized a commercially available 
defined media for inducing neural stem cell differentiation (Neurocult, Stem Cell Technologies, 
Inc.).  The specific component formulation of this defined medium is company information only 
and not available to the public, but the company has claimed it is based on the formulation 
determined by Reynolds et al. where NSCs are differentiated with removal of EGF from the 
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defined proliferation medium and addition of a small amount of serum [234, 235, 279].  In our 
work within Chapter 3 using adult rat neural stem cells, we prepared our own medium according 
to these references.  However, within this work we chose to focus on testing the ECM scaffolds 
without varying the soluble chemical factors within the medium and therefore used a 
commercially available source of medium to be consistent throughout experiments. 
The Neurocult medium formulation allows acceptable differentiation of the mNSCs on 
laminin coated 2D culture dishes, but might not be suitable for use in a 3D configuration as 
observed within our work.  Without the ability to maintain a scaffold entirely composed of 
laminin, the defined medium used to differentiate the mNSCs might need incorporation of 
additional soluble components.  We have demonstrated that collagen type I, growth factor 
reduced Matrigel, and HyStem (cross-linked hyaluronic acid) did not allow acceptable 
attachment of the mNSCs onto the 2D substrates or attachment onto the 3D hydrogel from the 
neurospheres into the scaffold in order to properly differentiate without the incorporation of 
additional soluble factors.  The HyStem hydrogel allowed substantial 3D structure formation 
with cells migrating from the neurospheres throughout the gel within the perfused bioreactor 
chamber only when placed horizontally inline with the chamber containing Matrigel of 
experiment MNS-3.  Chambers horizontally next to each other within this bioreactor have the 
same perfusion fibers running directly from one chamber to the other allowing secreted soluble 
factors to be exchanged before dilution into the entire tubing circuit volume.  Therefore, mNSC 
structure formation and increased neuronal differentiation within the HyStem gel of MNS-3 and 
not of MNS-5, most likely is attributed to soluble factors released from the Matrigel.   
The medium perfusion fibers of the bioreactor have a molecular weight cutoff of 400 kD 
(kiloDaltons).  Glycosan Biosystems Inc. claims the cross-linked HyStem gel has a pore size 
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allowing diffusion of molecules under 70 kD in size.  There are many active ECM components 
and growth factors within Matrigel, as described above.  TGF-β has been demonstrated to drive 
glial differentiation in human NSCs [306].  bFGF and EGF are the growth factors used to 
prevent differentiation of NSCs to maintain expansion of the cells.  Nerve growth factor (NGF) 
is an active neurotrophic factor able to modulate axonal processes in primary neurons.  However, 
results of culturing the mNSCs in Matrigel directly resulted in increased astrocyte differentiation 
from the cells.  If one of these soluble growth factors released from the Matrigel containing 
chamber of bioreactor experiment MNS-3 were responsible for increased neuronal differentiation 
in the neighboring HyStem containing chamber, there must be a non-soluble component to the 
Matrigel that prevents this same neuronal differentiation that is blocked by the molecular weight 
cutoff of the perfusion fibers or HyStem pore size.  It is possible that TGF-β, bFGF, or EGF 
present within the Matrigel could have prevented the neuronal differentiation within the 
Matrigel, but of interest that the same results did not occur within the neighboring HyStem 
chamber. 
The migration of cells from the neurospheres within the HyStem chamber of bioreactor 
experiment MNS-3 occurred within the first 12 hours after seeding the neurospheres within the 
bioreactor as opposed to very little migration from the neurospheres within HyStem of 
experiment MNS-5.  There was an immediate response of the neurospheres within the chamber 
next to the Matrigel containing chamber instead of a delayed response due to degradation of 
large ECM molecule components of the Matrigel.  Laminin within Matrigel is of the form 
laminin-1 with three chains, designated α1, β1, β2 (or γ1) [298].  The β1 and β2 chains coil 
around the α1 chain creating a four-armed tertiary protein structure that allows multiple binding 
domains with the other basement membrane protein components [307].  The molecular weights 
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of the separate chains are α1 = 400 kD, β1 = 222 kD, and β2 = 210 kD [294].  The type IV 
collagen within Matrigel is composed of two chains in the form α1(IV)2α2(IV) [298].  The 
molecular weights of these two chains are 185 kD and 170 kD.  These high molecular weights 
render these ECM components unlikely candidates in their ability to perfuse from one chamber 
to the other in the 4 chamber bioreactor as well as through the HyStem gel pores [308].  It is 
possible that later degradation of these ECM components are able to perfuse into the circulation, 
but the response of the mNSC structure formation within the HyStem chamber next to the 
Matrigel was immediate.  Also, the mNSCs within the chamber containing HyStem plus 100 
µg/mL laminin within experiment MNS-5 achieved morphologies within the first culture day 
different to that seen in the MNS-3 chamber.  The cells in the HyStem chamber next to the 
Matrigel chamber of MNS-3 had a migratory response out from the neurospheres into the 
surrounding hydrogel allowing structure formation between spheres within the first culture day.  
The cells within the HyStem chamber containing laminin of MNS-5 instead appeared to have a 
more flattened morphology with increased attachment and spreading of the cells in the 
neurospheres to the surrounding hydrogel within the first culture day. 
Within this work we chose to focus on analysis of the neuronal and astrocytic 
differentiation of the mouse neural stem cells within the different cultures.   Immunostaining for 
O4, an early oligodendrocyte marker, was initially performed on laminin coated 2D control 
cultures, but resulted in low detection of cells possibly differentiating towards the 
oligodendrocyte lineage.  Additionally, quantification of gene expression for MBP, an 
oligodendrocyte marker, was performed with qRT-PCR with mRNA collected from the mouse 
neural stem cells differentiated with collagen and Matrigel as substrates or 3D hydrogels.  These 
results showed very low expression levels of MBP and oligodendrocyte presence of cells at the 
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end of the differentiation period.  However, it is important to further analyze differentiation of 
neural stem cells into oligodendrocytes.  These cells are the more desired cell types able to be 
obtained from neural stem cells for therapies specifically in myelin-associated diseases.  For 
example, multiple sclerosis is an auto-immune disorder where the immune system specifically 
attacks the myelin sheats provided by oligodendrocytes that maintain insulation of signaling 
neurons preventing neurons from properly signaling and communicating and controlling 
functions.  Conditions and environments useful in driving oligodendrocyte differentiation of 
neural stem cells are therefore of great interest in achieving these cell types for possible cell 
therapies and creating models of myelinated neurons in developing therapeutic strategies for 
diseases involving these cells.  Also, a proper in vitro culture model of a neuronal network of 
cells with signaling neurons within the bioreactor devices will require a mixed population of 
cells including myelination of neurons by oligodendrocytes.  Further work could investigate the 
oligodendrocyte differentiation of these cells resulting from differentiation within different ECM 
hydrogel scaffolds. 
Further experiments are necessary to reproduce the increased structure formation and 
neuronal differentiation of the mNSCs within the HyStem hydrogels due to soluble Matrigel 
factor perfusion within the four chamber bioreactor.  Experiments can be performed to both test 
the effects soluble components released from Matrigel hydrogels within surrounding medium 
and separately test effects of individual Matrigel components on mNSC cultures to determine 
which factors are inhibitory or permissive for cell attachment or neuronal differentiation.  Also, it 
is possible that the inhibitory factor of Matrigel preventing it from being a suitable hydrogel 
useful in NSC cultures could be the density of this hydrogel.  Within experiment MNS-3, the 
cells of the Matrigel containing chamber remained as neurospheres with no changes in 
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morphology until culture day 6.  It was only after the six days of culture that the cells began to 
extend processes from the neurospheres into the hydrogel.  However, within the statically 
cultured 3D Matrigel cultures, the neurospheres extended processes within the first day of culture 
and therefore opposes this theory.  Thonhoff et al. have also demonstrated increased astrocyte 
differentiation from human fetal neural stem cells cultured within 3D Matrigel hydrogels [309].  
The aspect of the cross-linked HyStem hydrogel providing a longer lasting hydrogel makes it a 
more acceptable matrix useful for scaffolds for neural stem cells in long term dynamic cultures.  
The HyStem hydrogel has the ability to last within long term cultures, but improvements to the 
culture medium used for the mNSCs to be effective within the HyStem hydrogels must be 
improved upon. 
3.5 CONCLUSION 
It is likely that in vitro regulation of neurosphere attachment, proliferation, migration, and 
differentiation is as complex as the in vivo regulation by coordination of temporal and spacial 
changes in cell surface receptors responding to different growth factors and extracellular matrix 
molecules.  Our results have provided a first step in describing mouse neural stem cell 
differentiation in a 3D organization with varying the ECM components.  The HyStem 3D ECM 
hydrogel matrix provides a stable scaffold allowing neural stem cell structure formation and 
differentiation under 3D dynamic conditions in vitro within the bioreactor device with the 
appropriate additive soluble factors and should continue to be used for establishing these 
cultures.  Optimization of neural stem cell cultures within our hollow fiber-based bioreactor 
devices could allow multiple investigations into the mechanisms of neural stem cell expansion, 
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migration, and differentiation.  The next experiments should focus on the soluble factors 
necessary for enhanced neuronal differentiation of the NSCs within the HyStem hydrogels in the 
3D dynamic environment.  The bioreactor system allows easy manipulation of the culture 
environment in order to more accurately study the properties of the neural stem cells due to the 
variations within the culture environment.  The study of neural stem cell expansion and 
differentiation under 3D dynamic conditions could help to more accurately predict the outcome 
of methods used with in vivo studies using NSCs as a cell therapy.  Additionally, human neural 
stem cells could be cultured within the bioreactor devices to directly describe the abilities of 
NSCs to be delivered into a dynamic three-dimensional environment similar to the body. 
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4.0  LASER MODIFIED HOLLOW FIBER SCAFFOLDS TO 
COMPARTMENTALIZE IN VITRO NEURONAL CELL CULTURE SYSTEMS FOR 3D 
DIRECTED AXONAL OUTGROWTH 
4.1 INTRODUCTION 
4.1.1 Significance of compartmentalization of axons from cell bodies in vitro 
The objective of the work within this chapter was to further advance the ability to achieve a 
superior in vitro neuronal cell culture model.  The above chapters discuss the ability of the 
hollow fiber-based bioreactors to allow high density 3D neuronal cell growth, but the work here 
demonstrates our ability to fabricate a scaffold useful for bioreactor designs to control and direct 
neuronal axon growth within the in vitro 3D dynamic culture model.  The scaffold designed here 
can allow neuronal cell bodies to be separated from their axons inducing compartmentalization 
for controlled signaling interactions among neurons.  This compartmentalization will allow 
unique environments to be applied both to the neuronal cell bodies cultured within the cell 
compartment of the culture model and to the process/axon growth within the scaffolds, 
simultaneously.  This differential growth could be useful for analyzing axonal regeneration from 
neuronal cell bodies.  Most importantly this aspect of the proposed culture models will allow 
controlled growth of the configuration of the neuronal cells and specifically the direction of the 
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axon growth and synapse formation with other axons for controlled signaling.  Separation of 
neuronal cell axons from their bodies through a cylindrical 3D scaffold mimics axonal growth in 
vivo from the brain through the spinal column.  Testing therapeutic reagents for extending axonal 
regeneration within in vitro culture models integrating this same configuration for neuronal cell 
cultures might prove very valuable for more accurate assessment of the effects of these reagents. 
4.1.2 Excimer laser ablation in tissue engineering 
We have developed this scaffold for controlling specific neuronal cell body and axonal process 
outgrowth in vitro by performing excimer laser ablation modifications to microporous 
polyethersulfone (PES) hollow fibers.  Excimer laser ablation for tissue engineering applications 
was performed in 1994 by Nakayama and Matsuda to create pores in polymer scaffolds for 
cardiovascular tissue engineering [310].  Further work has been performed by Tiaw et al. to 
produce porous poly(caprolactone) sheets with excimer laser ablation for a possible skin 
substitute [311].  There have been other reports on the use of excimer laser ablation on polymer 
scaffolds to manipulate cell growth, but none for controlling neuronal cell growth [312-315].  
 Excimer laser ablation was utilized to generate specifically sized channels within the 
walls of PES hollow fibers in order to compartmentalize growth of neuronal cell bodies from 
their axonal processes and further facilitate directed process growth into the 3-D space of the 
fiber lumens.  Compartmentalization of neuronal cell bodies from their axons may lead to 
controlled synaptic networking between cell bodies within a 3D space.  Further incorporation of 
these scaffolds into a hollow fiber-based bioreactor to establish high-density 3-D in vitro 
neuronal cell culture models with defined axonal pathways in the directions of the lumens of the 
scaffolds will allow creation of a tool for studying 3-D neuronal networking in vitro.  The growth 
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of only the neuronal axons into the fiber scaffolds allows a direct method of analyzing directed 
neurite outgrowth within a 3-D space at high densities that more accurately mimics the in vivo 
environment. 
Figure 61 is a diagram describing this proposed advanced in vitro neuronal cell culture 
model with a hollow fiber-based bioreactor foundation including incorporation of excimer laser 
modified hollow fiber scaffolds able to direct axonal growth throughout the system.  The picture 
on the left describes the overall design concept of the bioreactor where multiple cell 
compartments can be connected using the modified hollow fiber scaffolds permitting axonal 
growth from one compartment to another. The picture on the top right describes the 3D neuronal 
process outgrowth within the hollow fiber-based bioreactor cell compartment achieved within 
the previous chapters. The picture on the bottom right describes the concept of the desired 
objective for the laser modified hollow fiber scaffold used to compartmentalize neuronal cell 
body growth from directed axon growth through the lumen of the scaffold.  Figure 62 is a 
diagram of a simplified version of this design concept based on the 4 chambered analytical 
bioreactor.  This design would allow high density 3D neurite outgrowth from neurons within 
each of the two cell compartment chambers.  These two chambers would be connected only via 
the lumen of a single hollow fiber scaffold able to direct axonal growth from one compartment to 
the other through first through the laser created channels of the scaffold.  Reagents having the 
potential to affect axonal outgrowth into the scaffold could be applied as gradients to the upper 
cell compartment by perfusion through the separate hollow fiber bundle of the lower cell 
compartment and through the lumen of the scaffold fiber.  This design would enable testing of 
chemotropic factor gradients on high density tissue-like neuronal cell cultures in 3D assessing 
the ability to enhance nerve regeneration by directed axonal outgrowth. 
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Figure 61. Diagram describing design concept of advanced in vitro neuronal cell culture model with a hollow fiber-




Figure 62. Diagram of design concept for simplified neuronal cell bioreactor in vitro culture model 
utilizing a single laser modified hollow fiber scaffold for directed axonal growth from one compartment to the other. 
4.2 METHODS 
4.2.1 Laser modification of PES flat sheet membranes and hollow fibers 
Ultrafiltration microporous polyethersulfone hollow fibers (MicroPES TF10, Membrana, 
Wuppertal, Germany) with inner diameter of 300 ± 40 µm, wall thickness of 100 ± 25 µm, and 
maximum pore size of 0.5 µm were used.  PES flat sheet membrane counterparts (Membrana, 
Wuppertal, Germany) to these fibers with similar pore structure were also used to enable 
characterization of laser modifications on 2D surfaces.  All laser modifications were performed 
with a KrF 248 nm nanosecond excimer laser (Lambda-Physik EMG-202) with a full-width-half-
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maximum pulse duration of 25 ns at a pulse frequency of 2Hz, at room temperature in an open 
air atmosphere.  The laser beam path through the mask projection system to the sample stage is 
shown in Figure 63.  Laser pulse energy was controlled at position Figure 63(a) by rotation of a 
variable attenuator plate (JPSA Laser UM-VA) and measured with a Molectron JD-100 
pyroelectric joulemeter. 
 
Figure 63. Schematic view of excimer projection irradiation system and Gaussian fluence profile using 25 
µm copper mask and unattenuated beam (peak surface fluence at 1,200 mJ/cm2). a) Variable attenuator, b) fused 
silica plate, c) joulemeter, d) adjustable field lens, e) turning mirror, f) copper mask, g) singlet lens, uncoated f = 
100mm, h) X-Y sample stage, i) diode laser, j) fiber optic line to photodetector. 
Circular channels were created in PES fibers by laser beam projection through a 
prefabricated copper mask with a 25 µm diameter pinhole at position (f) in Figure 63 and singlet 
projection lens at positioned at (g) for 5X demagnification.  This resulted in a circular beam 5 
µm in diameter incident the side of the PES fiber.  Channel creation was optimized by varying 
each laser setting of pulse number, placement of the projection lens, and laser fluence, or energy 
density, independently.  Single rows of 5 μm diameter channels were patterned onto PES fiber 
walls using 35-50 pulses (N = 35-50) at a peak surface fluence of 1,200 mJ/cm2.   
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For comparison, large area PES flat sheet membrane surfaces were modified without a 
mask at laser fluence values used in channel creation.  Fluence calibration in both cases was 
obtained with a series of single shots on silicon and SiO2 multilayer thin film wafers under flood 
irradiation (without mask) and with the 25 µm copper mask at known pulse energies.  Using a 
technique described elsewhere [316], the absolute fluence under flood irradiation as well as the 
spatial fluence variation in the projected beam with the 25 µm mask could be determined.  This 
was used to laser modify a continuous area on the PES flat sheet membranes with different 
fluences under flood irradiation that mimicked the surfaces cells would see along channel walls.  
The PES flat sheet membranes were modified under flood irradiation with rows of single laser 
pulses overlapping to have 5 pulses within one beam diameter in order to correct for the 
Guassian beam profile.  Fluences used were similar to those using the 25 µm mask.  These 
surfaces considerably approximates the fiber channel walls because only a small fraction of the 
50 pulses used to create the channels modifies the final wall surface due to the narrow Gaussian 
beam profile.  These flat sheet membranes allowed surface characterization of the laser 
modifications to the PES surfaces.  
 
4.2.2 Surface characterization of laser modified PES flat sheet membranes 
4.2.2.1 Contact angle measurements 
To analyze changes in surface chemistry after laser modification, advancing and receding contact 
angle measurements were performed on unmodified PES flat sheet membranes and membranes 
modified with peak surface fluences of 300, 600, 900, and 1200 mJ/cm2.  These measurements 
were performed by placing a 3 μl ultrapure water droplet on sample surface, adding 1 µl to 
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existing droplet for advancing angle, capturing image with VCA2000 video contact angle system 
(goniometer, Advanced Surface Technology Inc.), then removing 1 µl for receding angle, and 
capturing another image of this droplet.  Computer software calculated the angle of contact 
between surface and adjacent droplet edge.  Ten independent measurements were performed per 
each sample resulting in two angle measurements per droplet. 
4.2.2.2 Quantification of laminin adsorption on PES flat sheet membranes 
PES flat sheet membranes both unmodified and modified with a peak laser surface fluence of 
1,200 mJ/cm2 were cut into disks (n=5 of each) fitting the wells of 48-well plates (BD and Co., 
Franklin Lakes, NJ), sterilized for cell culture by ethylene oxide, and subsequently washed with 
phosphate buffered saline (PBS; Gibco/Invitrogen Corp., Grand Island, NY).  Each of the PES 
disks and n=5 TCPS control wells were incubated at 37 °C in a humidified incubator with 
atmosphere of 5% CO2 for 12 hours with 10 μg/ml laminin in 400 μl PBS (total 4 μg laminin per 
disk).  The supernatants from each well were removed and collected.  The non-adsorbed laminin 
from each disk was detected using a Micro BCATM Protein Assay Kit (Pierce, Rockford, IL) 
[317].  For this assay, 200 µl of each of the supernatants were added to 200 µl of the BCA 
working reagent in a 48 well plate (only half of the supernatant was analyzed).  A standard was 
made with known amounts of laminin diluted in PBS in separate wells with same volume of 
working reagent and total volume.  These plates were incubated for 2 hours in 5% CO2 
humidified incubator.  Solutions were then measured with Fluorometer (SpectraFluor Plus; 
Tecan Group Ltd., Mannedorf, Switzerland) at 560 nm.  Total µg adsorbed laminin was 
calculated by doubling the amount measured to get the total amount of non-adsorbed laminin and 
then subtracted from the total 4 µg amount added. 
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4.2.2.3 PC12 cell adhesion assay on PES flat sheet membranes 
PES flat sheet membranes both unmodified and modified with peak laser surface fluences of 
300, 600, 900, and 1200 mJ/cm2 (n=5 of each) were cut into disks fitting the wells of 48-well 
plates as performed above for the laminin adsorption study.  Laminin adsorption to n = 5 disks of 
each group was performed as above with n = 5 of the unmodified disks incubated with only PBS 
for 12 hours. The neuronal-like rat pheochromocytoma cell line (PC12; ATCC, Manassas, VA) 
was used to allow easy plating and quantification of cells attached to modified disk surfaces.  
4x104 PC12 cells were plated onto each sample surface with DMEM/F-12 media 
(Gibco/Invitrogen Corp.) including 10% horse serum (Gibco/Invitrogen Corp.), 5% fetal bovine 
serum (Gibco/Invitrogen Corp.), and 1000 IU/ml penicillin/1000 μg/ml streptomycin 
(Gibco/Invitrogen Corp.) and allowed to attach for 12 hours at 37 °C in humidified incubator 
with atmosphere of 5% CO2.  Disks were then washed with PBS and transferred to new wells 
and plates were stored at -80ºC at least 4 hours to freeze kill adhered cells.  Adhered cells to 
surfaces of different laser modified PES membrane disks were quantified using CyQUANT-
GR™ nucleic acid fluorescence assay kit (Molecular Probes/Invitrogen Corp., Eugene, OR).  
Fluorescent measurements of CyQUANT-GR™ reagent were taken with a Fluorometer 
(SpectraFluor Plus; Tecan Group Ltd., Mannedorf, Switzerland) after 15 minute incubation on 
disks. A calibration curve with known cell amounts translated the fluorescence readings into cell 
numbers. 
4.2.3 Primary rat neural progenitor cell differentiation on modified hollow fibers 
Interactions of a neuronal cell type on PES hollow fibers with laser created channels were 
assayed by culturing adult rat neural progenitor cells (NPCs) isolated from the subventricular 
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zone of adult rat brains (generously donated by Dr. Glenn Gobbel, University of Pittsburgh) 
[295].  Single fibers with a single row of 5 µm diameter laser created channels were coated first 
with poly-ornithine and then 10 µg/ml laminin.  Undifferentiated neurospheres were plated at a 
density of 1x105 cells/ml onto fibers along with differentiation media consisting of DMEM/F12 
(Gibco/Invitrogen Corp.) with an additional 3 mM D-glucose, 1.2 mM sodium bicarbonate, 0.46 
mM HEPES, 2% B27 (Gibco/Invitrogen Corp.), 0.1 mg/ml apo-transferrin, 23 μg/ml insulin, 55 
μM putrescine, 20 nM progesterone, 30 nM sodium selenite, 1000 IU/ml penicillin/1000 μg/ml 
streptomycin (Gibco/Invitrogen Corp.), 20 ng/ml bFGF, and 3% fetal calf serum (FCS; 
Gibco/Invitrogen Corp.).  These cultures were maintained for 1 week with media replacement 
every 2 days. 
Results of these cell cultures were analyzed by fluorescent immunocytochemisty staining 
of β-III-tubulin and Hoechst counterstaining along with SEM.  Fiber samples for 
immunocytochemistry were first fixed by washing with PBS, fixed in 4% paraformaldehyde for 
30 minutes, and finally rinsed two times in PBS.  Samples were then prepared for staining by 
permeabilization in 0.3% Triton-X, washed in PBS, and blocked with goat serum.  β-III-tubulin 
(TUJ1) primary monoclonal antibody (dilution 1:750; Covance, Princeton, NJ) in 3% goat 
serum/PBS was added for 1 hour and then washed with PBS.  Secondary antibody used was 
Alexa Flour 594 anti-mouse (dilution 1:1000; Molecular Probes/Invitrogen Corp.) in 3% goat 
serum/PBS for 1 hour.  Samples were then washed twice with PBS and counterstained with 
Hoechst dye (dilution 1:500). 
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4.2.4 Scanning electron microscopy 
The topographies of laser modified PES flat sheet membranes and PES fibers with laser created 
channels were examined using field emission SEM (Philips XL-30; FEI Company, Hillsboro, 
OR) after samples were sputter coated with Au/Pd layer using a Cressington 108 Auto 
(Cressington, Watford, UK).  For fiber samples including rat neural progenitor cells, the SEM 
preparation procedure involved fixing the cells with a 2.5% solution of glutaraldehyde, treatment 
with osmium tetraoxide, and alcohol dehydration followed by critical point drying. 
4.2.5 Statistical analysis 
Statistical analyses of experiments included first a one-way ANOVA using Statistical Analysis 
Software.  To compare two groups within an experiment, variance ratios were compared to 
corresponding F-values to statistically validate either equal or unequal variances.  Finally, to 
determine statistical significance between means of two groups within an experiment, two-tailed 
Fisher’s protected t-tests with either the validated equal or unequal variances was performed with 
a confidence interval of 95%.  All data points are expressed as mean ± standard deviation. 
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4.3 RESULTS 
4.3.1 Peak fluence of KrF excimer laser pulse at PES surface 
The multilayer silicon/SiO2 thin film wafer measurements under flood irradiation and mask 
projection irradiation combined with a numerical model allowed determination of the absolute 
fluence profile of the beam at the sample surface [316].  The fluence profile of the beam using 
the 25 μm mask is shown in Figure 63.  The x-axis shows the maximum diameter of the beam at 
the sample surface to be 5 μm, enabling creation of channels somewhat less than 5 µm using this 
mask.  Successful calibration also permitted matching of the peak surface fluence in the 
projected beam to the flood irradiation experiments using PES flat sheet membranes, by 
adjusting the overall laser attenuator settings. 
4.3.2 Optimization of laser created channels in PES hollow fibers 
The three major variable settings on our KrF excimer laser system are the number of pulses to 
the sample (N), the position of the projection lens, and the fluence of the beam (F in mJ/cm2).  A 
series of tests were run in order to determine the individual effects of each setting on the creation 
of channels within the PES fiber walls (results shown in Figure 64).  The number of laser pulses 
to the PES surface was able to change the amount of material removed from the channel and 
hence its depth.  Figure 64(a-c) depicts the results with SEM images of channels in PES fiber 
walls with increasing the pulse number on the PES fiber surface with constant F = 1,200 mJ/cm2 
from (a) N = 10 to (b) N = 20 and (c) N = 40.  At this fluence it was found that with N = 50 a 
channel can be created that extends through the entire wall thickness of the fibers (channels used 
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in experiments with these settings are shown in Figure 65).  Next, the position of the projection 
lens was varied while holding constant an F = 1,200 mJ/cm2 and N = 50.  This enabled changing 
the focus of the projected beam image and led to altering the contour and slope of the edges of 
the channels created within the PES fiber walls.  Figure 64(d-e) shows representative SEM 
images of channels created with two different lens positions.  The channel in Figure 64(d) was 
created with the projected beam image in focus to produce steeper, more precise edges.  Figure 
64(e) depicts a channel formed with the lens position raised to result in the beam being slightly 
out of focus.  This results in more sloped edges of the channels towards the outer surface of 
fibers while still keeping the smaller 5 µm diameters at the inner surface. Finally, tests were 
performed varying the beam fluence with an attenuator plate within the beam path (Figure 63a). 
Other settings were held at N = 50 and lens position at the above mentioned setting to create the 
sloped edges.  Results of SEM images of channels created with three representative fluences are 
shown in Figure 64(f-k).  The effect of varying laser fluence was on the intensity of the beam 
being projected onto the PES fiber sample.  Decreasing the fluence led to decreasing the 
diameter of the channel created within the PES fiber wall.  It was not possible to create channels 
through the entire wall thicknesses of the fibers below F = 600 mJ/cm2 as shown in Figure 64(f). 
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Figure 64. SEM images of channel creation in PES fiber with the following settings: F = 1,200 mJ/cm2 and 
(a) N = 10, (b) N = 20, (c) N = 40 (arrowheads highlight different channel depths); F = 1,200 mJ/cm2 and N = 50 
with demagnifying singlet lens positions (d) in focus and (e) out of focus (arrowheads highlight edge differences); 
and N = 50, singlet lens out of focus, and fluences of (f,i) 600 mJ/cm2, (g,j) 900 mJ/cm2, and (h,k) 1,200 mJ/cm2 ((f-
h) outer fiber surface and (i-k) inside luminal fiber surface (created channels circled to distinguish between natural 
pores); scale bars = 5 µm). 
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The optimal settings for reproducibly creating 5 µm diameter channels with smooth 
sloped edges leading to the inner lumens of the PES fibers are using an F = 1,200 mJ/cm2, N = 
50, and a lens position to make the beam slightly out of focus.  SEM images of channels with 
these settings are shown in Figure 65.  The arrangement of these channels on the PES fibers that 
have further been used in the cell culture experiments are shown in Figure 65c.  However, any 
desired channel pattern could easily be created in the fiber walls with this system. 
 
Figure 65. SEM images of channels in PES fibers further used in cell culture experiments viewed from (a) 
outer fiber surface and (b) inside luminal fiber surface (scale bars = 5 µm). Pattern of channels used in cell culture 
experiments shown in (c) single row arrangement along axis of fiber (scale bar = 100 µm).  Laser settings used are 
1,200 mJ/cm2, 50 pulses at 2 Hz, and demagnifying lens position out of focus. 
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4.3.3 PES flat sheet membrane surface wettability varying laser fluence 
SEM images of these flat sheet membranes modified with different laser fluences producing 
surfaces similar to the walls of the channels created within the fibers revealed no major 
microstructural/topographical differences (images not shown).  In order to determine any 
changes in the surface hydrophilicity with laser modification that could possibly affect cell 
interactions with the channels, contact angle measurements were taken.  The results of the 
measured contact angles on these different PES flat sheet membranes are listed in Table 4.  The 
unmodified PES flat sheet membrane surfaces are extremely hydrophilic consistent with these 
fibers being used mainly for ultrafiltration. The contact angles of droplets on these unmodified 
surfaces were next to zero due to the membrane almost completely absorbing the droplet.  
However, as the fluence of the laser beam is increased the contact angles of droplets on the 
modified surfaces increases significantly resulting in very hydrophobic surfaces with contact 
angles over 100º.  The higher fluence of 1,200 mJ/cm2 that is used in creating channels in the 
fiber walls results in an extremely hydrophobic surface with advancing and receding angles of 
125º ± 1.5º and 110º ± 5.2º respectively. 
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Table 4. Contact angle measurements on PES flat sheet membrane surfaces modified with varying laser 
fluences (n=10 droplets per surface). 
 
4.3.4 Laminin adsorption on laser modified PES flat sheet membrane surfaces 
In order to determine protein adsorption changes to the surfaces of laser modified MicroPES 
fibers from unmodified surfaces, counterpart flat sheet membrane disks were coated with 10 
µg/ml laminin (total of 4 µg) for 12 hours.  A MicroBCA assay kit was used to measure total 
amounts of non-adsorbed laminin within the supernatants of the laminin added to the PES disks 
after the 12 hours.  The results of n=5 disks of each of TCPS surfaces, unmodified PES, and laser 
modified PES disks using F = 1,200 mJ/cm2 are shown in Figure 66.  The means of the total 
adsorbed laminin quantities for the TCPS, unmodified, and laser modified disks were 0.433µg ± 
0.148, 0.044 µg ± 0.035, and 0.522 µg ± 0.189, respectively.  The laminin adsorbed to the TCPS 
surfaces and the laser modified PES surfaces with F = 1,200 mJ/cm2 were significantly higher 
compared to the unmodified PES surfaces (p-value < 0.01). 
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Figure 66. Quantification of laminin after adsorption of 10 μg/ml for 12 hours to TCPS and PES flat sheet 
membranes unmodified and laser modified with F = 1,200 mJ/cm2 (bars = mean ± SD, n = 5, and * = p-value < 
0.01). 
4.3.5 PC12 cell adhesion to PES flat sheet membrane surfaces varying laser fluence 
Rat PC12 neuron-like cells were seeded onto the different PES flat sheet membrane surfaces 
modified with the same laser fluences as tested for contact angle measurements to see 
correlations between wettability of the surface and cell adhesion.  The results quantifying the 
percentage of PC12 cells that adhered to the different surfaces normalized to the control tissue 
culture treated polystyrene (TCPS) surfaces are shown in Figure 67.  Groups included the 
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completely unmodified PES surface, unmodified PES surface coated with 10 µg/ml laminin, and 
laser modified PES disks coated with 10 µg/ml laminin.  First, PC12 cell attachment on the 
unmodified PES surfaces was increased significantly by coating with laminin compared to the 
completely unmodified surface (p-value < 0.001) demonstrating the reason for coating the total 
fiber surface with laminin for further cell culture use.  Within the laminin coated surfaces, the 
results showed a significant increase in PC12 cell attachment to PES membranes with a laser 
modification at a fluence of 1,200 mJ/cm2 compared to the unmodified coated membranes (p-
value < 0.05).  Overall, the results in Figure 67 show the trend of increasingly enhanced PC12 
cell adhesion by modifying the PES surface with increasing laser fluences up to 1,200 mJ/cm2, 





Figure 67. PC12 cell adhesion on PES flat sheet membrane surfaces modified with varying laser fluences 
followed by EtO sterilization and coating with 10 µg/ml laminin with the exception of the first group being the 
completely unmodified membrane surface (data normalized to tissue culture treated polystyrene (TCPS) control 
surfaces, bars = mean ± SD, n = 5, and * = p-value < 0.05). 
4.3.6 Primary rat NPC differentiation on laser modified PES hollow fibers 
With the aim of proving the laser modified PES fibers to be biocompatible we cultured and 
differentiated adult rat NPCs on their outer surfaces.  Fluorescent immunocytochemistry staining 
and SEM images representing the growth of the differentiated neurons on these fiber surfaces 
including the laser channels are shown in Figure 68.  Figure 68a shows β-III-tubulin/Alexa 594 
in processes of NPCs differentiated along the neuronal lineage (all cell nuclei counterstained 
with Hoechst dye).  The staining shows substantial process growth across the PES fiber surfaces.  
Figure 68b illustrates the growth of the differentiated neural progenitor cells on the outer fiber 
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surface including a single row of evenly spaced 5 µm laser created channels.  Some channels are 
not seen due to covering cell body clusters.  Figure 68c depicts the growth of two cell body 
clusters around two laser created channels and their process connections between each other and 
to the channels.  Figure 68d shows a higher magnification of one neuronal process leading from 
a multiple cell body cluster growing down into the laser created channel towards the inner lumen 
of the PES fiber.  These laser-created channels within the PES fiber walls appear compatible for 
adult rat NPC growth and prove conducive to cell process outgrowth across them. 
 
Figure 68. Images of primary adult rat neural stem cells differentiated on laser modified PES fiber 
including channels (arrowheads point to laser channels and white arrows point to process growth into laser created 
channels). (a) β-III-tubulin/Alexa Flour 594 stained neuronal processes with Hoechst nuclei counterstain, scale bar = 




4.4.1 Channel creation in PES hollow fibers via excimer laser ablation 
A series of investigations varying different parameters within the KrF excimer laser system has 
established an optimal combination of settings in order to generate 5 µm diameter channels 
through the walls of PES hollow fibers.  To facilitate the ablation of sufficient material to create 
a channel passing entirely through the 100 µm wall to the inner lumen of the fiber, a pulse 
number of N = 50 was necessary when using a fluence of F = 1,200 mJ/cm2.  The etch depth per 
pulse with excimer laser ablation of polyethersulfone films has been reported to be from 0.32-
0.50 µm with F = 1,000 mJ/cm2 [318-320], but is it possible that we achieved a much greater 
etch depth per pulse due to the highly porous nature of our PES fibers and membranes.  Small 
changes in the projection lens position (Figure 1g) in the vertical direction allowed control over 
the focus of the beam.  It is possible that creation of channels using a slightly unfocused beam 
having larger diameters at the fiber surface forms larger areas for the neuronal cell processes to 
notice the channels and can better facilitate continued growth into the fiber lumen.   Martele et 
al. reported detrimental structural debris formation on polyurethanes with excimer laser ablation 
[321], but we have not seen any fragment deposition of this kind using polyethersulfone that 
would hinder cell growth.  Therefore, the optimal settings used in our laser system in creating 
channels suitable for our neuronal cell/axonal process compartmentalization were with F = 1,200 
mJ/cm2, N = 50, and the projection lens position set slightly out of focus.  Using a 25 µm pinhole 
mask along with the 5X demagnifying projection lens at the settings mentioned above we are 
reproducibly able to generate smoother sloped edged channels that taper in diameter towards the 
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luminal fiber side down to approximately 5 µm in diameter.  Lower fluences and/or a smaller 
pinhole in the mask projection can allow even smaller diameter channels. 
Polyethersulfone (PES) is a non-degradable, biocompatible polymer typically utilized as 
hollow fiber membranes in medical applications such as ultrafiltration and hemodialysis devices 
due to its biocompatibility, excellent thermal stability, and chemical resistance [322-325].  Yu 
and Bellamkonda have demonstrated significant sciatic nerve regeneration using a nerve guide 
conduit based on semi-permeable polysulfone tubes [326]. Recently, Unger et al. have 
demonstrated good cell attachment and growth of different cell types on PES hollow fiber 
membranes [327].  We use similar commercially available PES hollow fibers with unproblematic 
laser modification as scaffolds for directing neuronal cell and axon growth in vitro.  The cell 
studies reported here have demonstrated compartmentalization of the neuronal cell bodies of the 
differentiated adult rat neuronal cell bodies from the processes via the 5 µm diameter laser 
created channels.  Observation of these cell cultures on the laser modified PES hollow fibers 
revealed spontaneous growth of the processes into the channels proving good biocompatibility of 
the laser modified surface.   
Use of these modified PES ultrafiltration hollow fiber membranes as scaffolds will allow 
incorporation into a 3-D hollow fiber-based bioreactor utilizing the same PES fiber membranes 
as the integral perfusion system for delivering nutrients to the cell compartment along with 
integral oxygenation fibers.  These bioreactors will be constructed based on the technology 
previously developed by our group [116-118, 137, 222].  The purpose of separating the cell 
bodies from the axonal processes lies in the ability of the lumens of the fibers to further direct 
axonal process growth in a 3-D space at high tissue density by using the bioreactor device to 
provide gradients of neurotrophic factors, such as nerve growth factor (NGF), through the 
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lumens of the fibers.  Use of multiple hollow fibers with these laser created channels could allow 
a 3D space for neuronal cultures with specific axonal growth and signaling, enabling a system 
for superior testing of directed neurite outgrowth and behavior in three dimensions.  Many 
researchers investigate neural networks in vitro on two-dimensional surfaces such as 
microelectrode arrays (MEAs).  Maher et al. have created a micromachined silicon chip with 
wells to hold neurons for controlled cell positions contacting electrodes [328].  Recently, Suzuki 
et al. have layered a patterned agarose gel film on an MEA to control cell positions on the chip 
[79].  These systems allow specific neuronal signaling and recordings from low-density cultures.  
Heron et al. have recently developed an in vitro method of co-culturing neurons with astrocytes 
in Matrigel to determine effects of protein gradients on axonal outgrowth within a cellular 
environment.  These authors believe the higher density cell environment to be a crucial part of in 
vitro neuronal culture investigations instead of the more typical neuronal monolayer culture on 
synthetic biomaterials [329].  Our laser modified PES hollow fiber scaffolds incorporated into a 
hollow fiber-based bioreactor as discussed here will allow the high-density 3-D neuronal and 
possibly co-culture growth and organization, which hopefully will lead to either more accurate or 
representative responses from the cells when stimulated. 
The device can more specifically be used to culture neural stem cells at high densities to 
assess the effect of different drug or therapeutic protein stimulation on their abilities to direct 
axonal growth from these cultures.  The device configuration with the laser modified scaffolds 
compartmentalizing the neuronal cell bodies from the axons will recreate an in vitro model of the 
spinal cord and can be used to test different reagents on the ability of the high density nerve 
tissue to grow throughout the fiber scaffolds.  The other intended use of the device would be to 
control networking of high density neuronal cultures in vitro.  The cell bodies of one 
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compartment can be connected to another cell body compartment using the laser modified fiber 
scaffolds where the axons of the cells from one compartment grow throughout the scaffold fiber 
lumens and form synapses with the cell bodies of the other connecting cell body compartment. 
4.4.2 Significance of laser modification to PES hollow fiber/membrane surface 
Surface characterization of the laser modified PES surfaces was performed via contact angle 
measurements, quantification of laminin adsorption, quantification of PC12 cell adhesion, and 
assessment of rat neural progenitor cell interactions.  These experiments, with the exception of 
the NPC cultures, were accomplished using laser modified flat sheet PES membranes with laser 
fluence matched to the peak fluence of the channel experiments.  The results with the PES 
membranes demonstrated increased hydrophobicity, increased laminin adsorption, and enhanced 
PC12 cell adhesion in the high fluence laser modified surfaces compared to the unmodified PES 
surface.  Previous laser modification of polyethersulfone with the intent to control cell 
interactions has included either CO2 laser plasma treatment or UV-assisted graft polymerization 
in order to increase the membrane permeability and hydrophilicity to prevent fouling [330, 331].  
However, our results show that KrF excimer laser modification of PES with the high peak 
surface fluences necessary to create the channels resulted in ablation of the polymer with 
possible re-deposition of broken polymer chain molecules back onto the surface that created a 
hydrophobic surface that is more favorable for cell growth after coating with the laminin protein.  
Others have also reported an increased hydrophobicity of a polymer surface after excimer laser 
ablation [332, 333]. 
It is hypothesized that excimer laser ablation in polyethersulfone is due to the 
photothermal ablation model where random polymer chain scission occurs and fragments are 
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ejected from the surface with some re-deposition back onto the surface and reacting with the 
surface radicals created [334].  Duncan et al. reported XPS results of excimer laser ablation of 
certain polymers to have decreased O/C ratio with high fluences possibly due to the higher 
energies creating an increased volume expansion and fragment velocity preventing oxygen 
radicals from forming [313].  Analysis with TOF mass spectrometry of ejected and re-deposited 
fragments of excimer laser ablation on polysulfone films by Kokai et al. resulted in increased 
deposition of hydrocarbon species with higher laser fluences [334, 335]. 
The increasingly hydrophobic surface observed with the higher fluence of F = 1,200 
mJ/cm2 most likely permits the observed increase in laminin adsorption onto the areas 
surrounding and inside the laser created channels within the PES fibers leading to increased cell 
attachment.  Hernández et al. have recently analyzed laminin molecule adsorption and 
conformation onto surfaces with varying -OH group densities using the phase signal of AFM 
[336].  This work demonstrated the most laminin molecules adsorbed to the more hydrophobic 
surfaces with the fewest -OH groups.  The excimer laser modification works similarly with 
decreasing the O/C ratio as reported by Duncan et al. and allows the increase in laminin 
adsorption.  Laminin is known to enhance neuronal cell adhesion and neurite extension [73, 280, 
337-339].  Dertinger et al. have demonstrated axon orientation from rat hippocampal neurons in 
the direction of increasing surface density of laminin [340].  The spontaneous process outgrowth 
of the differentiated rat NPCs toward the laser channels on the fiber scaffolds demonstrated here 
might be due to the increased density of laminin molecules surrounding these channels due to the 
laser surface modification.  Therefore, the laser modification leading to structured channels able 
to direct axon processes into the scaffold wall also creates an enhanced region around the 
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channels that the neuronal cell processes might attach and be influenced to grow across further 
leading them down into the lumens of the fibers as desired. 
4.5 CONCLUSIONS 
KrF excimer laser ablation was successfully conducted to reproducibly generate tapered 5 µm 
diameter channels within PES hollow fiber walls.  This laser modification resulted in channel 
wall surfaces compatible and even beneficial to neuronal process growth through the walls of the 
PES fibers.  The 5 µm diameter channels are able to allow process growth into the fiber walls 
while preventing entrance of the neuronal cell bodies into the fiber scaffold.  These channels 
within the PES fibers comprise a scaffold allowing compartmentalization of the neuronal cell 
bodies from the axonal processes in order to further control and direct axonal growth for 3D in 
vitro neural tissue engineering. 
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5.0  FUTURE EXPERIMENTS 
5.1 MOUSE NEURAL STEM CELL 4 CHAMBER BIOREACTORS 
The experiments performed in Chapter 3 lead to a basic understanding of behavior of mouse 
neural stem cell differentiation within different 3D ECM matrices and the effects of dynamic 
culture conditions.  These experiments have also brought about a multitude of further questions 
regarding the behavior of these cells within a 3D matrix.  The work presented here focused on 
the differentiation of the mouse neural stem cells.  However, it would also be of interest to 
investigate expansion of the stem cell population within a controlled scaleable system like the 
hollow fiber-based bioreactors on their ability to expand large quantities of the stem cells.  This 
feature would be necessary in providing these cells as a commercially available product used in 
clinical cell therapies were very large quantities of the stem cells are desired. 
The most significant future experiments would include further investigation of the results 
obtained within the 4 chamber bioreactor of experiment MNS-3 containing superior structure 
formation with increased neuronal differentiation within the HyStem hydrogel chamber adjacent 
to the Matrigel containing chamber.  First, control 3D hydrogels of Matrigel excluding cells 
could be maintained under static conditions within a 12 well tissue culture plate with Neurocult 
Differentiation medium.  This system could be maintained under normal static cell culture 
conditions over time in order for the medium to be conditioned with the factors released from the 
 205 
Matrigel hydrogel.  The medium could be collected at different time points throughout this 
culture with further hydrolytic degradation of the Matrigel with longer time points.  The 
collected medium could be tested on the differentiation of the mouse neurospheres plated on 2D 
laminin coated dishes.  This experiment could prove the hypothesis that it was soluble 
components released from the Matrigel hydrogels that lead to the increased neuronal 
differentiation within the HyStem chamber of bioreactor experiment MNS-3.  Further 
experiments could be employed to individually test the known components of Matrigel 
separately on the differentiation of the mouse neurospheres.  Addition of these factors, such as 
soluble laminin, TGF-β, NGF, PDGF, IGF-1, could be separately added to the differentiation and 
tested on control cultures to see which factors affect the differentiation.  Also, plates coated with 
adsorbed collagen IV and entactin could also be tested on the neurosphere differentiation 
because these are also components of Matrigel. 
We have been able to demonstrate with the presented results that optimal neuronal cell 
differentiation and survival from the mouse neural stem cells is dependent upon more than just 
the ECM scaffold the cells are encapsulated within.  It is equally important to improve the 
differentiation medium formulation for achieving neuronal differentiation from the neurospheres 
within 3D dynamic culture conditions.  The experiments described above provide an initial 
framework for improving the medium formulation testing Matrigel components, however, other 
growth factors useful in natural nervous system development in vivo could be tested such as 
BDNF and GDNF. 
Also, the neurospheres within the chamber of bioreactor MNS-5 containing HyStem with 
100 µg/mL laminin appeared to have initial migration and spreading of cells within the first few 
days, but then deteriorated after culture day 5.  It is possible that this deterioration was due to 
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loss of the laminin within the HyStem hydrogel since the laminin was only encapsulated within 
the hydrogel and not covalently linked.  Dynamic perfusion of this hydrogel within the 
bioreactor most likely lead to the release of laminin into the circulating medium where it is 
diluted within the large 75 mL volume.  Experiments testing methods for long-term 
incorporation of laminin within the system could prove very useful in achieving superior 
neuronal differentiation and survival from neural stem cells.  Also, custom hydrogels could be 
developed for achieving such a scaffold and could be investigated within the hollow fiber-based 
bioreactor.  Stabenfelt et al. have fabricated such a hydrogel made of methylcellulose 
functionalized with covalently linked laminin molecules [341].  Tysseling-Mattiace et al. have 
developed a scaffold of self-assemblying nanofibers displaying a surface of IKVAV sequences 
derived from laminin. 
Further definition of an injectable scaffold used to enhance neuronal differentiation of 
neural stem cells is particularly useful in clinical applications using these cells, but could also be 
used to accomplish further use of the hollow fiber-based bioreactor devices as tools for testing 
further control and manipulation of neural stem cells.  The enhanced culture of these cells within 
the devices could allow experiments testing the control over the migration of these cells 
throughout the 3D space of the bioreactor.  Results of these experiments could prove useful in 
developing strategies for enhancing the roles of endogenous neural stem cells in regenerating 
nervous system tissue destroyed by disease or trauma.  Also, the bioreactor could be useful in 
criculating defined culture medium including factors such as tumor necrosis factor-alpha (TNF-
α) which is present in the inflammatory conditions found after nervous system trauma in order to 
synthetically mimick the inflammatory environment while still attempting to control neural stem 
cell behavior under these conditions.  Other factors possibly tested such as this could be the 
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inhibitor molecules found within the adult CNS after spinal cord injuries preventing nerve 
regeneration in order to develop strategies allowing the neural stem cells to overcome these 
molecules and continue nerve regeneration. 
5.2 PRIMARY RAT CORTICAL NEURON BIOREACTORS 
Use of the PC12 cell line was able to demonstrate that neurite outgrowth within 3D could be 
enhanced by culture within the dynamic perfusion of the hollow fiber-based bioreactors.  
However, this cell line could not be used to analyze synapsin I as a marker only for synaptic 
transmission able to definitively prove that the bioreactor enhances the ability of neuronal cells 
to form superior synapse formation.  The contact inhibition of the cells used did not allow tissue 
formation and therefore possibly prevented superior neuronal networking capable within the 
bioreactor devices.  Further experiments would move from cell lines to primary neurons.  
Neuroscience research often utilizes cultures of embryonic day E17-E18 rat cortical neurons 
dissociated from cortical rat brain tissue. 
Experiments within this work initially used the PC12 cell line because it is an accepted 
cell line for modeling neuronal behavior especially directed neurite outgrowth.  The benefit of 
using a cell line is that the cells can easily be expanded to obtain the large number of cells 
required for bioreactor culture.  Past experiments using the 8 mL hollow fiber-based bioreactor 
typically has required a minimum of 1x108 cells for initial inoculation in order to have a 
successful outcome for any tissue formation.  The PC12 cell line was easily expanded to achieve 
these quantities.  We continued with experiments using mouse neural stem cells because data on 
culture of these cells in a 3D dynamic environment is valuable in developing clinical strategies 
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using these cells, but also because stem cells have the capability to be expanded.  The 8 mL 
hollow fiber-based bioreactor experiments for culture of mouse neural stem cells took 
approximately 8 weeks for expansion of the mNSCs from passage 1 to passage 8 in order to 
obtain >1x108 cells needed for the bioreactor experiment plus control cultures.  These 
experiments allowed us to demonstrate culture of primary neuronal cells within the bioreactors.  
 Adult mature neurons derived from the rat brain cortex are often used in cell culture 
experiments in the field of neuroscience, but mature neurons are post-mitotic and cannot be 
expanded.  There are approximately 1x108 neurons within a single rat brain [342].  However, 
isolation of these cells from rat brains results in substantially fewer numbers useful for cell 
culture.  BrainBits LLC is a company specializing in the commercial dissection and isolation of 
animal nervous system tissue obtaining neuronal cell populations available for sale making it 
easier to obtain primary neuronal cell cultures without isolating the cells.  BrainBits offers 
approximately 2x106 E18 rat cortical neurons for approximately $120, which is cost effective 
and prevents the need for maintenance of animals and dissections.  However, in order to perform 
a bioreactor experiment within the 8 mL bioreactor, either too many rats would need to be 
sacrificed on the same day of bioreactor inoculation or buying the cells from BrainBits would 
cost at least $6,000 to obtain 1x108 neurons.  This has made it undesirable for use to attempt 
these experiments.  It has only been recently that our group has been able to produce and 
successfully perform experiments using newer bioreactor designs, such as the 4 chambered 
analytical scale bioreactor, that have cell compartments with smaller volumes than the 8 mL 
bioreactor requiring fewer cells.  Therefore, the successful experiments in Chapter 3 using the 4 
chamber bioreactor with cell compartment volumes <1 mL has proved the feasibility of 
continued experiments using this device with primary rat cortical brain neuron cultures.  These 
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experiments could potentially be used to generate high density 3D neuronal tissue within the 
bioreactor that achieves superior synaptogenesis and neuronal network formation. 
5.3 DESIGN AND DEVELOPMENT OF NEURONAL CELL SPECIFIC 
BIOREACTOR INCLUDING FIBER SCAFFOLDS FOR DIRECTED AXONAL 
OUTGROWTH 
The purpose of this thesis has been to initiate development of a hollow fiber-based bioreactor 
specific for allowing high density neuronal cell cultures in 3D with control over directed axonal 
outgrowth.  We have achieved demonstrating the ability of the currently used bioreactors within 
the lab to support neuronal cell cultures.  We have also fabricated a scaffold allowing directed 
axonal growth in 3D useful in these hollow fiber-based bioreactors.  The continuation of this 
work would entail the combination of this modified scaffold into a novel hollow fiber-based 
bioreactor design allowing compartmentalized neuronal cell body cultures connected with the 
modified scaffolds fibers directing axonal growth to and from compartments.  A possible design 
scheme was described previously within section 4.1.  We have already begun fabrication of a 
prototype of employing the design described in Figure 62.  A photograph of this prototype is 
shown in Figure 69. 
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Figure 69. Photograph of first prototype for novel 2 chamber neuronal cell bioreactor incorporating 
scaffold laser modified PES hollow fibers. This is the bioreactor in development with placement of the gas and 
medium perfusion fiber bundles.  There is a top and bottom chamber like the desired design with their own 
independent perfusion fibers.  They do however share the same gas perfusion bundle, shown in the middle extending 
to both chambers.  Colored arrows depict flow patterns possible with these separate fiber bundles extending from the 
bioreactor that will further be capped for separate ports, to have separate tubing circuits connected to each chamber.  
Also, the medium perfusion flow paths allow counter-current flow within each chamber.  The separate perfusion 
circuits allow perfusion of a chemotropic factor of interest to be tested within the device possibly creating a gradient 
from the bottom chamber through the scaffold fibers to the top chamber for directed axonal outgrowth through the 
device. 
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Further completion of this prototype with incorporation of modified scaffold fibers 
connecting the two cell compartment chambers, will allow testing of this device with its ability 
to create gradients within the scaffold fibers.  Perfusion of fiber bundles through the cell 
compartments can be separated into two independent tubing circuits.  The newer perfusion 
systems have the capability to pump two tubing circuits, so this is already possible.  The medium 
perfused through the bottom chamber could include a dye used to color the medium through this 
chamber.  Experiments testing this perfusion could determine the transport of this color medium 
flow from one chamber to the other and how the colored medium becomes diluted in order to 
investigate gradient formation of the colored medium from one compartment to the other.  This 
would be the first step in testing this device to be used as a neuronal cell specific bioreactor able 
to provide chemotropic factor gradients within a 3D space to high density neuronal cell cultures 
for testing factors enhancing nerve regeneration. 
After the optimization of the design of this novel device, multiple experiments could 
finally be performed in using the device as the intended tool.  Primary neuronal cultures could be 
used within this smaller scale bioreactor for screening drugs or proteins useful for enhancing 
nerve regeneration.  Also, further experiments could be performed varying other bioreactor 
parameters such as flow rates and oxygen levels on their effects of neuronal cell cultures and 
axonal outgrowth.  It is likely that optimal clinical strategies for achieving functional recovery 
with nerve regeneration require combination therapies.  This novel bioreactor device could easily 
provide the model for testing these therapies in combination.  It is possible that chemotropic 
factors enhancing nerve regeneration are particularly useful only at specific concentrations and 
combinations.  This device would allow testing of the multiple protocols necessary in 
investigating the proper protocol of combination of these factors. 
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APPENDIX A 
ORIGINAL PC12 CELL LINE BIOREACTOR EXPERIMENTS 
PC12 Bioreactor Cultures. Two separate hollow fiber-based bioreactors were inoculated with 
PC12 cells in a collagen type I gel solution (BD Bioscience). One bioreactor was inoculated with 
a 3ml cell pellet suspended in a 1 mg/ml collagen solution. The other was inoculated with a 
1.5ml cell pellet in a 1.5 mg/ml collagen solution. Both cultures were kept for 6 days with 
perfusion of 75 ng/ml NGF supplemented media. Collagen gels with same initial cell densities 
were kept in parallel for each experiment in Petri dishes for same time period with NGF media 
exchange every other day. Tissue/fiber samples were removed from the bioreactor for 
histological and confocal fluorescence microscopy analysis. 
Results and Discussion.  Glucose consumption and lactate production increased at least two fold 
by end of bioreactor cultures. Bioreactor opening revealed macroscopic tissue formation in both 
experiments. Histological analysis qualitatively showed a higher density of cells than control 
Petri dish gels. Masson’s trichrome staining (Figure 1a) showed presence of injected collagen 
between fibers for use as cell matrix. Stacked confocal fluorescence images of Alexa488-
Phalloidin/DAPI stained bioreactor tissue samples showed high density 3D cell aggregates with 
some 3D neurite outgrowth between aggregates (single image shown inFigure 70).  PC12 cell 
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cultures in our bioreactor system showed high density tissue formation, but neurite outgrowth in 
3D from individual cells was prevented due to this tissue formation. 
 
Figure 70. a) Masson’s Trichrome stained section of higher density PC12 cell bioreactor (20X), b) confocal fluorescence of 





COMPATIBILITY OF INJECTABLE HYDROGELS IN HOLLOW FIBER-BASED 
BIOREACTORS 
Use of bioreactor test chamber to analyze compatibility of collagen gel with perfusion system.  A 
test chamber device was used to test the compatibility of the collagen gel matrix surrounding the 
PES microporous hollow fibers within the cell compartment space. This chamber is seen in 
Figure 71.  Pre- and post-bioreactor perfusion pressures were monitored via pressure transducers 
in order to assess any problems with fluid flow through the perfusion circuit due to collagen gel 
incorporation.  It will be necessary for pressures across perfusion fibers through cell chamber to 
remain stable to ensure constant flow through cell compartment.  To assess this, sterile H2O was 
pumped through the feed and recirculation tubing of the circuit volume to first fill the test 
chamber at flow rates giving similar pre- and post-bioreactor pressure measurements as that of 
the 8 ml bioreactors.  A heating element maintained test chamber at 37ºC to ensure proper 
gelation of collagen after injection.  Then flow was completely turned off to prevent the 
possibility of perfused H2O diluting or disrupting collagen gel formation.  A collagen solution at 
room temperature brought to pH 7.0-7.4 at a final concentration of 1 mg/mL was injected by two 
syringes each through the two cell compartment ports.  The viscous collagen solution filled the 
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chamber by forcing the H2O out through the PES fiber pores into the recirculation tubing.  Once 
in the test chamber the collagen gelled completely after 30 minutes and H2O flow was resumed.  
Pressure transducers connected to circuit were then used to measure any pressure changes across 
the test chamber due to collagen incorporation by comparison to previously measured values.  
The pressure levels remained stable compared to before and after collagen injection into the cell 
compartment with flow through the fibers.  This proved the compatibility of use of the collagen 
gel matrix within the bioreactor perfusion devices.  Also, perfusion fibers were then fixed in 10% 
buffered formalin at end of experiment and stained with aniline blue in order to observe any 
collagen deposition within fiber lumens to check for fiber membrane fouling.  The images of this 
staining of perfusion fibers is shown in Figure 72.  Collagen was only detected within the gel 
surrounding the extra-capillary space around the fibers, whereas no collagen was detected within 
the lumens of the perfusion fibers again proving compatibility of the use of collagen gel within 
the cell compartments of the bioreactors as an ECM scaffold enhancing cell behavior within the 
compartment. 
 
Figure 71. Bioreactor test chamber used for testing compatibility of collagen gel with perfusion fibers after 
inoculation into cell compartment within extra-capillary space. 
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Figure 72. Photographs of PES perfusion fibers taken from test chamber with compatibility testing of 
collagen gel formation around fibers within cell compartment.  Fibers were stained with aniline blue to detect 
collagen. Cut fiber revealed aniline blue collagen staining only on outer surface of fibers, with no staining within 
lumen of fibers demonstrating collagen gel does not clog fiber lumens interfering with perfusion. 
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APPENDIX C 
STATIC SINGLE FIBER CULTURE MODEL  
We have also constructed a small scale in vitro compartmentalized culture model with a 
single laser-modified PES hollow fiber in order to apply chemotropic gradients for attracting 
neuronal axons into the fiber scaffold under static conditions.  The model design was based on a 
modified 35 mm diameter polystyrene Petri dish.  The dish includes a middle divider to form two 
compartments.  A single PES microporous hollow fiber was sealed with compatible polyurethane 
along the diameter of the bottom of the Petri dish.  A plastic divider piece fitting the dimensions 
of the Petri dish with a slit to fit over the fiber was sealed perpendicularly across the top of the 
fiber in order to divide the dish into two separate compartments.  Movement of fluid and factors 
can only move from one compartment to the other via diffusion into fiber, through length of the 
fiber lumen, and out of the fiber.  The fiber in one compartment, termed the “cell compartment”, 
can be modified to include the laser generated channels (left side Figure 73).  The other 
compartment, termed the “factor compartment” can be used to apply chemotropic factor 
gradients by diffusion through the fiber to the cell compartment (right side Figure 73). 
This model can be used for testing compatibility of a single PES hollow fiber including 
laser channels with different neuronal cell types.  The compartmentalized configuration allows 
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application of chemotropic factor gradients by diffusion from one compartment to the other.  The 
purpose of these factor gradients is to attract the neuronal cell axons to grow into the laser 
channels and further down the lumen of the fiber scaffold.  To prepare for gradient applications 
to cell cultures within the models, a modified Petri dish top including two ports and reinforced 
with silicone is pressed firmly onto the top of the model in order to seal the two model 
compartments.  Then a 10 ml syringe was connected to one port to flush sterile PBS from one 
compartment to the other in order to wet the fiber lumen.  The PBS is then removed and cell 
media is replaced into both compartments and incubated overnight to allow media incorporation 
into the fiber lumen before cell seeding.  All single fiber culture experiments can be prepared by 
these methods. 
Bioactivity of NGF after gradient application to single fiber culture models was assessed 
by collection of cell compartment media from models at different time points and placement onto 
separately cultured PC12 cells on laminin coated 12 well plates (three models used for each time 
point).  Models used had either laser modification to include a single row of laser created 
channels (Figure 74: 5µm) or were normal fibers without channels (Figure 74: none).  Time 
points of media collection after NGF application to factor compartment were 6, 24, and 48 hours.  
PC12 cell % differentiation and number of neurites per cell was quantified from ten cells of each 
five high powered images taken after 24 hour treatment from each collected mediums.  Control 
known amounts of NGF were also applied to other PC12 cell wells and neurite outgrowth was 
quantified.  Figure 74 shows the results of these two measurements.  All time point measured 
levels of PC12 neurite outgrowth after model media treatments show levels significant from 0 
ng/ml of known NGF stimulation and are in the range of at least the active 25 ng/ml NGF 
stimulation (Figure 74).  NGF after diffusion in the single fiber culture models through the 
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modified PES fibers is confirmed to be bioactive and able to stimulate neuronal cells growing on 
the fiber scaffolds in the cell side compartment. 
This single fiber culture model allows testing of chemotropic factor gradients under static 
conditions, however we believe the culture was not reproducible in creating effective gradients 
for testing.  The gradients within the design system here are created by diffusion only due to 
concentration gradients.  However, any movement of the Petri dish creates a convective flow 
within the system disturbing the diffusion.  Also, the gradient would change significantly with 
the need for medium replacement in order to feed the cultured cells.  This does not allow a 
steady gradient through the fiber of the chemotropic factor being investigated.  Therefore, we 
believe continuation of testing gradients of factors for enhancing nerve regeneration through our 
laser modified hollow fiber scaffolds would be more accurately tested within a dynamic system 
where the gradients are controlled by the bioreactor perfusion systems. We therefore did not 
continue further experiments using static single fiber culture model. 
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Figure 73. Single fiber culture model showing compartmentalized 35 mm Petri dish connected by laser 




Figure 74.  Bioactivity of NGF after diffusion through single fiber culture models compared to positive 
control fresh NGF; samples collected from opposite compartment after time listed for diffusion through fiber within 
model and then placed on test PC12 cultures (neurites counted after 24 hrs medium stimulation). 
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